epocrates logo
epocrates logo
epocrates logo
  • 0

Drugs


Formulary
No Formulary Selected

Classes

  • All Drugs
  • Allergy/Cold/ENT
  • Anesthesia/Pain Management
  • Asthma/Pulmonary
  • Cardiovascular
  • Dental/Oral Care
  • Dermatologic
  • Diagnostic
  • Emergency
  • Endocrine/Metabolism
  • Gastrointestinal
  • Hematology/Oncology
  • Immunizations
  • Immunology
  • Infectious Disease
  • Nephrology/Urology
  • Neurologic
  • Nutrition/Electrolytes
  • Obstetrics/Gynecology
  • Ophthalmic
  • Psychiatric
  • Rheumatologic

Drug Names

# A B C D E F G H  I  J K L M N O P Q R S T U V W X Y Z
A+D Anti-Chafing Ointment
A+D Diaper Rash Cream
A+D First Aid Ointment
A+D Incontinence Support Skin Protectant & Rash Ointment
A+D Medicated Rash Ointment
A+D Original Ointment
A+D Overnight Healing Rash Ointment
abacavir
abacavir/dolutegravir/lamivudine
abacavir/lamivudine
abacavir/lamivudine/zidovudine
abaloparatide
abametapir topical
abatacept
Abecma
Abelcet
abemaciclib
Abigale
Abigale Lo
Abilify
Abilify Asimtufii
Abilify Discmelt
Abilify Maintena
Abilify MyCite
abiraterone acetate
abiraterone acetate micronized
Ablysinol
abobotulinumtoxinA
Abraxane
Abreva
Abreva Rapid Pain Relief
Abrilada (adalimumab-afzb)
abrocitinib
Abrysvo
Absorica
Absorica LD
Abstral
acalabrutinib
ACAM2000
acamprosate
Acanya
acarbose
Accolate
Accrufer
AccuNeb
Accupril
Accuretic
Accutane
acebutolol
aceclidine ophthalmic
Aceon
Acetadote
acetaminophen
acetaminophen rectal
acetaminophen/aspirin
acetaminophen/aspirin/caffeine
acetaminophen/aspirin/diphenhydramine
acetaminophen/caffeine
acetaminophen/caffeine/dihydrocodeine
acetaminophen/caffeine/pyrilamine
acetaminophen/chlorpheniramine
acetaminophen/chlorpheniramine/dextromethorphan
acetaminophen/chlorpheniramine/dextromethorphan/phenylephrine
acetaminophen/chlorpheniramine/dextromethorphan/pseudoephedrine
acetaminophen/chlorpheniramine/phenylephrine
acetaminophen/codeine
acetaminophen/dextromethorphan
acetaminophen/dextromethorphan/guaifenesin
acetaminophen/dextromethorphan/phenylephrine
acetaminophen/dextromethorphan/phenylephrine/guaifenesin
acetaminophen/dextromethorphan/pseudoephedrine
acetaminophen/diphenhydramine
acetaminophen/diphenhydramine/phenylephrine
acetaminophen/doxylamine/dextromethorphan
acetaminophen/doxylamine/dextromethorphan/phenylephrine
acetaminophen/guaifenesin
acetaminophen/ibuprofen
acetaminophen/pamabrom
acetaminophen/pamabrom/pyrilamine
acetaminophen/phenylephrine
acetaminophen/phenylephrine/guaifenesin
acetaminophen/pseudoephedrine
acetaminophen/triprolidine/dextromethorphan
acetaminophen/triprolidine/dextromethorphan/phenylephrine
acetazolamide
acetic acid otic
acetohydroxamic acid
acetylcholine intraocular
acetylcysteine
Aciphex
Aciphex Sprinkle
acitretin
aclidinium bromide inhaled
aclidinium bromide/formoterol inhaled
Aclovate
acoltremon ophthalmic
acoramidis
acrivastine/pseudoephedrine
Actemra
Acthar Gel
ActHIB
Acticlate
Actidose with Sorbitol
Actidose-Aqua
Actigall
Actimmune
Actiq
Activase
Activella
Actonel
Actonel with Calcium
ACTOplus met
ACTOplus met XR
Actos
Acular
Acular LS
Acuvail
Acuvue Theravision with Ketotifen
acyclovir
acyclovir oropharyngeal
acyclovir topical
acyclovir/hydrocortisone topical
Aczone
Adacel
adagrasib
Adakveo (crizanlizumab-tmca)
Adalat CC
adalimumab
ADAMTS13, recombinant
adapalene topical
adapalene/benzoyl peroxide topical
Adasuve
Adbry (tralokinumab-ldrm)
Adcetris
Adcirca
Adderall
Adderall XR
Addyi
adefovir dipivoxil
Adempas
Adenocard
Adenoscan
adenosine
adenovirus type 4 and type 7 vaccine, live oral
Adhansia XR
Adipex-P
Adlarity
Adlyxin
Admelog
ado-trastuzumab emtansine
Adoxa
Adquey
Adrenaclick
Adrenalin
Adriamycin
Adrucil
Adstiladrin (nadofaragene firadenovec-vncg)
aducanumab
Aduhelm (aducanumab-avwa)
Advair Diskus
Advair HFA
Advate
Advil
Advil Allergy & Congestion Relief
Advil Allergy Sinus
Advil Cold & Sinus
Advil Dual Action with Acetaminophen
Advil Dual Action with Acetaminophen Back Pain
Advil Migraine
Advil Multi-Symptom Cold & Flu
Advil PM
Advil Sinus Congestion & Pain
Advil Targeted Relief Cream
Adynovate
Adzenys ER
Adzenys XR-ODT
Adzynma (ADAMTS13, recombinant-krhn)
Aemcolo
afamelanotide
afamitresgene autoleucel
afatinib
Afeditab CR
aficamten
Afinitor
Afinitor Disperz
aflibercept intravitreal
Afluria
Afrezza
Afrin Allergy Sinus
Afrin No Drip Allergy Sinus
Afrin No Drip Allergy Sinus Night
Afrin No Drip Extra Moisturizing
Afrin No Drip Night
Afrin No Drip Original
Afrin No Drip Severe Congestion
Afrin Original
Afrin Severe Congestion
Afstyla
agalsidase beta
Agamree
Aggrastat
Aggrenox
Agrylin
Ahzantive (aflibercept-mrbb)
Aimovig (erenumab-aooe)
air polymer-type A
AirDuo Digihaler
AirDuo RespiClick
Airsupra
Ajovy (fremanezumab-vfrm)
AK-Dilate
AK-Poly-Bac
Akeega
Aklief
Akne-mycin
Akovaz
Akten
Aktipak
Akynzeo
Akynzeo IV
Ala-hist IR
Alahist CF
Alahist D
Alahist DM
Alahist PE
Alamast
Alavert
Alavert D-12 Hour
Alaway
albendazole
Albenza
albiglutide
Albuked
albumin (human)
Albuminar
Albuminex (albumin (human)-kjda)
AlbuRx
Albutein
albuterol
albuterol inhaled
albuterol/budesonide inhaled
alcaftadine ophthalmic
Alcaine
alclometasone topical
Aldactazide
Aldactone
Aldara
aldesleukin
Aldomet
Aldurazyme
Alecensa
alectinib
alemtuzumab
alendronate
alendronate/cholecalciferol
Alesse
Aleve
Aleve Arthritis Pain Gel
Aleve Back & Muscle Pain
Aleve Headache Pain
Aleve PM
Aleve-D Sinus & Cold
AleveX Lotion
AleveX Spray
Alfenta
alfentanil
alfuzosin
alglucosidase alfa
Alhemo (concizumab-mtci)
Alimta
Alinia
Aliqopa
alirocumab
aliskiren
aliskiren/hydrochlorothiazide
alitretinoin topical
Alka-Seltzer Cool Action Heartburn Relief Gum
Alka-Seltzer Extra Strength Heartburn ReliefChews
Alka-Seltzer Extra Strength Upset Stomach Relief
Alka-Seltzer Hangover Relief
Alka-Seltzer Heartburn + Gas ReliefChews
Alka-Seltzer Original
Alka-Seltzer Plus Cold & Flu FizzyChews
Alka-Seltzer Plus Cough & Sore Throat FizzyChews
Alka-Seltzer Plus Maximum Strength Cold & Cough
Alka-Seltzer Plus Maximum Strength Cold & Cough PowerMax
Alka-Seltzer Plus Maximum Strength Cold & Flu Day
Alka-Seltzer Plus Maximum Strength Cold & Flu Day PowerMax
Alka-Seltzer Plus Maximum Strength Cold & Flu Night
Alka-Seltzer Plus Maximum Strength Cold & Flu Night PowerMax
Alka-Seltzer Plus Maximum Strength Cough & Chest Congestion Power...
Alka-Seltzer Plus Maximum Strength Cough, Mucus & Congestion Powe...
Alka-Seltzer Plus Maximum Strength Cough, Mucus & Congestion Powe...
Alka-Seltzer Plus Maximum Strength Sinus Congestion & Pain PowerF...
Alka-Seltzer Plus Maximum Strength Sinus Congestion & Pain PowerM...
Alka-Seltzer Plus Maximum Strength Sinus, Allergy & Cough PowerMa...
Alka-Seltzer Plus Severe Cold & Cough PowerFast Fizz
Alka-Seltzer Plus Severe Cold & Flu Day
Alka-Seltzer Plus Severe Cold & Flu Night
Alka-Seltzer Plus Severe Cold & Flu PowerFast Fizz
Alka-Seltzer Plus Severe Cold PowerFast Fizz
Alka-Seltzer Plus Severe Cold PowerFast Fizz Night
Alka-Seltzer Plus Severe Cold PowerFast Fizz Non-Drowsy
Alka-Seltzer Plus Severe Sinus, Cold & Cough
Alka-Seltzer Upset Stomach Relief
Alkeran
Alkindi Sprinkle
Allegra Allergy 12 Hour
Allegra Allergy 24 Hour
Allegra Hives 24 Hour
Allegra-D 12 Hour Allergy & Congestion
Allegra-D 24 Hour Allergy & Congestion
Aller-chlor
Alli
allogeneic cell therapy
allopurinol
Allzital
almotriptan
Alocril
alogliptin
alogliptin/metformin
alogliptin/pioglitazone
Alomide
Aloprim
Alora
alosetron
Aloxi
alpelisib
alpha-tocopherol (vitamin E)
alpha1-proteinase inhibitor
Alphagan P
Alphanate
alprazolam
Alprolix
alprostadil
alprostadil intracavernous
alprostadil intraurethral
Alrex
Alsuma
Altabax
Altace
Altafluor Benox
Altavera
alteplase
alteplase intracatheter
Altoprev
Altreno
Altuviiio (antihemophilic factor (recombinant), Fc-VWF-XTEN fusio...
aluminum acetate topical (modified Burow's solution)
aluminum chloride topical
aluminum hydroxide
aluminum hydroxide/magnesium carbonate
aluminum hydroxide/magnesium hydroxide
aluminum hydroxide/magnesium hydroxide/simethicone
Alunbrig
Alvaiz
Alvesco
alvimopan
Alyacen 1/35
Alyacen 7/7/7
Alyftrek
Alyglo (immune globulin human-stwk)
Alymsys (bevacizumab-maly)
Alyq
Amabelz
amantadine
Amaryl
Ambien
Ambien CR
AmBisome
ambrisentan
amcinonide topical
Ameluz
Amerge
Amethia
Amethia Lo
Amethyst
Amicar
Amidate
amifampridine
amifostine
amikacin
amikacin liposomal inhaled
Amikin
amiloride
amiloride/hydrochlorothiazide
aminocaproic acid
aminolevulinic acid topical
aminophylline
amiodarone
amisulpride
Amitiza
amitriptyline
amivantamab
amivantamab/hyaluronidase
Amjevita (adalimumab-atto)
amlodipine
amlodipine/atorvastatin
amlodipine/benazepril
amlodipine/celecoxib
amlodipine/olmesartan medoxomil
amlodipine/valsartan
amlodipine/valsartan/hydrochlorothiazide
ammonium lactate topical
Ammonul
Amnesteem
Amondys 45
amoxapine
amoxicillin
amoxicillin/clavulanate
Amoxil
Amphadase
amphetamine
Amphocin
Amphojel
Amphotec
amphotericin B cholesteryl sulfate
amphotericin B deoxycholate
amphotericin B lipid complex
amphotericin B liposomal
ampicillin
ampicillin/sulbactam
Ampyra
Amrix
Amtagvi
Amvuttra
amyl nitrite/sodium nitrite/sodium thiosulfate
Amzeeq
anacaulase topical
Anacin
Anafranil
anagrelide
anakinra
Analpram E
Analpram HC
AnaMantle HC
Anaphylm
Anaprox
Anaprox DS
Anascorp
Anaspaz
anastrozole
Anavip
Anbesol Maximum Strength
Ancef
Ancobon
Andembry (garadacimab-gxii)
Andexxa (coagulation factor Xa (recombinant), inactivated-zhzo)
Androderm
AndroGel
Android
Androxy
Anectine
Angeliq
Angiomax
Angiomax RTU
angiotensin II
anidulafungin
anifrolumab
Anjeso
Anktiva (nogapendekin alfa inbakicept-pmln)
Annovera
Anoro Ellipta
Ansaid
ansuvimab
Antabuse
Antara
Anthim
Anthrasil
anthrax immune globulin (human)
anthrax vaccine
anthrax vaccine, adjuvanted
anti-inhibitor coagulant complex
anti-thymocyte globulin (rabbit)
antihemophilic factor (factor VIII, human)
antihemophilic factor (factor VIII, human)/von Willebrand factor ...
antihemophilic factor (factor VIII, recombinant)
antihemophilic factor (factor VIII, recombinant), Fc fusion prote...
antihemophilic factor (factor VIII, recombinant), glycopegylated
antihemophilic factor (factor VIII, recombinant), pegylated
antihemophilic factor (factor VIII, recombinant), porcine
antihemophilic factor (factor VIII, recombinant), single chain
antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein
antipyrine/benzocaine otic
antithrombin (recombinant)
antithrombin III
Antivert
Antizol
Anucort-HC
Anusol-HC Cream
Anusol-HC Suppository
Anzupgo
Apadaz
apalutamide
ApexiCon
ApexiCon E
Aphexda
Apidra
apitegromab
Apitegromab
apixaban
Aplenzin
Aplisol
Apokyn
apomorphine
Aponvie
apraclonidine ophthalmic
apremilast
aprepitant
Apresoline
Apretude
Apri
Apriso
aprocitentan
Aptensio XR
Aptiom
Aptivus
Aqneursa
Aquaphor
Aquaphor Baby Diaper Rash
Aquaphor Itch Relief
Aquasol A
Aquasol E
Aqvesme
Arakoda
Aralast NP
Aralen
Aranelle
Aranesp
Arava
Arazlo
Arbinoxa
Arbli
Arcalyst
Aredia
Arepanrix
Arexvy
arformoterol inhaled
argatroban
arginine
Aricept
Aricept ODT
Arikayce
Arimidex
arimoclomol
aripiprazole
aripiprazole bimonthly injection
aripiprazole lauroxil
aripiprazole monthly injection
Aristada
Aristada Initio
Arixtra
Armlupeg (pegfilgrastim-unne)
armodafinil
ArmonAir Digihaler
ArmonAir RespiClick
Armour Thyroid
Arnuity Ellipta
Aromasin
Arranon
arsenic trioxide
Artane
artemether/lumefantrine
artesunate
Arthriten
Arthritis Hot
Arthrotec
articaine/epinephrine
Arymo ER
Arynta
Arzerra
Asacol
Asacol HD
Asceniv (immune globulin human-slra)
asciminib
Ascor
ascorbic acid (vitamin C)
asenapine
asenapine transdermal
asfotase alfa
Ashlyna
Asmanex HFA
Asmanex Twisthaler
asparaginase
asparaginase Erwinia chrysanthemi
asparaginase erwinia chrysanthemi (recombinant)
Asparlas (calaspargase pegol-mknl)
Aspercreme
Aspercreme Arthritis Pain
Aspercreme Lidocaine 3 in 1 Foot Pain Relief Cream
Aspercreme Lidocaine Foot Pain Cream for Diabetic Skin
Aspercreme Lidocaine Pain Relief Cream
Aspercreme Lidocaine Pain Relief Liquid Roll-On
Aspercreme Lidocaine Pain Relief Patch
Aspercreme Lidocaine Pain Relief Spray
aspirin
aspirin/caffeine
aspirin/chlorpheniramine/dextromethorphan/phenylephrine
aspirin/chlorpheniramine/phenylephrine
aspirin/dextromethorphan/phenylephrine
aspirin/dipyridamole
aspirin/omeprazole
Aspruzyo Sprinkle
Astagraf XL
Astelin
Astepro Allergy
Asthmanefrin
Atacand
Atacand HCT
atacicept
Atacicept
Atarax
atazanavir
atazanavir/cobicistat
Atelvia
atenolol
atenolol/chlorthalidone
atezolizumab
atezolizumab/hyaluronidase
Atgam
atidarsagene autotemcel
Ativan
Atmeksi
atogepant
atoltivimab/maftivimab/odesivimab
atomoxetine
Atoncy
Atorvaliq
atorvastatin
atovaquone
atovaquone/proguanil
atracurium
Atralin
atrasentan
Atripla
AtroPen
atropine
atropine ophthalmic
atropine/pralidoxime
Atrovent HFA
Atrovent Nasal
ATryn
Attruby
Atzumi
Aubagio
Aubra EQ
Aucatzyl
Audenz
Augmentin
Augmentin ES-600
Augmentin XR
Augtyro
Aukelso (denosumab-kyqq)
Auralgan (original formulation)
auranofin
Aurlumyn
Aurovela 1.5/30
Aurovela 1/20
Aurovela 24 Fe
Aurovela Fe 1.5/30
Aurovela Fe 1/20
Auryxia
Austedo
Austedo XR
autologous mesenchymal stem cell-neurotrophic factor (MSC-NTF) ce...
Auvelity
Auvi-Q
avacincaptad pegol intravitreal
avacopan
Avage
avalglucosidase alfa
Avalide
avanafil
Avandaryl
Avandia
avapritinib
Avapro
avasopasem
Avasopasem
Avastin
avatrombopag
Aveed
Aveeno Anti-Itch Concentrated Lotion
Aveeno Baby Calming Comfort Lotion
Aveeno Baby Daily Moisture Cream
Aveeno Baby Daily Moisture Lotion
Aveeno Baby Eczema Therapy Moisturizing Cream
Aveeno Baby Eczema Therapy Nighttime Balm
Aveeno Baby Eczema Therapy Soothing Bath Treatment
Aveeno Calm + Restore Skin Therapy Balm
Aveeno Daily Moisturizing Lotion
Aveeno Eczema Therapy Moisturizing Cream
Aveeno Eczema Therapy Nighttime Itch Relief Balm
Aveeno Eczema Therapy Rescue Relief Treatment Gel Cream
Aveeno Hydrocortisone Anti-Itch Cream
Aveeno Positively Radiant Clear Complexion
Aveeno Skin Relief Hand Cream
Aveeno Skin Relief Moisturizing Lotion
Aveeno Skin Relief Overnight Cream
Aveeno Soothing Bath Treatment
Avelox
avelumab
Averi
Avgemsi
Aviane
Avidoxy
Avinza
Avita
Avlayah (tividenofusp alfa-eknm)
Avmapki Fakzynja Co-Pack
Avodart
Avonex
Avopef
Avsola (infliximab-axxq)
Avtozma (tocilizumab-anoh)
avutometinib and defactinib
Avycaz
Avzivi (bevacizumab-tnjn)
Awiqli (insulin icodec-abae)
axatilimab
Axert
axicabtagene ciloleucel
Axid
Axiron
axitinib
Axtle
Aygestin
Ayvakit
azacitidine
Azactam
Azasan
AzaSite
azathioprine
Azedra
azelaic acid topical
azelastine nasal
azelastine ophthalmic
azelastine/fluticasone propionate nasal
Azelex
Azilect
azilsartan medoxomil
azilsartan medoxomil/chlorthalidone
azithromycin
azithromycin ophthalmic
Azmacort
Azmiro
Azo Urinary Pain Relief
Azo Urinary Pain Relief Maximum Strength
Azopt
Azor
Azstarys
aztreonam
aztreonam inhaled
aztreonam/avibactam
Azulfidine
Azulfidine EN-tabs
Azurette

close

 

Select a medication above to begin.

dexamethasone sodium phosphate

generic

Drug Monograph

  • Black Box Warnings
  • Adult Dosing
  • Peds Dosing
  • Contraindications/Cautions
  • Drug Interactions
  • Adverse Reactions
  • Safety/Monitoring
  • Pregnancy/Lactation
  • Pharmacology
  • Formulary
  • Manufacturer/Pricing
  • Patient Education
  • Pill Pictures
  • Add to Interaction Check
  • Dosing Calculator

Adult Dosing .

Dosage forms:  INJ: 4 mg per mL, 10 mg per mL

Dosage Form Details

[formulation clarification]
Info: 10 mg per mL vial for IM or IV use only

corticosteroid-responsive conditions

[IM/IV route]
Dose: 0.5-9 mg/day IM/IV divided q6-12h; Info: dose, frequency varies by condition; use lowest effective dose, shortest effective tx duration; taper dose gradually to D/C if high-dose or long-term use
[intra-articular route, small joints]
Dose: 0.8-1 mg intra-articularly x1; Info: use 4 mg per mL vial; dose, frequency varies by condition and injection site; use lowest effective dose, shortest effective tx duration; taper dose gradually to D/C if high-dose or long-term use
[intra-articular route, large joints]
Dose: 2-4 mg intra-articularly x1; Info: use 4 mg per mL vial; dose, frequency varies by condition and injection site; use lowest effective dose, shortest effective tx duration; taper dose gradually to D/C if high-dose or long-term use
[soft tissue injection]
Dose: 0.4-4 mg INJ into affected area x1; Info: use 4 mg per mL vial; dose, frequency varies by condition and injection site; use lowest effective dose, shortest effective tx duration; taper dose gradually to D/C if high-dose or long-term use
[intralesional injection]
Dose: individualize dose intralesionally x1; Info: use 4 mg per mL vial; dose, frequency varies by condition and injection site; use lowest effective dose, shortest effective tx duration; taper dose gradually to D/C if high-dose or long-term use

adrenal insufficiency

[0.03-0.15 mg/kg/day IM/IV divided q6-12h]

cerebral edema, acute

[4 mg IM/IV q6h]
Start: 10 mg IV x1; Info: continue until symptoms subside, taper dose over 5-7 days to D/C; switch to PO when possible

COVID-19 (off-label)

[6 mg IV qd for up to 10 days]
Info: for hospitalized patients with suspected or confirmed severe COVID-19 requiring supplemental oxygen or mechanical ventilation; may use alternative glucocorticoids such as methylprednisolone 32 mg/day, prednisone 40 mg/day, hydrocortisone 160 mg/day

nausea/vomiting prevention, chemo-related (off-label)

[highly-emetogenic parenteral chemo]
Dose: 12 mg IV x1 on day 1 before chemo, then may give 8 mg IV qd on days 2-4; Info: part of multi-drug regimen; search 'CINV' for epocrates Chemo-Induced Nausea & Vomiting in Adults decision tool
[moderately-emetogenic parenteral chemo]
Dose: 12 mg IV x1 on day 1 before chemo, then may give 8 mg IV qd on days 2-3; Info: part of multi-drug regimen; search 'CINV' for epocrates Chemo-Induced Nausea & Vomiting in Adults decision tool
[low-emetogenic parenteral chemo]
Dose: 8-12 mg IV x1 before chemo; Info: may repeat 8-12 mg IV qd for multi-day chemo; search 'CINV' for epocrates Chemo-Induced Nausea & Vomiting in Adults decision tool

breakthrough nausea/vomiting, chemo-related (off-label)

[12 mg IV qd]
Info: search 'CINV' for epocrates Chemo-Induced Nausea & Vomiting in Adults decision tool

nausea/vomiting prevention, XRT-related (off-label)

[4 mg IV qd]
Info: part of multi-drug regimen; give dose before each XRT

shock, unresponsive (off-label)

[1-6 mg/kg/dose IV q2-6h prn]
Start: 40 mg IV x1; Alt: 20 mg IV x1 then 3 mg/kg/24h IV; Info: dosing regimens vary; taper dose over 5-7 days to D/C

altitude sickness (off-label)

[4 mg IM/IV q6h]
Info: for high altitude cerebral edema, give loading dose 8 mg IM/IV x1

fetal lung maturation (off-label)

[6 mg IM q12h x4 doses]
Info: for pregnant patients 24 wk,0 days-33 wk,6 days gestation at high risk of preterm delivery; may consider for pregnant patients at least 23 wk,0 days gestation at high risk of preterm delivery within 7 days; may repeat x1 for pregnant patients <34wk,0 days gestation at imminent risk of preterm birth within 7 days and no prior antenatal steroid use within 14 days

malignant spinal cord compression (off-label)

[16 mg/day IV divided q6h]
Start: 10 mg IV x1; begin when neurological symptoms present; Info: taper dose gradually to D/C

ARDS, early (off-label)

[20 mg IV qd x5 days, then 10 mg IV qd x5 days or until extubation]
Start: within 24h of onset

renal dosing

[no adjustment]
renal impairment: no adjustment
HD/PD: no adjustment; no supplement

hepatic dosing

[not defined]

Peds Dosing .

Dosage forms:  INJ: 4 mg per mL, 10 mg per mL

corticosteroid-responsive conditions

[0.08-0.3 mg/kg/day IM/IV divided q6-12h]
Info: dose, frequency varies by condition; taper dose gradually to D/C if high-dose or long-term use

adrenal insufficiency

[0.03-0.3 mg/kg/day IM/IV divided q6-12h]

cerebral edema, acute

[1-1.5 mg/kg/day IM/IV divided q4-6h]
Start: 1-2 mg/kg/dose IM/IV x1; Max: 16 mg/day; Info: continue until symptoms subside, taper dose over 5-7 days to D/C; switch to PO when possible

COVID-19 (off-label)

[0.15 mg/kg/dose IV qd for up to 10 days]
Max: 6 mg/dose; Info: for hospitalized patients with suspected or confirmed severe COVID-19 requiring supplemental oxygen or mechanical ventilation; may use alternative glucocorticoids such as methylprednisolone 0.8 mg/kg/dose up to 32 mg/dose, prednisone 1 mg/kg/dose up to 40 mg/dose, or hydrocortisone 4 mg/kg/dose up to 160 mg/dose

croup (off-label)

[0.6 mg/kg/dose IM/IV x1]
Max: 20 mg/dose; Info: may use 0.15-0.3 mg/kg/dose IM/IV x1 for mild-moderate croup

chronic lung disease prevention (off-label)

[premature neonates, 8-27 days old]
Dose: 0.075 mg/kg/dose IV q12h x3 days, then 0.05 mg/kg/dose IV q12h x3 days, then 0.025 mg/kg/dose IV q12h x2 days, then 0.01 mg/kg/dose IV q12h x2 days; Info: for high-risk ventilator-dependent patients

airway edema (off-label)

[0.5-2 mg/kg/day IM/IV divided q6h x4-6 doses after extubation]
Start: 24h before extubation

nausea/vomiting prevention, chemo-related (off-label)

[highly-emetogenic parenteral chemo]
Dose: 6 mg/m^2/dose IV q6h; Info: part of multi-drug regimen
[moderately-emetogenic parenteral chemo, BSA <0.6 m^2]
Dose: 2 mg IV q12h; Info: part of multi-drug regimen
[moderately-emetogenic parenteral chemo, BSA >0.6 m^2]
Dose: 4 mg IV q12h; Info: part of multi-drug regimen

meningitis, bacterial (off-label)

[>6 wk old]
Dose: 0.6 mg/kg/day IV divided q6h x2 days; Start: with 1st dose antibiotic

malignant spinal cord compression (off-label)

[0.25-0.5 mg/kg/dose IV q6h]
Start: 1-2 mg/kg/dose IV x1; begin when neurological symptoms present; Max: 16 mg/dose; Info: taper dose gradually to D/C

altitude sickness (off-label)

[0.15 mg/kg/dose IM/IV q6h]
Max: 4 mg/dose

renal dosing

[no adjustment]
renal impairment: no adjustment
HD/PD: no adjustment; no supplement

hepatic dosing

[not defined]

Contraindications / Cautions .

    com.epocrates.rxweb.beans.StringCollection@6505161e
  • hypersensitivity to drug or ingredient
  • systemic fungal infection
  • cerebral malaria
  • amebiasis, active
  • amebiasis, latent
  • ocular HSV infection
  • thrombocytopenic purpura (IM use)
  • joint, unstable (intra-articular use)
  • abrupt withdrawal (high-dose or long-term use)
  • caution: hypersensitivity to corticosteroids
  • caution: hypersensitivity to sulfites
  • caution: epidural use
  • caution: neonates
  • caution: peds patients
  • caution: adolescent patients
  • caution: immunosuppressed patients
  • caution: infection, active
  • caution: infection risk
  • caution: measles exposure (non-immune patients)
  • caution: varicella exposure (non-immune patients)
  • caution: HTN
  • caution: pheochromocytoma risk
  • caution: CHF
  • caution: MI, recent
  • caution: diabetes mellitus
  • caution: PUD
  • caution: ulcerative colitis
  • caution: diverticulitis
  • caution: intestinal anastomosis, recent
  • caution: GI perforation risk
  • caution: seizure disorder
  • caution: myasthenia gravis
  • caution: psychiatric disorder
  • caution: thyroid disorder
  • caution: osteoporosis
  • caution: osteoporosis risk
  • caution: tumor lysis syndrome risk, high
  • caution: renal impairment
  • caution: cirrhosis

Drug Interactions .

Overview

dexamethasone

corticosteroid

Interaction Characteristics:
  • CYP3A4 substrate
  • 11-beta-hydroxysteroid dehydrogenase type 1 substrate
  • CYP3A4 inducer, weak
  • affects growth hormone diagnostic test results
  • binds to anion exchange resin/polymer
  • corticosteroid
  • GI mucosal injury/bleeding risk
  • hyperammonemia
  • hyperglycemic effects
  • hypernatremia
  • hypertensive effects
  • hypokalemia
  • immunomodulatory effects
  • interferes w/ ACTH analog test
  • lowers seizure threshold
  • thrombogenic effects

Contraindicated

  • adenovirus vaccine, live
  • dexamethasone sodium phosphate (generic)
    +
    adenovirus vaccine, live
    1 interaction

    Contraindicated

    dexamethasone + adenovirus vaccine, live

    contraindicated; vaccinate at least 1mo before or 1mo after long-term (>2wk) high-dose systemic steroids: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • BCG live intravesical
  • dexamethasone sodium phosphate (generic)
    +
    BCG live intravesical
    1 interaction

    Contraindicated

    dexamethasone + BCG live intravesical

    contraindicated: combo may incr. risk of disseminated BCG infection; may decr. immune response (immunosuppressive effects)

  • chikungunya vaccine, live
  • dexamethasone sodium phosphate (generic)
    +
    chikungunya vaccine, live
    1 interaction

    Contraindicated

    dexamethasone + chikungunya vaccine, live

    contraindicated; vaccinate at least 1mo before or 1mo after long-term (>2wk) high-dose systemic steroids: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • cholera vaccine, live
  • dexamethasone sodium phosphate (generic)
    +
    cholera vaccine, live
    1 interaction

    Contraindicated

    dexamethasone + cholera vaccine, live

    contraindicated; vaccinate at least 1mo before or 1mo after long-term (>2wk) high-dose systemic steroids: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • dengue vaccine, live
  • dexamethasone sodium phosphate (generic)
    +
    dengue vaccine, live
    1 interaction

    Contraindicated

    dexamethasone + dengue vaccine, live

    contraindicated; vaccinate at least 1mo before or 1mo after long-term (>2wk) high-dose systemic steroids: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • desmopressin
  • dexamethasone sodium phosphate (generic)
    +
    desmopressin
    1 interaction

    Contraindicated

    dexamethasone + desmopressin

    DESMOPRESSIN INJECTABLE: contraindicated; OTHER DESMOPRESSIN ROUTES: monitor sodium, BP: combo may incr. risk of HTN, hyponatremia, including life-threatening (additive effects)

  • influenza nasal vaccine, live
  • dexamethasone sodium phosphate (generic)
    +
    influenza nasal vaccine, live
    1 interaction

    Contraindicated

    dexamethasone + influenza nasal vaccine, live

    contraindicated; vaccinate at least 1mo before or 1mo after long-term (>2wk) high-dose systemic steroids: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • iohexol
  • dexamethasone sodium phosphate (generic)
    +
    iohexol
    1 interaction

    Contraindicated

    dexamethasone + iohexol

    contraindicated if intrathecal iohexol and intrathecal dexamethasone use; otherwise, avoid combo if intrathecal iohexol use; monitor thrombosis s/sx if IV iohexol and multiple myeloma use: combo may incr. risk of seizures, thromboembolism (additive effects)

  • iopamidol
  • dexamethasone sodium phosphate (generic)
    +
    iopamidol
    1 interaction

    Contraindicated

    dexamethasone + iopamidol

    contraindicated if intrathecal iopamidol use and intrathecal dexamethasone use; otherwise, caution advised if intrathecal iopamidol use, consider holding dexamethasone at least 48h before and at least 24h after intrathecal iopamidol; monitor thrombosis s/sx, especially if multiple myeloma use: combo may incr. risk of seizures, thromboembolism (additive effects)

  • measles/mumps/rubella vaccine, live
  • dexamethasone sodium phosphate (generic)
    +
    measles/ mumps/ rubella vaccine, live
    1 interaction

    Contraindicated

    dexamethasone + measles/ mumps/ rubella vaccine, live

    contraindicated; vaccinate at least 1mo before or 1mo after long-term (>2wk) high-dose systemic steroids: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • mifepristone
  • dexamethasone sodium phosphate (generic)
    +
    mifepristone
    1 interaction

    Contraindicated

    dexamethasone + mifepristone

    contraindicated if chronic, lifesaving corticosteroid use; otherwise, monitor potassium if daily mifepristone use: combo may decr. dexamethasone efficacy; may incr. risk of hypokalemia (antagonistic effects; additive effects)

  • ranolazine
  • dexamethasone sodium phosphate (generic)
    +
    ranolazine
    1 interaction

    Contraindicated

    dexamethasone + ranolazine

    contraindicated: combo may decr. ranolazine levels, efficacy (hepatic metabolism induced)

  • rilpivirine
  • dexamethasone sodium phosphate (generic)
    +
    rilpivirine
    1 interaction

    Contraindicated

    dexamethasone + rilpivirine

    contraindicated if dexamethasone use >1 dose: combo may decr. rilpivirine levels, efficacy (hepatic metabolism induced)

  • rotavirus vaccine, live
  • dexamethasone sodium phosphate (generic)
    +
    rotavirus vaccine, live
    1 interaction

    Contraindicated

    dexamethasone + rotavirus vaccine, live

    contraindicated; vaccinate at least 1mo before or 1mo after long-term (>2wk) high-dose systemic steroids: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • smallpox vaccine, live
  • dexamethasone sodium phosphate (generic)
    +
    smallpox vaccine, live
    1 interaction

    Contraindicated

    dexamethasone + smallpox vaccine, live

    contraindicated; vaccinate at least 1mo before or 1mo after long-term (>2wk) high-dose systemic steroids: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • talimogene laherparepvec
  • dexamethasone sodium phosphate (generic)
    +
    talimogene laherparepvec
    1 interaction

    Contraindicated

    dexamethasone + talimogene laherparepvec

    contraindicated: combo may incr. risk of disseminated herpetic infection; may decr. immune response (immunosuppressive effects)

  • typhoid vaccine, live
  • dexamethasone sodium phosphate (generic)
    +
    typhoid vaccine, live
    1 interaction

    Contraindicated

    dexamethasone + typhoid vaccine, live

    contraindicated; vaccinate at least 1mo before or 1mo after long-term (>2wk) high-dose systemic steroids: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • varicella vaccine, live
  • dexamethasone sodium phosphate (generic)
    +
    varicella vaccine, live
    1 interaction

    Contraindicated

    dexamethasone + varicella vaccine, live

    contraindicated; vaccinate at least 1mo before or 1mo after long-term (>2wk) high-dose systemic steroids: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

  • yellow fever vaccine, live
  • dexamethasone sodium phosphate (generic)
    +
    yellow fever vaccine, live
    1 interaction

    Contraindicated

    dexamethasone + yellow fever vaccine, live

    contraindicated; vaccinate at least 1mo before or 1mo after long-term (>2wk) high-dose systemic steroids: combo may result in inadequate vaccine response, incr. risk of disseminated infection (immunosuppressive effects)

Avoid/Use Alternative

  • adagrasib
  • dexamethasone sodium phosphate (generic)
    +
    adagrasib
    1 interaction

    Avoid/Use Alternative

    dexamethasone + adagrasib

    if multiple myeloma use, use alternative or monitor hypercorticism s/sx; otherwise, caution advised: combo may incr. dexamethasone levels, risk of systemic corticosteroid effects including Cushing syndrome and adrenal suppression, serious infection, other adverse effects (hepatic metabolism inhibited)

  • afamitresgene autoleucel
  • dexamethasone sodium phosphate (generic)
    +
    afamitresgene autoleucel
    1 interaction

    Avoid/Use Alternative

    dexamethasone + afamitresgene autoleucel

    avoid combo: combo may decr. afamitresgene autoleucel efficacy; may incr. risk of serious infection (antagonistic effects; additive effects)

  • aldesleukin
  • dexamethasone sodium phosphate (generic)
    +
    aldesleukin
    1 interaction

    Avoid/Use Alternative

    dexamethasone + aldesleukin

    avoid combo: combo may incr. risk of serious infection, seizures; may decr. aldesleukin efficacy (additive effects; antagonistic effects)

  • amifampridine
  • dexamethasone sodium phosphate (generic)
    +
    amifampridine
    1 interaction

    Avoid/Use Alternative

    dexamethasone + amifampridine

    consider alternative: combo may incr. risk of seizures (additive effects)

  • amphotericin
  • dexamethasone sodium phosphate (generic)
    +
    amphotericin
    1 interaction

    Avoid/Use Alternative

    dexamethasone + amphotericin

    use alternative or monitor potassium, ECG: combo may incr. risk of hypokalemia, cardiac arrhythmias (additive effects)

  • apalutamide
  • dexamethasone sodium phosphate (generic)
    +
    apalutamide
    1 interaction

    Avoid/Use Alternative

    dexamethasone + apalutamide

    if multiple myeloma use, consider alternative; otherwise, consider incr. dexamethasone dose: combo may decr. dexamethasone levels, efficacy (hepatic metabolism induced)

  • arsenic trioxide
  • dexamethasone sodium phosphate (generic)
    +
    arsenic trioxide
    1 interaction

    Avoid/Use Alternative

    dexamethasone + arsenic trioxide

    use alternative or monitor potassium, ECG: combo may incr. risk of hypokalemia, QT prolongation, cardiac arrhythmias (additive effects)

  • artemether/lumefantrine
  • dexamethasone sodium phosphate (generic)
    +
    artemether/ lumefantrine
    1 interaction

    Avoid/Use Alternative

    dexamethasone + artemether/ lumefantrine

    use alternative: combo may decr. artemether/lumefantrine levels, efficacy (hepatic metabolism induced)

  • astragalus
  • dexamethasone sodium phosphate (generic)
    +
    astragalus
    1 interaction

    Avoid/Use Alternative

    dexamethasone + astragalus

    avoid combo: combo may decr. dexamethasone efficacy (antagonistic effects)

  • atazanavir
  • dexamethasone sodium phosphate (generic)
    +
    atazanavir
    1 interaction

    Avoid/Use Alternative

    dexamethasone + atazanavir

    avoid combo: combo may decr. atazanavir levels, efficacy; may incr. dexamethasone levels, risk of systemic corticosteroid effects including Cushing syndrome and adrenal suppression, serious infection, other adverse effects (hepatic metabolism induced; hepatic metabolism inhibited)

  • axicabtagene ciloleucel
  • dexamethasone sodium phosphate (generic)
    +
    axicabtagene ciloleucel
    1 interaction

    Avoid/Use Alternative

    dexamethasone + axicabtagene ciloleucel

    avoid combo unless severe cytokine release syndrome tx: combo may decr. axicabtagene ciloleucel efficacy; may incr. risk of serious infection (antagonistic effects; additive effects)

  • betamethasone
  • dexamethasone sodium phosphate (generic)
    +
    betamethasone
    1 interaction

    Avoid/Use Alternative

    dexamethasone + betamethasone

    avoid combo: combo may incr. risk of systemic corticosteroid effects including Cushing syndrome and adrenal suppression, serious infection, GI ulceration, perforation, bleeding, hypokalemia, HTN, other adverse effects (additive effects, duplicate therapy)

  • brexucabtagene autoleucel
  • dexamethasone sodium phosphate (generic)
    +
    brexucabtagene autoleucel
    1 interaction

    Avoid/Use Alternative

    dexamethasone + brexucabtagene autoleucel

    avoid combo unless severe cytokine release syndrome tx: combo may decr. brexucabtagene autoleucel efficacy; may incr. risk of serious infection (antagonistic effects; additive effects)

  • budesonide
  • dexamethasone sodium phosphate (generic)
    +
    budesonide
    1 interaction

    Avoid/Use Alternative

    dexamethasone + budesonide

    avoid combo: combo may decr. budesonide levels, efficacy; may incr. risk of systemic corticosteroid effects, including Cushing syndrome, adrenal suppression, serious infection, HTN, hypokalemia, other adverse effects (hepatic metabolism induced; additive effects, duplicate therapy)

  • butalbital
  • dexamethasone sodium phosphate (generic)
    +
    butalbital
    1 interaction

    Avoid/Use Alternative

    dexamethasone + butalbital

    if multiple myeloma use, consider alternative; otherwise, consider incr. dexamethasone dose: combo may decr. dexamethasone levels, efficacy (hepatic metabolism induced)

  • carbamazepine
  • dexamethasone sodium phosphate (generic)
    +
    carbamazepine
    1 interaction

    Avoid/Use Alternative

    dexamethasone + carbamazepine

    if multiple myeloma use, consider alternative; otherwise, monitor carbamazepine levels, consider incr. dexamethasone dose: combo may decr. levels, efficacy of both drugs; may alter seizure control (hepatic metabolism induced; antagonistic effects, dexamethasone may decr. seizure threshold)

  • ceritinib
  • dexamethasone sodium phosphate (generic)
    +
    ceritinib
    1 interaction

    Avoid/Use Alternative

    dexamethasone + ceritinib

    if multiple myeloma use, use alternative or monitor hypercorticism s/sx; otherwise, caution advised: combo may incr. dexamethasone levels, risk of systemic corticosteroid effects including Cushing syndrome and adrenal suppression, serious infection, other adverse effects (hepatic metabolism inhibited)

  • chloramphenicol
  • dexamethasone sodium phosphate (generic)
    +
    chloramphenicol
    1 interaction

    Avoid/Use Alternative

    dexamethasone + chloramphenicol

    if multiple myeloma use, use alternative or monitor hypercorticism s/sx; otherwise, caution advised: combo may incr. dexamethasone levels, risk of systemic corticosteroid effects including Cushing syndrome and adrenal suppression, serious infection, other adverse effects (hepatic metabolism inhibited)

  • cholestyramine
  • dexamethasone sodium phosphate (generic)
    +
    cholestyramine
    1 interaction

    Avoid/Use Alternative

    dexamethasone + cholestyramine

    if multiple myeloma use, avoid combo; otherwise, give oral dexamethasone at least 1h before or 4-6h after each cholestyramine dose: combo may decr. dexamethasone levels, efficacy (absorption decreased/delayed)

  • ciltacabtagene autoleucel
  • dexamethasone sodium phosphate (generic)
    +
    ciltacabtagene autoleucel
    1 interaction

    Avoid/Use Alternative

    dexamethasone + ciltacabtagene autoleucel

    avoid combo unless severe cytokine release syndrome or neurological toxicity tx: combo may decr. ciltacabtagene autoleucel efficacy; may incr. risk of serious infection (antagonistic effects; additive effects)

  • cladribine oral
  • dexamethasone sodium phosphate (generic)
    +
    cladribine oral
    1 interaction

    Avoid/Use Alternative

    dexamethasone + cladribine oral

    use alternative; reserve dexamethasone for emergent use: combo may incr. risk of serious infection (additive effects)

  • clarithromycin
  • dexamethasone sodium phosphate (generic)
    +
    clarithromycin
    1 interaction

    Avoid/Use Alternative

    dexamethasone + clarithromycin

    if multiple myeloma use, use alternative or monitor hypercorticism s/sx; otherwise, caution advised: combo may incr. dexamethasone levels, risk of systemic corticosteroid effects including Cushing syndrome and adrenal suppression, serious infection, other adverse effects; may decr. clarithromycin levels, efficacy (hepatic metabolism inhibited; hepatic metabolism induced)

  • cobicistat
  • dexamethasone sodium phosphate (generic)
    +
    cobicistat
    1 interaction

    Avoid/Use Alternative

    dexamethasone + cobicistat

    if multiple myeloma use, use alternative or monitor hypercorticism s/sx; otherwise, consider alternative (incl. prednisolone or prednisone), especially if long-term corticosteroid use: combo may decr. cobicistat levels, efficacy; may incr. dexamethasone levels, risk of systemic corticosteroid effects including Cushing syndrome and adrenal suppression, serious infection, other adverse effects (hepatic metabolism induced; hepatic metabolism inhibited)

  • codeine
  • dexamethasone sodium phosphate (generic)
    +
    codeine
    1 interaction

    Avoid/Use Alternative

    dexamethasone + codeine

    use alternative or monitor withdrawal sx: combo may decr. codeine and active metabolite morphine levels, efficacy (hepatic metabolism induced, may decr. production of active metabolite morphine)

  • cortisone
  • dexamethasone sodium phosphate (generic)
    +
    cortisone
    1 interaction

    Avoid/Use Alternative

    dexamethasone + cortisone

    avoid combo: combo may incr. risk of systemic corticosteroid effects including Cushing syndrome and adrenal suppression, serious infection, GI ulceration, perforation, bleeding, hypokalemia, HTN, other adverse effects (additive effects, duplicate therapy)

  • darunavir
  • dexamethasone sodium phosphate (generic)
    +
    darunavir
    1 interaction

    Avoid/Use Alternative

    dexamethasone + darunavir

    if multiple myeloma use, use alternative or monitor hypercorticism s/sx; otherwise, consider alternative (incl. prednisolone or prednisone), especially if long-term corticosteroid use: combo may decr. darunavir levels, efficacy; may incr. dexamethasone levels, risk of systemic corticosteroid effects including Cushing syndrome and adrenal suppression, serious infection, other adverse effects (hepatic metabolism induced; hepatic metabolism inhibited)

  • deflazacort
  • dexamethasone sodium phosphate (generic)
    +
    deflazacort
    1 interaction

    Avoid/Use Alternative

    dexamethasone + deflazacort

    avoid combo: combo may decr. deflazacort active metabolite levels, efficacy; may incr. risk of systemic corticosteroid effects, including Cushing syndrome, adrenal suppression, serious infection, GI ulceration, perforation, bleeding, thromboembolism, hypokalemia, HTN, other adverse effects (hepatic metabolism induced; additive effects, duplicate therapy)

  • desogestrel (contraceptive)
  • dexamethasone sodium phosphate (generic)
    +
    desogestrel (contraceptive)
    1 interaction

    Avoid/Use Alternative

    dexamethasone + desogestrel (contraceptive)

    use additional non-hormonal or alternative contraception during and x28 days after dexamethasone tx; monitor thrombosis s/sx, especially w/ concomitant estrogen or multiple myeloma use: combo may decr. desogestrel levels, contraceptive efficacy; may incr. risk of thromboembolism (hepatic metabolism induced; additive effects)

  • dexamethasone
  • dexamethasone sodium phosphate (generic)
    +
    dexamethasone
    1 interaction

    Avoid/Use Alternative

    dexamethasone + dexamethasone

    avoid combo: combo may incr. risk of systemic corticosteroid effects including Cushing syndrome and adrenal suppression, serious infection, hypokalemia, GI ulceration, bleeding, perforation, HTN, thromboembolism, other adverse effects (additive effects, duplicate therapy)

  • dienogest (contraceptive)
  • dexamethasone sodium phosphate (generic)
    +
    dienogest (contraceptive)
    1 interaction

    Avoid/Use Alternative

    dexamethasone + dienogest (contraceptive)

    use additional non-hormonal or alternative contraception during and x28 days after dexamethasone tx; monitor thrombosis s/sx, especially if multiple myeloma use or w/ concomitant estrogen use: combo may decr. dienogest levels, contraceptive efficacy; may incr. risk of thromboembolism (hepatic metabolism induced; additive effects)

  • dolutegravir
  • dexamethasone sodium phosphate (generic)
    +
    dolutegravir
    1 interaction

    Avoid/Use Alternative

    dexamethasone + dolutegravir

    avoid combo: combo may decr. dolutegravir levels, efficacy (hepatic metabolism induced)

  • drospirenone (contraceptive)
  • dexamethasone sodium phosphate (generic)
    +
    drospirenone (contraceptive)
    1 interaction

    Avoid/Use Alternative

    dexamethasone + drospirenone (contraceptive)

    use additional non-hormonal or alternative contraception during and x28 days after dexamethasone tx; monitor thrombosis s/sx, especially if multiple myeloma use or w/ concomitant estrogen use: combo may decr. drospirenone levels, contraceptive efficacy; may incr. risk of thromboembolism (hepatic metabolism induced; additive effects)

  • elvitegravir
  • dexamethasone sodium phosphate (generic)
    +
    elvitegravir
    1 interaction

    Avoid/Use Alternative

    dexamethasone + elvitegravir

    consider alternative: combo may decr. elvitegravir levels, efficacy (hepatic metabolism induced)

  • encorafenib
  • dexamethasone sodium phosphate (generic)
    +
    encorafenib
    1 interaction

    Avoid/Use Alternative

    dexamethasone + encorafenib

    if multiple myeloma use, consider alternative; otherwise, consider incr. dexamethasone dose: combo may decr. dexamethasone levels, efficacy (hepatic metabolism induced)

  • enzalutamide
  • dexamethasone sodium phosphate (generic)
    +
    enzalutamide
    1 interaction

    Avoid/Use Alternative

    dexamethasone + enzalutamide

    if multiple myeloma use, consider alternative; otherwise, consider incr. dexamethasone dose: combo may decr. dexamethasone levels, efficacy (hepatic metabolism induced)

  • epinephrine inhaled
  • dexamethasone sodium phosphate (generic)
    +
    epinephrine inhaled
    1 interaction

    Avoid/Use Alternative

    dexamethasone + epinephrine inhaled

    avoid combo: combo may incr. risk of HTN, including hypertensive crisis (additive effects)

  • estradiol (contraceptive)
  • dexamethasone sodium phosphate (generic)
    +
    estradiol (contraceptive)
    1 interaction

    Avoid/Use Alternative

    dexamethasone + estradiol (contraceptive)

    use additional non-hormonal or alternative contraception during and x28 days after dexamethasone tx; monitor BP, thrombosis s/sx, especially if multiple myeloma use: combo may decr. estradiol levels, contraceptive efficacy; may incr. risk of HTN, thromboembolism (hepatic metabolism induced; additive effects)

  • ethinyl estradiol (contraceptive)
  • dexamethasone sodium phosphate (generic)
    +
    ethinyl estradiol (contraceptive)
    1 interaction

    Avoid/Use Alternative

    dexamethasone + ethinyl estradiol (contraceptive)

    use additional non-hormonal or alternative contraception during and x28 days after dexamethasone tx; monitor BP, thrombosis s/sx, especially if multiple myeloma use: combo may decr. ethinyl estradiol levels, contraceptive efficacy; may incr. risk of HTN, thromboembolism (hepatic metabolism induced; additive effects)

  • ethynodiol (contraceptive)
  • dexamethasone sodium phosphate (generic)
    +
    ethynodiol (contraceptive)
    1 interaction

    Avoid/Use Alternative

    dexamethasone + ethynodiol (contraceptive)

    use additional non-hormonal or alternative contraception during and x28 days after dexamethasone tx; monitor thrombosis s/sx, especially if multiple myeloma use or w/ concomitant estrogen use: combo may decr. ethynodiol and active metabolite levels, contraceptive efficacy; may incr. risk of thromboembolism (hepatic metabolism induced; additive effects)

  • etonogestrel (contraceptive)
  • dexamethasone sodium phosphate (generic)
    +
    etonogestrel (contraceptive)
    1 interaction

    Avoid/Use Alternative

    dexamethasone + etonogestrel (contraceptive)

    use additional non-hormonal or alternative contraception during and x28 days after dexamethasone tx; monitor thrombosis s/sx, especially if multiple myeloma use or w/ concomitant estrogen use: combo may decr. etonogestrel levels, contraceptive efficacy; may incr. risk of thromboembolism (hepatic metabolism induced; additive effects)

  • etravirine
  • dexamethasone sodium phosphate (generic)
    +
    etravirine
    1 interaction

    Avoid/Use Alternative

    dexamethasone + etravirine

    consider alternative, especially w/ long-term dexamethasone use: combo may decr. levels of both drugs, efficacy (hepatic metabolism induced)

  • fentanyl
  • dexamethasone sodium phosphate (generic)
    +
    fentanyl
    1 interaction

    Avoid/Use Alternative

    dexamethasone + fentanyl

    use alternative or monitor withdrawal sx: combo may decr. fentanyl levels, efficacy (hepatic metabolism induced)

  • fosphenytoin
  • dexamethasone sodium phosphate (generic)
    +
    fosphenytoin
    1 interaction

    Avoid/Use Alternative

    dexamethasone + fosphenytoin

    if multiple myeloma use, consider alternative; otherwise, consider incr. dexamethasone dose: combo may decr. dexamethasone levels, efficacy; may alter seizure control (hepatic metabolism induced; antagonistic effects, dexamethasone may decr. seizure threshold)

  • furosemide
  • dexamethasone sodium phosphate (generic)
    +
    furosemide
    1 interaction

    Avoid/Use Alternative

    dexamethasone + furosemide

    use alternative or monitor BP, potassium: combo may decr. antihypertensive agent efficacy; may incr. risk of hypokalemia (antagonistic effects; additive effects)

  • hydrocortisone
  • dexamethasone sodium phosphate (generic)
    +
    hydrocortisone
    1 interaction

    Avoid/Use Alternative

    dexamethasone + hydrocortisone

    avoid combo: combo may incr. risk of systemic corticosteroid effects, including Cushing syndrome and adrenal suppression, serious infection, GI ulceration, perforation, bleeding, hypokalemia, HTN, other adverse effects; may decr. hydrocortisone levels, efficacy (additive effects, duplicate therapy; hepatic metabolism induced)

  • idecabtagene vicleucel
  • dexamethasone sodium phosphate (generic)
    +
    idecabtagene vicleucel
    1 interaction

    Avoid/Use Alternative

    dexamethasone + idecabtagene vicleucel

    avoid combo unless severe cytokine release syndrome or neurological toxicity tx: combo may decr. idecabtagene vicleucel efficacy; may incr. risk of serious infection (antagonistic effects; additive effects)

  • idelalisib
  • dexamethasone sodium phosphate (generic)
    +
    idelalisib
    1 interaction

    Avoid/Use Alternative

    dexamethasone + idelalisib

    if multiple myeloma use, use alternative or monitor hypercorticism s/sx; otherwise, caution advised: combo may incr. dexamethasone levels, risk of systemic corticosteroid effects including Cushing syndrome and adrenal suppression, serious infection, other adverse effects (hepatic metabolism inhibited, additive effects)

  • itraconazole
  • dexamethasone sodium phosphate (generic)
    +
    itraconazole
    1 interaction

    Avoid/Use Alternative

    dexamethasone + itraconazole

    if multiple myeloma use, use alternative or monitor hypercorticism s/sx during and x2wk after itraconazole tx; otherwise, caution advised: combo may incr. dexamethasone levels, risk of systemic corticosteroid effects including Cushing syndrome and adrenal suppression, serious infection, other adverse effects; may decr. itraconazole levels, efficacy (hepatic metabolism inhibited; hepatic metabolism induced)

  • ivosidenib
  • dexamethasone sodium phosphate (generic)
    +
    ivosidenib
    1 interaction

    Avoid/Use Alternative

    dexamethasone + ivosidenib

    if multiple myeloma use, consider alternative; otherwise, consider incr. dexamethasone dose: combo may decr. dexamethasone levels, efficacy (hepatic metabolism induced)

  • ketoconazole
  • dexamethasone sodium phosphate (generic)
    +
    ketoconazole
    1 interaction

    Avoid/Use Alternative

    dexamethasone + ketoconazole

    if multiple myeloma use, use alternative or monitor hypercorticism s/sx during and up to 1wk after ketoconazole tx; otherwise, monitor for breakthrough fungal infection: combo may incr. dexamethasone levels, risk of systemic corticosteroid effects including Cushing syndrome and adrenal suppression, serious infection, other adverse effects; may decr. ketoconazole levels, efficacy (hepatic metabolism inhibited; hepatic metabolism induced)

  • levoketoconazole
  • dexamethasone sodium phosphate (generic)
    +
    levoketoconazole
    1 interaction

    Avoid/Use Alternative

    dexamethasone + levoketoconazole

    if multiple myeloma use, use alternative or monitor hypercorticism s/sx; otherwise, caution advised: combo may incr. dexamethasone levels, risk of systemic corticosteroid effects including Cushing syndrome and adrenal suppression, serious infection, other adverse effects; may decr. levoketoconazole levels, efficacy (hepatic metabolism inhibited; hepatic metabolism induced)

  • levonorgestrel (contraceptive)
  • dexamethasone sodium phosphate (generic)
    +
    levonorgestrel (contraceptive)
    1 interaction

    Avoid/Use Alternative

    dexamethasone + levonorgestrel (contraceptive)

    use additional non-hormonal or alternative contraception during and x28 days after dexamethasone tx; monitor thrombosis s/sx, especially if multiple myeloma use or w/ concomitant estrogen use: combo may decr. levonorgestrel levels, contraceptive efficacy; may incr. risk of thromboembolism (hepatic metabolism induced; additive effects)

  • levonorgestrel (post-coital contraceptive)
  • dexamethasone sodium phosphate (generic)
    +
    levonorgestrel (post-coital contraceptive)
    1 interaction

    Avoid/Use Alternative

    dexamethasone + levonorgestrel (post-coital contraceptive)

    consider alternative: combo may decr. levonorgestrel levels, post-coital contraceptive efficacy (hepatic metabolism induced)

  • lifileucel
  • dexamethasone sodium phosphate (generic)
    +
    lifileucel
    1 interaction

    Avoid/Use Alternative

    dexamethasone + lifileucel

    avoid combo: combo may decr. lifileucel efficacy; may incr. risk of serious infection (antagonistic effects; additive effects)

  • lisocabtagene maraleucel
  • dexamethasone sodium phosphate (generic)
    +
    lisocabtagene maraleucel
    1 interaction

    Avoid/Use Alternative

    dexamethasone + lisocabtagene maraleucel

    avoid combo unless severe cytokine release syndrome tx: combo may decr. lisocabtagene maraleucel efficacy; may incr. risk of serious infection (antagonistic effects; additive effects)

  • lonafarnib
  • dexamethasone sodium phosphate (generic)
    +
    lonafarnib
    1 interaction

    Avoid/Use Alternative

    dexamethasone + lonafarnib

    if multiple myeloma use, use alternative or monitor hypercorticism s/sx; otherwise, caution advised: combo may incr. dexamethasone levels, risk of systemic corticosteroid effects including Cushing syndrome and adrenal suppression, serious infection, other adverse effects; may decr. lonafarnib levels, efficacy (hepatic metabolism inhibited; hepatic metabolism induced)

  • lopinavir/ritonavir
  • dexamethasone sodium phosphate (generic)
    +
    lopinavir/ ritonavir
    1 interaction

    Avoid/Use Alternative

    dexamethasone + lopinavir/ ritonavir

    if multiple myeloma use, use alternative or monitor hypercorticism s/sx; otherwise, consider alternative (incl. prednisolone), especially if long-term corticosteroid use: combo may incr. dexamethasone levels, risk of systemic corticosteroid effects including Cushing syndrome and adrenal suppression, serious infection, other adverse effects; may decr. lopinavir/ritonavir levels, efficacy (hepatic metabolism inhibited; hepatic metabolism induced)

  • lumacaftor/ivacaftor
  • dexamethasone sodium phosphate (generic)
    +
    lumacaftor/ ivacaftor
    1 interaction

    Avoid/Use Alternative

    dexamethasone + lumacaftor/ ivacaftor

    if multiple myeloma use, consider alternative; otherwise, consider incr. dexamethasone dose, monitor BP: combo may decr. dexamethasone levels, efficacy; may incr. risk of HTN (hepatic metabolism induced; additive effects)

  • lumateperone
  • dexamethasone sodium phosphate (generic)
    +
    lumateperone
    1 interaction

    Avoid/Use Alternative

    dexamethasone + lumateperone

    avoid combo: combo may decr. lumateperone levels, efficacy (hepatic metabolism induced)

  • lutetium Lu 177 dotatate
  • dexamethasone sodium phosphate (generic)
    +
    lutetium Lu 177 dotatate
    1 interaction

    Avoid/Use Alternative

    dexamethasone + lutetium Lu 177 dotatate

    avoid repeated high-dose dexamethasone: combo may decr. lutetium Lu 177 dotatate efficacy (subtype 2 somatostatin receptor downregulation)

  • macimorelin
  • dexamethasone sodium phosphate (generic)
    +
    macimorelin
    1 interaction

    Avoid/Use Alternative

    dexamethasone + macimorelin

    avoid combo or D/C dexamethasone, allowing sufficient washout time before diagnostic test: combo may interfere with test results (dexamethasone may affect pituitary secretion of growth hormone)

  • mavacamten
  • dexamethasone sodium phosphate (generic)
    +
    mavacamten
    1 interaction

    Avoid/Use Alternative

    dexamethasone + mavacamten

    consider alternative or monitor cardiac fxn: combo may decr. levels, efficacy of both drugs (hepatic metabolism induced)

  • medroxyprogesterone (contraceptive)
  • dexamethasone sodium phosphate (generic)
    +
    medroxyprogesterone (contraceptive)
    1 interaction

    Avoid/Use Alternative

    dexamethasone + medroxyprogesterone (contraceptive)

    use additional non-hormonal or alternative contraception during and x28 days after dexamethasone tx; monitor thrombosis s/sx, especially if multiple myeloma use: combo may decr. medroxyprogesterone levels, contraceptive efficacy; may incr. risk of thromboembolism (hepatic metabolism induced; additive effects)

  • meperidine
  • dexamethasone sodium phosphate (generic)
    +
    meperidine
    1 interaction

    Avoid/Use Alternative

    dexamethasone + meperidine

    use alternative or monitor for withdrawal sx: combo may decr. meperidine levels, efficacy; may incr. normeperidine levels, risk of neurotoxicity (hepatic metabolism induced, incr. toxic metabolite formation)

  • methylprednisolone
  • dexamethasone sodium phosphate (generic)
    +
    methylprednisolone
    1 interaction

    Avoid/Use Alternative

    dexamethasone + methylprednisolone

    avoid combo: combo may incr. risk of systemic corticosteroid effects including Cushing syndrome and adrenal suppression, serious infection, GI ulceration, perforation, bleeding, HTN, hypokalemia, other adverse effects (additive effects, duplicate therapy)

  • midodrine
  • dexamethasone sodium phosphate (generic)
    +
    midodrine
    1 interaction

    Avoid/Use Alternative

    dexamethasone + midodrine

    use alternative or monitor BP: combo may incr. risk of HTN (additive effects)

  • mitotane
  • dexamethasone sodium phosphate (generic)
    +
    mitotane
    1 interaction

    Avoid/Use Alternative

    dexamethasone + mitotane

    if multiple myeloma use, consider alternative; otherwise, consider incr. dexamethasone dose, monitor cortisol and corticotropin (ACTH) levels: combo may decr. dexamethasone levels, efficacy (hepatic metabolism induced, mitotane may cause adrenal insufficiency)

  • natalizumab
  • dexamethasone sodium phosphate (generic)
    +
    natalizumab
    1 interaction

    Avoid/Use Alternative

    dexamethasone + natalizumab

    avoid combo: combo may incr. risk of serious infection (additive effects)

  • nefazodone
  • dexamethasone sodium phosphate (generic)
    +
    nefazodone
    1 interaction

    Avoid/Use Alternative

    dexamethasone + nefazodone

    if multiple myeloma use, use alternative or monitor hypercorticism s/sx; otherwise, caution advised: combo may incr. dexamethasone levels, risk of systemic corticosteroid effects including Cushing syndrome and adrenal suppression, serious infection, other adverse effects; may decr. nefazodone levels, efficacy (hepatic metabolism inhibited; hepatic metabolism induced)

  • nelfinavir
  • dexamethasone sodium phosphate (generic)
    +
    nelfinavir
    1 interaction

    Avoid/Use Alternative

    dexamethasone + nelfinavir

    if multiple myeloma use, use alternative or monitor hypercorticism s/sx; otherwise, caution advised: combo may incr. dexamethasone levels, risk of systemic corticosteroid effects including Cushing syndrome and adrenal suppression, serious infection, other adverse effects; may decr. nelfinavir levels, efficacy (hepatic metabolism inhibited; hepatic metabolism induced)

  • nevirapine
  • dexamethasone sodium phosphate (generic)
    +
    nevirapine
    1 interaction

    Avoid/Use Alternative

    dexamethasone + nevirapine

    avoid concomitant corticosteroids during nevirapine dose initiation and escalation; otherwise, caution advised: combo within first 14 days of nevirapine tx may incr. skin rash risk, severity; may decr. nevirapine levels, efficacy (mechanism unknown; hepatic metabolism induced)

  • norelgestromin (contraceptive)
  • dexamethasone sodium phosphate (generic)
    +
    norelgestromin (contraceptive)
    1 interaction

    Avoid/Use Alternative

    dexamethasone + norelgestromin (contraceptive)

    use additional non-hormonal or alternative contraception during and x28 days after dexamethasone tx; monitor thrombosis s/sx, especially if multiple myeloma use or w/ concomitant estrogen use: combo may decr. norelgestromin levels, contraceptive efficacy; may incr. risk of thromboembolism (hepatic metabolism induced; additive effects)

  • norethindrone (contraceptive)
  • dexamethasone sodium phosphate (generic)
    +
    norethindrone (contraceptive)
    1 interaction

    Avoid/Use Alternative

    dexamethasone + norethindrone (contraceptive)

    use additional non-hormonal or alternative contraception during and x28 days after dexamethasone tx; monitor thrombosis s/sx, especially w/ concomitant estrogen or multiple myeloma use: combo may decr. norethindrone levels, contraceptive efficacy; may incr. risk of thromboembolism (hepatic metabolism induced; additive effects)

  • norgestimate (contraceptive)
  • dexamethasone sodium phosphate (generic)
    +
    norgestimate (contraceptive)
    1 interaction

    Avoid/Use Alternative

    dexamethasone + norgestimate (contraceptive)

    use additional non-hormonal or alternative contraception during and x28 days after dexamethasone tx; monitor thrombosis s/sx, especially if multiple myeloma use or w/ concomitant estrogen use: combo may decr. norgestimate and active metabolites levels, contraceptive efficacy; may incr. risk of thromboembolism (hepatic metabolism induced; additive effects)

  • norgestrel (contraceptive)
  • dexamethasone sodium phosphate (generic)
    +
    norgestrel (contraceptive)
    1 interaction

    Avoid/Use Alternative

    dexamethasone + norgestrel (contraceptive)

    use additional non-hormonal or alternative contraception during and x28 days after dexamethasone tx; monitor thrombosis s/sx, especially w/ concomitant estrogen or multiple myeloma use: combo may decr. norgestrel levels, contraceptive efficacy; may incr. risk of thromboembolism (hepatic metabolism induced; additive effects)

  • obecabtagene autoleucel
  • dexamethasone sodium phosphate (generic)
    +
    obecabtagene autoleucel
    1 interaction

    Avoid/Use Alternative

    dexamethasone + obecabtagene autoleucel

    avoid combo unless severe cytokine release syndrome or ICANS tx: combo may incr. risk of serious infection; may decr. obecabtagene autoleucel efficacy (additive effects; antagonistic effects)

  • oliceridine
  • dexamethasone sodium phosphate (generic)
    +
    oliceridine
    1 interaction

    Avoid/Use Alternative

    dexamethasone + oliceridine

    use alternative or monitor withdrawal sx; consider oliceridine dose adjustment: combo may decr. oliceridine levels, efficacy (hepatic metabolism induced)

  • oxycodone
  • dexamethasone sodium phosphate (generic)
    +
    oxycodone
    1 interaction

    Avoid/Use Alternative

    dexamethasone + oxycodone

    use alternative or monitor withdrawal sx: combo may decr. oxycodone levels, efficacy (hepatic metabolism induced)

  • pentobarbital
  • dexamethasone sodium phosphate (generic)
    +
    pentobarbital
    1 interaction

    Avoid/Use Alternative

    dexamethasone + pentobarbital

    if multiple myeloma use, consider alternative; otherwise, consider incr. dexamethasone dose: combo may decr. dexamethasone levels, efficacy (hepatic metabolism induced)

  • phenobarbital
  • dexamethasone sodium phosphate (generic)
    +
    phenobarbital
    1 interaction

    Avoid/Use Alternative

    dexamethasone + phenobarbital

    if multiple myeloma use, consider alternative; otherwise, consider incr. dexamethasone dose: combo may decr. dexamethasone levels, efficacy; may alter seizure control (hepatic metabolism induced; antagonistic effects, dexamethasone may decr. seizure threshold)

  • phenytoin
  • dexamethasone sodium phosphate (generic)
    +
    phenytoin
    1 interaction

    Avoid/Use Alternative

    dexamethasone + phenytoin

    if multiple myeloma use, consider alternative; otherwise, consider incr. dexamethasone dose: combo may decr. dexamethasone levels, efficacy; may alter seizure control (hepatic metabolism induced; antagonistic effects, dexamethasone may decr. seizure threshold)

  • pimecrolimus topical
  • dexamethasone sodium phosphate (generic)
    +
    pimecrolimus topical
    1 interaction

    Avoid/Use Alternative

    dexamethasone + pimecrolimus topical

    avoid combo: combo may incr. risk of serious infection (additive effects)

  • posaconazole
  • dexamethasone sodium phosphate (generic)
    +
    posaconazole
    1 interaction

    Avoid/Use Alternative

    dexamethasone + posaconazole

    if multiple myeloma use, use alternative or monitor hypercorticism s/sx; otherwise, monitor potassium: combo may incr. dexamethasone levels, risk of systemic corticosteroid effects including Cushing syndrome and adrenal suppression, serious infection, hypokalemia, other adverse effects (hepatic metabolism inhibited, additive effects)

  • prednisolone
  • dexamethasone sodium phosphate (generic)
    +
    prednisolone
    1 interaction

    Avoid/Use Alternative

    dexamethasone + prednisolone

    avoid combo: combo may incr. risk of systemic corticosteroid effects including Cushing syndrome and adrenal suppression, serious infection, GI ulceration, perforation, bleeding, hypokalemia, HTN, other adverse effects (additive effects, duplicate therapy)

  • prednisone
  • dexamethasone sodium phosphate (generic)
    +
    prednisone
    1 interaction

    Avoid/Use Alternative

    dexamethasone + prednisone

    avoid combo: combo may incr. risk of systemic corticosteroid effects including Cushing syndrome and adrenal suppression, serious infection, GI ulceration, perforation, bleeding, hypokalemia, HTN, other adverse effects (additive effects, duplicate therapy)

  • primidone
  • dexamethasone sodium phosphate (generic)
    +
    primidone
    1 interaction

    Avoid/Use Alternative

    dexamethasone + primidone

    if multiple myeloma use, consider alternative; otherwise, consider incr. dexamethasone dose: combo may decr. dexamethasone levels, efficacy; may alter seizure control (hepatic metabolism induced; antagonistic effects, dexamethasone may decr. seizure threshold)

  • rabies vaccine
  • dexamethasone sodium phosphate (generic)
    +
    rabies vaccine
    1 interaction

    Avoid/Use Alternative

    dexamethasone + rabies vaccine

    if possible, avoid high-dose systemic steroid tx or vaccinate at least 2wk before starting long-term (>2wk) high-dose systemic steroids; consider post-immunization titer check: combo may result in inadequate vaccine response (immunosuppressive effects)

  • ribociclib
  • dexamethasone sodium phosphate (generic)
    +
    ribociclib
    1 interaction

    Avoid/Use Alternative

    dexamethasone + ribociclib

    if multiple myeloma use, use alternative or monitor hypercorticism s/sx; otherwise, caution advised: combo may incr. dexamethasone levels, risk of systemic corticosteroid effects including Cushing syndrome and adrenal suppression, serious infection, other adverse effects; may decr. ribociclib levels, efficacy (hepatic metabolism inhibited; hepatic metabolism induced)

  • rifabutin
  • dexamethasone sodium phosphate (generic)
    +
    rifabutin
    1 interaction

    Avoid/Use Alternative

    dexamethasone + rifabutin

    if multiple myeloma use, consider alternative; otherwise, consider incr. dexamethasone dose: combo may decr. dexamethasone levels, efficacy (hepatic metabolism induced)

  • rifampin
  • dexamethasone sodium phosphate (generic)
    +
    rifampin
    1 interaction

    Avoid/Use Alternative

    dexamethasone + rifampin

    if multiple myeloma use, consider alternative; otherwise, consider incr. dexamethasone dose: combo may decr. dexamethasone levels, efficacy (hepatic metabolism induced)

  • ritonavir
  • dexamethasone sodium phosphate (generic)
    +
    ritonavir
    1 interaction

    Avoid/Use Alternative

    dexamethasone + ritonavir

    if multiple myeloma use, use alternative or monitor hypercorticism s/sx; otherwise, consider alternative (incl. prednisolone), especially if long-term corticosteroid use; lower risk w/ nirmatrelvir/ritonavir tx: combo may decr. ritonavir levels, efficacy; may incr. dexamethasone levels, risk of systemic corticosteroid effects including Cushing syndrome and adrenal suppression, serious infection, other adverse effects (hepatic metabolism induced; hepatic metabolism inhibited)

  • segesterone (contraceptive)
  • dexamethasone sodium phosphate (generic)
    +
    segesterone (contraceptive)
    1 interaction

    Avoid/Use Alternative

    dexamethasone + segesterone (contraceptive)

    use additional non-hormonal or alternative contraception during and x28 days after dexamethasone tx; monitor thrombosis s/sx, especially if multiple myeloma use or w/ concomitant estrogen use: combo may decr. segesterone levels, contraceptive efficacy; may incr. risk of thromboembolism (hepatic metabolism induced; additive effects)

  • St. John's wort
  • dexamethasone sodium phosphate (generic)
    +
    St. John's wort
    1 interaction

    Avoid/Use Alternative

    dexamethasone + St. John's wort

    if multiple myeloma use, consider alternative; otherwise, consider incr. dexamethasone dose: combo may decr. dexamethasone levels, efficacy (hepatic metabolism induced)

  • tipranavir
  • dexamethasone sodium phosphate (generic)
    +
    tipranavir
    1 interaction

    Avoid/Use Alternative

    dexamethasone + tipranavir

    if multiple myeloma use, use alternative or monitor hypercorticism s/sx; otherwise, caution advised: combo may incr. dexamethasone levels, risk of systemic corticosteroid effects including Cushing syndrome and adrenal suppression, serious infection, other adverse effects; may decr. tipranavir levels, efficacy (hepatic metabolism inhibited; hepatic metabolism induced)

  • tisagenlecleucel
  • dexamethasone sodium phosphate (generic)
    +
    tisagenlecleucel
    1 interaction

    Avoid/Use Alternative

    dexamethasone + tisagenlecleucel

    avoid combo unless severe cytokine release syndrome tx: combo may decr. tisagenlecleucel efficacy; may incr. risk of serious infection (antagonistic effects; additive effects)

  • tramadol
  • dexamethasone sodium phosphate (generic)
    +
    tramadol
    1 interaction

    Avoid/Use Alternative

    dexamethasone + tramadol

    use alternative or monitor withdrawal sx: combo may decr. tramadol levels, efficacy; may incr. risk of seizures (hepatic metabolism induced; additive effects)

  • tranexamic acid
  • dexamethasone sodium phosphate (generic)
    +
    tranexamic acid
    1 interaction

    Avoid/Use Alternative

    dexamethasone + tranexamic acid

    avoid combo: combo may incr. risk of thromboembolism (additive effects)

  • tucatinib
  • dexamethasone sodium phosphate (generic)
    +
    tucatinib
    1 interaction

    Avoid/Use Alternative

    dexamethasone + tucatinib

    if multiple myeloma use, use alternative or monitor hypercorticism s/sx; otherwise, caution advised: combo may incr. dexamethasone levels, risk of systemic corticosteroid effects including Cushing syndrome and adrenal suppression, serious infection, other adverse effects (hepatic metabolism inhibited)

  • ulipristal (post-coital contraceptive)
  • dexamethasone sodium phosphate (generic)
    +
    ulipristal (post-coital contraceptive)
    1 interaction

    Avoid/Use Alternative

    dexamethasone + ulipristal (post-coital contraceptive)

    avoid combo: combo may decr. ulipristal levels, post-coital contraceptive efficacy (hepatic metabolism induced)

  • vaccinia immune globulin
  • dexamethasone sodium phosphate (generic)
    +
    vaccinia immune globulin
    1 interaction

    Avoid/Use Alternative

    dexamethasone + vaccinia immune globulin

    use alternative or monitor thrombosis s/sx, especially if multiple myeloma use; use lowest vaccinia immune globulin concentration and infusion rate possible: combo may incr. risk of thromboembolism (additive effects)

  • vamorolone
  • dexamethasone sodium phosphate (generic)
    +
    vamorolone
    1 interaction

    Avoid/Use Alternative

    dexamethasone + vamorolone

    avoid combo: combo may incr. risk of systemic corticosteroid effects including Cushing syndrome and adrenal suppression, serious infection, GI ulceration, perforation, bleeding, thromboembolism, hypokalemia, HTN, other adverse effects (additive effects, duplicate therapy)

  • voriconazole
  • dexamethasone sodium phosphate (generic)
    +
    voriconazole
    1 interaction

    Avoid/Use Alternative

    dexamethasone + voriconazole

    if multiple myeloma use, use alternative or monitor hypercorticism s/sx; otherwise, monitor for breakthrough fungal infection: combo may incr. dexamethasone levels, risk of systemic corticosteroid effects including Cushing syndrome and adrenal suppression, serious infection, other adverse effects; may decr. voriconazole levels, efficacy (hepatic metabolism inhibited; hepatic metabolism induced)

  • zuranolone
  • dexamethasone sodium phosphate (generic)
    +
    zuranolone
    1 interaction

    Avoid/Use Alternative

    dexamethasone + zuranolone

    avoid combo: combo may decr. zuranolone levels, efficacy (hepatic metabolism induced)

Monitor/Modify Tx

  • abemaciclib
  • dexamethasone sodium phosphate (generic)
    +
    abemaciclib
    1 interaction

    Monitor/Modify Tx

    dexamethasone + abemaciclib

    monitor thrombosis s/sx, especially if multiple myeloma use: combo may decr. abemaciclib levels, efficacy; may incr. risk of serious infection, thromboembolism (hepatic metabolism induced; additive effects)

  • abiraterone acetate
  • dexamethasone sodium phosphate (generic)
    +
    abiraterone acetate
    1 interaction

    Monitor/Modify Tx

    dexamethasone + abiraterone acetate

    monitor BP, potassium: combo may incr. risk of HTN, hypokalemia (additive effects)

  • abrocitinib
  • dexamethasone sodium phosphate (generic)
    +
    abrocitinib
    1 interaction

    Monitor/Modify Tx

    dexamethasone + abrocitinib

    monitor thrombosis s/sx, especially if multiple myeloma use: combo may incr. risk of serious infection, thromboembolism (additive effects)

  • acarbose
  • dexamethasone sodium phosphate (generic)
    +
    acarbose
    1 interaction

    Monitor/Modify Tx

    dexamethasone + acarbose

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • acebutolol
  • dexamethasone sodium phosphate (generic)
    +
    acebutolol
    1 interaction

    Monitor/Modify Tx

    dexamethasone + acebutolol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • acetazolamide
  • dexamethasone sodium phosphate (generic)
    +
    acetazolamide
    1 interaction

    Monitor/Modify Tx

    dexamethasone + acetazolamide

    monitor potassium: combo may incr. risk of hypokalemia; may alter seizure control (additive effects; antagonistic effects, dexamethasone may decr. seizure threshold)

  • afatinib
  • dexamethasone sodium phosphate (generic)
    +
    afatinib
    1 interaction

    Monitor/Modify Tx

    dexamethasone + afatinib

    monitor bleeding s/sx: combo may incr. risk of GI ulceration, perforation, bleeding, including life-threatening (additive effects)

  • aficamten
  • dexamethasone sodium phosphate (generic)
    +
    aficamten
    1 interaction

    Monitor/Modify Tx

    dexamethasone + aficamten

    monitor cardiac fxn, incl. LVEF: combo may decr. aficamten levels, efficacy (hepatic metabolism induced)

  • aflibercept
  • dexamethasone sodium phosphate (generic)
    +
    aflibercept
    1 interaction

    Monitor/Modify Tx

    dexamethasone + aflibercept

    monitor thrombosis s/sx, especially if multiple myeloma use: combo may incr. risk of thromboembolism (additive effects)

  • albuterol
  • dexamethasone sodium phosphate (generic)
    +
    albuterol
    1 interaction

    Monitor/Modify Tx

    dexamethasone + albuterol

    monitor potassium, BP: combo may incr. risk of hypokalemia, HTN (additive effects)

  • albuterol inhaled
  • dexamethasone sodium phosphate (generic)
    +
    albuterol inhaled
    1 interaction

    Monitor/Modify Tx

    dexamethasone + albuterol inhaled

    monitor potassium, BP: combo may incr. risk of hypokalemia, HTN (additive effects)

  • alendronate
  • dexamethasone sodium phosphate (generic)
    +
    alendronate
    1 interaction

    Monitor/Modify Tx

    dexamethasone + alendronate

    monitor bleeding s/sx: combo may incr. risk of upper GI ulceration, perforation, bleeding (additive effects)

  • aliskiren
  • dexamethasone sodium phosphate (generic)
    +
    aliskiren
    1 interaction

    Monitor/Modify Tx

    dexamethasone + aliskiren

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • almotriptan
  • dexamethasone sodium phosphate (generic)
    +
    almotriptan
    1 interaction

    Monitor/Modify Tx

    dexamethasone + almotriptan

    monitor BP: combo may incr. risk of HTN (additive effects)

  • aloe
  • dexamethasone sodium phosphate (generic)
    +
    aloe
    1 interaction

    Monitor/Modify Tx

    dexamethasone + aloe

    monitor potassium w/ aloe laxative doses: combo may incr. risk of hypokalemia (additive effects)

  • alogliptin
  • dexamethasone sodium phosphate (generic)
    +
    alogliptin
    1 interaction

    Monitor/Modify Tx

    dexamethasone + alogliptin

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • amiloride
  • dexamethasone sodium phosphate (generic)
    +
    amiloride
    1 interaction

    Monitor/Modify Tx

    dexamethasone + amiloride

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • aminocaproic acid
  • dexamethasone sodium phosphate (generic)
    +
    aminocaproic acid
    1 interaction

    Monitor/Modify Tx

    dexamethasone + aminocaproic acid

    monitor thrombosis s/sx, especially if multiple myeloma use: combo may incr. risk of thromboembolism (additive effects)

  • amlodipine
  • dexamethasone sodium phosphate (generic)
    +
    amlodipine
    1 interaction

    Monitor/Modify Tx

    dexamethasone + amlodipine

    monitor BP: combo may decr. (lev)amlodipine levels, efficacy (hepatic metabolism induced, antagonistic effects)

  • amphetamine
  • dexamethasone sodium phosphate (generic)
    +
    amphetamine
    1 interaction

    Monitor/Modify Tx

    dexamethasone + amphetamine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • angiotensin II
  • dexamethasone sodium phosphate (generic)
    +
    angiotensin II
    1 interaction

    Monitor/Modify Tx

    dexamethasone + angiotensin II

    monitor BP, thrombosis s/sx, especially if multiple myeloma use: combo may incr. risk of HTN, thromboembolism (additive effects)

  • anthrax immune globulin
  • dexamethasone sodium phosphate (generic)
    +
    anthrax immune globulin
    1 interaction

    Monitor/Modify Tx

    dexamethasone + anthrax immune globulin

    monitor thrombosis s/sx, especially if multiple myeloma use; use lowest anthrax immune globulin infusion rate possible: combo may incr. risk of thromboembolism (additive effects)

  • anthrax vaccine
  • dexamethasone sodium phosphate (generic)
    +
    anthrax vaccine
    1 interaction

    Monitor/Modify Tx

    dexamethasone + anthrax vaccine

    if possible, vaccinate at least 2wk before starting long-term (>2wk) high-dose systemic steroids; consider post-immunization titer check: combo may result in inadequate vaccine response (immunosuppressive effects)

  • anti-inhibitor coagulant complex
  • dexamethasone sodium phosphate (generic)
    +
    anti-inhibitor coagulant complex
    1 interaction

    Monitor/Modify Tx

    dexamethasone + anti-inhibitor coagulant complex

    monitor thrombosis s/sx, especially w/ anti-inhibitor coagulant complex dose >100 units/kg and/or multiple myeloma use: combo may incr. risk of thromboembolism (additive effects)

  • antihemophilic factor (factor VIII)/von Willebrand factor complex
  • dexamethasone sodium phosphate (generic)
    +
    antihemophilic factor (factor VIII)/ von Willebrand factor complex
    1 interaction

    Monitor/Modify Tx

    dexamethasone + antihemophilic factor (factor VIII)/ von Willebrand factor complex

    monitor thrombosis s/sx, especially if multiple myeloma use: combo may incr. risk of thromboembolism (additive effects)

  • aprepitant
  • dexamethasone sodium phosphate (generic)
    +
    aprepitant
    1 interaction

    Monitor/Modify Tx

    dexamethasone + aprepitant

    if aprepitant 3-day regimen, decr. dexamethasone PO dose 50%; aprepitant single dose-regimen OK: combo may incr. dexamethasone levels, risk of systemic corticosteroid effects including Cushing syndrome and adrenal suppression, serious infection, other adverse effects (hepatic metabolism inhibited)

  • aprocitentan
  • dexamethasone sodium phosphate (generic)
    +
    aprocitentan
    1 interaction

    Monitor/Modify Tx

    dexamethasone + aprocitentan

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • arformoterol inhaled
  • dexamethasone sodium phosphate (generic)
    +
    arformoterol inhaled
    1 interaction

    Monitor/Modify Tx

    dexamethasone + arformoterol inhaled

    monitor potassium, BP: combo may incr. risk of hypokalemia, HTN (additive effects)

  • armodafinil
  • dexamethasone sodium phosphate (generic)
    +
    armodafinil
    1 interaction

    Monitor/Modify Tx

    dexamethasone + armodafinil

    monitor BP: combo may incr. risk of HTN (additive effects)

  • asciminib
  • dexamethasone sodium phosphate (generic)
    +
    asciminib
    1 interaction

    Monitor/Modify Tx

    dexamethasone + asciminib

    monitor BP, thrombosis s/sx, especially if multiple myeloma use: combo may incr. risk of HTN, thromboembolism (additive effects)

  • asparaginase
  • dexamethasone sodium phosphate (generic)
    +
    asparaginase
    1 interaction

    Monitor/Modify Tx

    dexamethasone + asparaginase

    monitor potassium, thrombosis s/sx, especially if multiple myeloma use: combo may incr. risk of hypokalemia, thromboembolism (additive effects)

  • aspirin
  • dexamethasone sodium phosphate (generic)
    +
    aspirin
    1 interaction

    Monitor/Modify Tx

    dexamethasone + aspirin

    monitor bleeding s/sx: combo may incr. risk of GI ulceration, perforation, bleeding, including life-threatening; may decr. levels of aspirin, efficacy (additive effects; mechanism unknown)

  • atenolol
  • dexamethasone sodium phosphate (generic)
    +
    atenolol
    1 interaction

    Monitor/Modify Tx

    dexamethasone + atenolol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • atidarsagene autotemcel
  • dexamethasone sodium phosphate (generic)
    +
    atidarsagene autotemcel
    1 interaction

    Monitor/Modify Tx

    dexamethasone + atidarsagene autotemcel

    monitor thrombosis s/sx, especially if multiple myeloma use: combo may incr. risk of serious infection, thromboembolism (additive effects)

  • atogepant
  • dexamethasone sodium phosphate (generic)
    +
    atogepant
    1 interaction

    Monitor/Modify Tx

    dexamethasone + atogepant

    monitor BP; CHRONIC MIGRAINE: incr. atogepant dose to 60 mg/day; EPISODIC MIGRAINE: incr. atogepant dose to 30 or 60 mg/day: combo may decr. atogepant levels, efficacy; may incr. risk of HTN (hepatic metabolism induced; additive effects)

  • atomoxetine
  • dexamethasone sodium phosphate (generic)
    +
    atomoxetine
    1 interaction

    Monitor/Modify Tx

    dexamethasone + atomoxetine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • atropine ophthalmic
  • dexamethasone sodium phosphate (generic)
    +
    atropine ophthalmic
    1 interaction

    Monitor/Modify Tx

    dexamethasone + atropine ophthalmic

    monitor BP: combo may incr. risk of HTN (additive effects)

  • avatrombopag
  • dexamethasone sodium phosphate (generic)
    +
    avatrombopag
    1 interaction

    Monitor/Modify Tx

    dexamethasone + avatrombopag

    monitor platelets, thrombosis s/sx, especially if multiple myeloma use: combo may incr. risk of thromboembolism (additive effects)

  • axitinib
  • dexamethasone sodium phosphate (generic)
    +
    axitinib
    1 interaction

    Monitor/Modify Tx

    dexamethasone + axitinib

    monitor BP, bleeding or thrombosis s/sx, especially if multiple myeloma use: combo may decr. axitinib levels, efficacy; may incr. risk of HTN, GI ulceration, perforation, bleeding (including life-threatening), thromboembolism (hepatic metabolism induced; additive effects)

  • azilsartan medoxomil
  • dexamethasone sodium phosphate (generic)
    +
    azilsartan medoxomil
    1 interaction

    Monitor/Modify Tx

    dexamethasone + azilsartan medoxomil

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • baricitinib
  • dexamethasone sodium phosphate (generic)
    +
    baricitinib
    1 interaction

    Monitor/Modify Tx

    dexamethasone + baricitinib

    monitor thrombosis s/sx, especially if multiple myeloma use: combo may incr. risk of serious infection, thromboembolism (additive effects)

  • bazedoxifene
  • dexamethasone sodium phosphate (generic)
    +
    bazedoxifene
    1 interaction

    Monitor/Modify Tx

    dexamethasone + bazedoxifene

    monitor thrombosis s/sx, especially if multiple myeloma use: combo may incr. risk of thromboembolism (additive effects)

  • bempedoic acid
  • dexamethasone sodium phosphate (generic)
    +
    bempedoic acid
    1 interaction

    Monitor/Modify Tx

    dexamethasone + bempedoic acid

    monitor tendon rupture s/sx: combo may incr. risk of tendon rupture (additive effects)

  • benazepril
  • dexamethasone sodium phosphate (generic)
    +
    benazepril
    1 interaction

    Monitor/Modify Tx

    dexamethasone + benazepril

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • benzphetamine
  • dexamethasone sodium phosphate (generic)
    +
    benzphetamine
    1 interaction

    Monitor/Modify Tx

    dexamethasone + benzphetamine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • betaxolol
  • dexamethasone sodium phosphate (generic)
    +
    betaxolol
    1 interaction

    Monitor/Modify Tx

    dexamethasone + betaxolol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • bevacizumab
  • dexamethasone sodium phosphate (generic)
    +
    bevacizumab
    1 interaction

    Monitor/Modify Tx

    dexamethasone + bevacizumab

    monitor BP, bleeding or thrombosis s/sx, especially if multiple myeloma use: combo may incr. risk of HTN, GI ulceration, perforation, bleeding (including life-threatening), thromboembolism (additive effects)

  • bexagliflozin
  • dexamethasone sodium phosphate (generic)
    +
    bexagliflozin
    1 interaction

    Monitor/Modify Tx

    dexamethasone + bexagliflozin

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • binimetinib
  • dexamethasone sodium phosphate (generic)
    +
    binimetinib
    1 interaction

    Monitor/Modify Tx

    dexamethasone + binimetinib

    monitor thrombosis s/sx, especially if multiple myeloma use: combo may incr. risk of thromboembolism (additive effects)

  • bismuth subsalicylate
  • dexamethasone sodium phosphate (generic)
    +
    bismuth subsalicylate
    1 interaction

    Monitor/Modify Tx

    dexamethasone + bismuth subsalicylate

    monitor BP w/ high-dose bismuth subsalicylate: combo may incr. risk of HTN (additive effects)

  • bisoprolol
  • dexamethasone sodium phosphate (generic)
    +
    bisoprolol
    1 interaction

    Monitor/Modify Tx

    dexamethasone + bisoprolol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • botulism immune globulin
  • dexamethasone sodium phosphate (generic)
    +
    botulism immune globulin
    1 interaction

    Monitor/Modify Tx

    dexamethasone + botulism immune globulin

    monitor thrombosis s/sx, especially if multiple myeloma use; use lowest botulism immune globulin infusion rate possible: combo may incr. risk of thromboembolism (additive effects)

  • brentuximab vedotin
  • dexamethasone sodium phosphate (generic)
    +
    brentuximab vedotin
    1 interaction

    Monitor/Modify Tx

    dexamethasone + brentuximab vedotin

    monitor bleeding s/sx: combo may incr. risk of serious infection, GI ulceration, perforation, bleeding, including life-threatening (additive effects)

  • brigatinib
  • dexamethasone sodium phosphate (generic)
    +
    brigatinib
    1 interaction

    Monitor/Modify Tx

    dexamethasone + brigatinib

    monitor BP: combo may decr. brigatinib levels, efficacy; may incr. risk of HTN (hepatic metabolism induced; additive effects)

  • brolucizumab
  • dexamethasone sodium phosphate (generic)
    +
    brolucizumab
    1 interaction

    Monitor/Modify Tx

    dexamethasone + brolucizumab

    monitor thrombosis s/sx, especially if multiple myeloma use: combo may incr. risk of thromboembolism (additive effects)

  • bromocriptine
  • dexamethasone sodium phosphate (generic)
    +
    bromocriptine
    1 interaction

    Monitor/Modify Tx

    dexamethasone + bromocriptine

    monitor glucose in type 2 diabetes mellitus pts: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • bumetanide
  • dexamethasone sodium phosphate (generic)
    +
    bumetanide
    1 interaction

    Monitor/Modify Tx

    dexamethasone + bumetanide

    monitor potassium, BP: combo may incr. risk of hypokalemia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • buprenorphine
  • dexamethasone sodium phosphate (generic)
    +
    buprenorphine
    1 interaction

    Monitor/Modify Tx

    dexamethasone + buprenorphine

    monitor withdrawal sx: combo may decr. buprenorphine levels, efficacy (hepatic metabolism induced)

  • bupropion
  • dexamethasone sodium phosphate (generic)
    +
    bupropion
    1 interaction

    Monitor/Modify Tx

    dexamethasone + bupropion

    monitor BP; consider lower bupropion doses: combo may incr. risk of HTN, seizures (additive effects)

  • C1 esterase inhibitor
  • dexamethasone sodium phosphate (generic)
    +
    C1 esterase inhibitor
    1 interaction

    Monitor/Modify Tx

    dexamethasone + C1 esterase inhibitor

    monitor thrombosis s/sx, especially if multiple myeloma use: combo may incr. risk of thromboembolism (additive effects)

  • cabazitaxel
  • dexamethasone sodium phosphate (generic)
    +
    cabazitaxel
    1 interaction

    Monitor/Modify Tx

    dexamethasone + cabazitaxel

    monitor bleeding s/sx: combo may incr. risk of serious infection, GI ulceration, perforation, bleeding, including life-threatening (additive effects)

  • cabozantinib
  • dexamethasone sodium phosphate (generic)
    +
    cabozantinib
    1 interaction

    Monitor/Modify Tx

    dexamethasone + cabozantinib

    monitor BP, bleeding or thrombosis s/sx, especially if multiple myeloma use: combo may decr. cabozantinib levels, efficacy; may incr. risk of GI ulceration, perforation, bleeding (including life-threatening), HTN, thromboembolism (hepatic metabolism induced; additive effects)

  • caffeine
  • dexamethasone sodium phosphate (generic)
    +
    caffeine
    1 interaction

    Monitor/Modify Tx

    dexamethasone + caffeine

    monitor BP; avoid excessive caffeine intake: combo may incr. risk of HTN (additive effects)

  • caffeine citrate
  • dexamethasone sodium phosphate (generic)
    +
    caffeine citrate
    1 interaction

    Monitor/Modify Tx

    dexamethasone + caffeine citrate

    monitor BP: combo may incr. risk of HTN (additive effects)

  • calaspargase
  • dexamethasone sodium phosphate (generic)
    +
    calaspargase
    1 interaction

    Monitor/Modify Tx

    dexamethasone + calaspargase

    monitor thrombosis s/sx, especially if multiple myeloma use: combo may incr. risk of thromboembolism (additive effects)

  • canagliflozin
  • dexamethasone sodium phosphate (generic)
    +
    canagliflozin
    1 interaction

    Monitor/Modify Tx

    dexamethasone + canagliflozin

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • candesartan cilexetil
  • dexamethasone sodium phosphate (generic)
    +
    candesartan cilexetil
    1 interaction

    Monitor/Modify Tx

    dexamethasone + candesartan cilexetil

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • cannabis
  • dexamethasone sodium phosphate (generic)
    +
    cannabis
    1 interaction

    Monitor/Modify Tx

    dexamethasone + cannabis

    monitor BP: combo may incr. risk of HTN (additive effects)

  • captopril
  • dexamethasone sodium phosphate (generic)
    +
    captopril
    1 interaction

    Monitor/Modify Tx

    dexamethasone + captopril

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • carfilzomib
  • dexamethasone sodium phosphate (generic)
    +
    carfilzomib
    1 interaction

    Monitor/Modify Tx

    dexamethasone + carfilzomib

    monitor BP, potassium, thrombosis s/sx, especially if multiple myeloma use; consider antiviral prophylaxis: combo may incr. risk of HTN, hypokalemia, serious infection, thromboembolism (additive effects)

  • carglumic acid
  • dexamethasone sodium phosphate (generic)
    +
    carglumic acid
    1 interaction

    Monitor/Modify Tx

    dexamethasone + carglumic acid

    monitor ammonia levels: combo may decr. carglumic acid efficacy (antagonistic effects)

  • carvedilol
  • dexamethasone sodium phosphate (generic)
    +
    carvedilol
    1 interaction

    Monitor/Modify Tx

    dexamethasone + carvedilol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • caspofungin
  • dexamethasone sodium phosphate (generic)
    +
    caspofungin
    1 interaction

    Monitor/Modify Tx

    dexamethasone + caspofungin

    consider incr. caspofungin dose to 70 mg/day in adults, 70 mg/m^2 in peds: combo may decr. caspofungin levels, efficacy (mechanism unknown, hepatic metabolism possibly induced)

  • celecoxib
  • dexamethasone sodium phosphate (generic)
    +
    celecoxib
    1 interaction

    Monitor/Modify Tx

    dexamethasone + celecoxib

    monitor BP, bleeding or thrombosis s/sx, especially if multiple myeloma use; use lowest effective celecoxib dose, shortest effective tx duration: combo may incr. risk of HTN, GI ulceration, perforation, bleeding (including life-threatening), thromboembolism (additive effects)

  • cetuximab
  • dexamethasone sodium phosphate (generic)
    +
    cetuximab
    1 interaction

    Monitor/Modify Tx

    dexamethasone + cetuximab

    monitor potassium: combo may incr. risk of hypokalemia (additive effects)

  • chikungunya vaccine
  • dexamethasone sodium phosphate (generic)
    +
    chikungunya vaccine
    1 interaction

    Monitor/Modify Tx

    dexamethasone + chikungunya vaccine

    if possible, vaccinate at least 2wk before starting long-term (>2wk) high-dose systemic steroids; consider post-immunization titer check: combo may result in inadequate vaccine response (immunosuppressive effects)

  • chlorothiazide
  • dexamethasone sodium phosphate (generic)
    +
    chlorothiazide
    1 interaction

    Monitor/Modify Tx

    dexamethasone + chlorothiazide

    monitor potassium, BP: combo may incr. risk of hypokalemia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • chlorthalidone
  • dexamethasone sodium phosphate (generic)
    +
    chlorthalidone
    1 interaction

    Monitor/Modify Tx

    dexamethasone + chlorthalidone

    monitor potassium, BP: combo may incr. risk of hypokalemia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • chorionic gonadotropin
  • dexamethasone sodium phosphate (generic)
    +
    chorionic gonadotropin
    1 interaction

    Monitor/Modify Tx

    dexamethasone + chorionic gonadotropin

    monitor thrombosis s/sx, especially if multiple myeloma use: combo may incr. risk of thromboembolism (additive effects)

  • cinacalcet
  • dexamethasone sodium phosphate (generic)
    +
    cinacalcet
    1 interaction

    Monitor/Modify Tx

    dexamethasone + cinacalcet

    monitor bleeding s/sx: combo may incr. risk of GI ulceration, perforation, bleeding (additive effects)

  • cisplatin
  • dexamethasone sodium phosphate (generic)
    +
    cisplatin
    1 interaction

    Monitor/Modify Tx

    dexamethasone + cisplatin

    monitor potassium: combo may incr. risk of serious infection, hypokalemia (additive effects)

  • clevidipine
  • dexamethasone sodium phosphate (generic)
    +
    clevidipine
    1 interaction

    Monitor/Modify Tx

    dexamethasone + clevidipine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • clonidine
  • dexamethasone sodium phosphate (generic)
    +
    clonidine
    1 interaction

    Monitor/Modify Tx

    dexamethasone + clonidine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • clozapine
  • dexamethasone sodium phosphate (generic)
    +
    clozapine
    1 interaction

    Monitor/Modify Tx

    dexamethasone + clozapine

    monitor thrombosis s/sx, especially if multiple myeloma use: combo may incr. risk of seizures, thromboembolism (additive effects)

  • coagulation factor IX
  • dexamethasone sodium phosphate (generic)
    +
    coagulation factor IX
    1 interaction

    Monitor/Modify Tx

    dexamethasone + coagulation factor IX

    monitor thrombosis s/sx, especially if multiple myeloma use: combo may incr. risk of thromboembolism (additive effects)

  • coagulation factor VIIa
  • dexamethasone sodium phosphate (generic)
    +
    coagulation factor VIIa
    1 interaction

    Monitor/Modify Tx

    dexamethasone + coagulation factor VIIa

    monitor thrombosis s/sx, especially if multiple myeloma use: combo may incr. risk of thromboembolism (additive effects)

  • coagulation factor XIII A-subunit
  • dexamethasone sodium phosphate (generic)
    +
    coagulation factor XIII A-subunit
    1 interaction

    Monitor/Modify Tx

    dexamethasone + coagulation factor XIII A-subunit

    monitor thrombosis s/sx, especially if multiple myeloma use: combo may incr. risk of thromboembolism (additive effects)

  • cocaine
  • dexamethasone sodium phosphate (generic)
    +
    cocaine
    1 interaction

    Monitor/Modify Tx

    dexamethasone + cocaine

    monitor BP, HR: combo may incr. cocaine levels, risk of HTN, tachycardia, other adverse effects (plasma metabolism possibly inhibited, additive effects)

  • colesevelam
  • dexamethasone sodium phosphate (generic)
    +
    colesevelam
    1 interaction

    Monitor/Modify Tx

    dexamethasone + colesevelam

    monitor glucose in type 2 diabetes mellitus pts: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • colestipol
  • dexamethasone sodium phosphate (generic)
    +
    colestipol
    1 interaction

    Monitor/Modify Tx

    dexamethasone + colestipol

    give oral dexamethasone at least 1h before or 4h after each colestipol dose: combo may decr. dexamethasone levels, efficacy (absorption decreased/delayed)

  • concizumab
  • dexamethasone sodium phosphate (generic)
    +
    concizumab
    1 interaction

    Monitor/Modify Tx

    dexamethasone + concizumab

    monitor thrombosis s/sx, especially if multiple myeloma use: combo may incr. risk of thromboembolism (additive effects)

  • copanlisib
  • dexamethasone sodium phosphate (generic)
    +
    copanlisib
    1 interaction

    Monitor/Modify Tx

    dexamethasone + copanlisib

    monitor BP: combo may incr. risk of serious infection, HTN (additive effects, copanlisib may cause infusion-related HTN)

  • corticotropin
  • dexamethasone sodium phosphate (generic)
    +
    corticotropin
    1 interaction

    Monitor/Modify Tx

    dexamethasone + corticotropin

    monitor bleeding s/sx, potassium, BP: combo may incr. risk of GI ulceration, perforation, bleeding, serious infection, hypokalemia, HTN (additive effects)

  • cosyntropin
  • dexamethasone sodium phosphate (generic)
    +
    cosyntropin
    1 interaction

    Monitor/Modify Tx

    dexamethasone + cosyntropin

    hold dexamethasone on day of test: combo may interfere with test results (dexamethasone may alter plasma cortisol levels)

  • COVID-19 vaccine
  • dexamethasone sodium phosphate (generic)
    +
    COVID-19 vaccine
    1 interaction

    Monitor/Modify Tx

    dexamethasone + COVID-19 vaccine

    if possible, vaccinate at least 2wk before starting long-term (>2wk) high-dose systemic steroids; consider post-immunization titer check: combo may result in inadequate vaccine response (immunosuppressive effects)

  • crizotinib
  • dexamethasone sodium phosphate (generic)
    +
    crizotinib
    1 interaction

    Monitor/Modify Tx

    dexamethasone + crizotinib

    monitor potassium: combo may incr. dexamethasone levels, risk of systemic corticosteroid effects including Cushing syndrome and adrenal suppression, serious infection, other adverse effects; may decr. crizotinib levels, efficacy; may incr. risk of hypokalemia (hepatic metabolism inhibited; hepatic metabolism induced; additive effects)

  • cyclophosphamide
  • dexamethasone sodium phosphate (generic)
    +
    cyclophosphamide
    1 interaction

    Monitor/Modify Tx

    dexamethasone + cyclophosphamide

    monitor CBC, renal, cardiac fxn: combo may incr. cyclophosphamide active metabolite levels, risk of serious infection, myelosuppression, nephrotoxicity, cardiotoxicity, other adverse effects (hepatic metabolism possibly induced, incr. active metabolite formation; additive effects)

  • cyclosporine
  • dexamethasone sodium phosphate (generic)
    +
    cyclosporine
    1 interaction

    Monitor/Modify Tx

    dexamethasone + cyclosporine

    monitor cyclosporine levels, BP: combo may decr. cyclosporine levels, efficacy; may incr. dexamethasone levels, risk of systemic corticosteroid effects including Cushing syndrome and adrenal suppression, serious infection, other adverse effects; may incr. risk of seizures, HTN (hepatic metabolism induced; hepatic metabolism inhibited; additive effects)

  • cysteamine
  • dexamethasone sodium phosphate (generic)
    +
    cysteamine
    1 interaction

    Monitor/Modify Tx

    dexamethasone + cysteamine

    monitor bleeding s/sx: combo may incr. risk of GI ulceration, perforation, bleeding (additive effects)

  • cytomegalovirus immune globulin
  • dexamethasone sodium phosphate (generic)
    +
    cytomegalovirus immune globulin
    1 interaction

    Monitor/Modify Tx

    dexamethasone + cytomegalovirus immune globulin

    monitor thrombosis s/sx, especially if multiple myeloma use: combo may incr. risk of thromboembolism (additive effects)

  • danazol
  • dexamethasone sodium phosphate (generic)
    +
    danazol
    1 interaction

    Monitor/Modify Tx

    dexamethasone + danazol

    monitor BP, thrombosis s/sx, especially if multiple myeloma use: combo may incr. dexamethasone levels, risk of systemic corticosteroid effects including Cushing syndrome and adrenal suppression, serious infection, HTN, hypercalcemia, thromboembolism, other adverse effects (hepatic metabolism inhibited, additive effects)

  • dapagliflozin
  • dexamethasone sodium phosphate (generic)
    +
    dapagliflozin
    1 interaction

    Monitor/Modify Tx

    dexamethasone + dapagliflozin

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • darbepoetin alfa
  • dexamethasone sodium phosphate (generic)
    +
    darbepoetin alfa
    1 interaction

    Monitor/Modify Tx

    dexamethasone + darbepoetin alfa

    monitor BP, thrombosis s/sx, especially if multiple myeloma use: combo may incr. risk of HTN, thromboembolism (additive effects)

  • decitabine
  • dexamethasone sodium phosphate (generic)
    +
    decitabine
    1 interaction

    Monitor/Modify Tx

    dexamethasone + decitabine

    monitor potassium w/ IV decitabine use; otherwise, caution advised: combo may incr. risk of hypokalemia, serious infection (additive effects)

  • deferasirox
  • dexamethasone sodium phosphate (generic)
    +
    deferasirox
    1 interaction

    Monitor/Modify Tx

    dexamethasone + deferasirox

    monitor bleeding s/sx: combo may incr. risk of GI ulceration, perforation, bleeding, including life-threatening (additive effects)

  • desvenlafaxine
  • dexamethasone sodium phosphate (generic)
    +
    desvenlafaxine
    1 interaction

    Monitor/Modify Tx

    dexamethasone + desvenlafaxine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • deuruxolitinib
  • dexamethasone sodium phosphate (generic)
    +
    deuruxolitinib
    1 interaction

    Monitor/Modify Tx

    dexamethasone + deuruxolitinib

    monitor bleeding or thrombosis s/sx, especially if multiple myeloma use: combo may incr. risk of thromboembolism, GI ulceration, perforation, bleeding, serious infection (additive effects)

  • dexmethylphenidate
  • dexamethasone sodium phosphate (generic)
    +
    dexmethylphenidate
    1 interaction

    Monitor/Modify Tx

    dexamethasone + dexmethylphenidate

    monitor BP: combo may incr. risk of HTN (additive effects)

  • dextroamphetamine
  • dexamethasone sodium phosphate (generic)
    +
    dextroamphetamine
    1 interaction

    Monitor/Modify Tx

    dexamethasone + dextroamphetamine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • dichlorphenamide
  • dexamethasone sodium phosphate (generic)
    +
    dichlorphenamide
    1 interaction

    Monitor/Modify Tx

    dexamethasone + dichlorphenamide

    monitor potassium: combo may incr. risk of hypokalemia (additive effects)

  • diclofenac
  • dexamethasone sodium phosphate (generic)
    +
    diclofenac
    1 interaction

    Monitor/Modify Tx

    dexamethasone + diclofenac

    monitor BP, bleeding or thrombosis s/sx, especially if multiple myeloma use; use lowest effective diclofenac dose, shortest effective tx duration: combo may incr. risk of HTN, GI ulceration, perforation, bleeding (including life-threatening), thromboembolism (additive effects)

  • diclofenac topical
  • dexamethasone sodium phosphate (generic)
    +
    diclofenac topical
    1 interaction

    Monitor/Modify Tx

    dexamethasone + diclofenac topical

    monitor BP, bleeding or thrombosis s/sx, especially if multiple myeloma use; use lowest effective diclofenac dose, shortest effective tx duration: combo may incr. risk of HTN, thromboembolism, GI ulceration, perforation, bleeding, including life-threatening (additive effects)

  • diethylpropion
  • dexamethasone sodium phosphate (generic)
    +
    diethylpropion
    1 interaction

    Monitor/Modify Tx

    dexamethasone + diethylpropion

    monitor BP: combo may incr. risk of HTN (additive effects)

  • diflunisal
  • dexamethasone sodium phosphate (generic)
    +
    diflunisal
    1 interaction

    Monitor/Modify Tx

    dexamethasone + diflunisal

    monitor BP, bleeding or thrombosis s/sx, especially if multiple myeloma use; use lowest effective diflunisal dose, shortest effective tx duration: combo may incr. risk of GI ulceration, perforation, bleeding (including life-threatening), thromboembolism, HTN (additive effects)

  • digoxin
  • dexamethasone sodium phosphate (generic)
    +
    digoxin
    1 interaction

    Monitor/Modify Tx

    dexamethasone + digoxin

    monitor electrolytes: combo may incr. risk of digoxin toxicity, cardiac arrhythmias (electrolyte abnormalities may incr. digoxin sensitivity)

  • dihydroergotamine
  • dexamethasone sodium phosphate (generic)
    +
    dihydroergotamine
    1 interaction

    Monitor/Modify Tx

    dexamethasone + dihydroergotamine

    monitor BP: combo may incr. risk of severe HTN, vasospasm, ischemia (additive effects)

  • diltiazem
  • dexamethasone sodium phosphate (generic)
    +
    diltiazem
    1 interaction

    Monitor/Modify Tx

    dexamethasone + diltiazem

    monitor BP, HR: combo may incr. dexamethasone levels, risk of systemic corticosteroid effects including Cushing syndrome and adrenal suppression, serious infection, other adverse effects; may decr. diltiazem levels, efficacy (hepatic metabolism inhibited; hepatic metabolism induced, antagonistic effects)

  • dimethyl fumarate
  • dexamethasone sodium phosphate (generic)
    +
    dimethyl fumarate
    1 interaction

    Monitor/Modify Tx

    dexamethasone + dimethyl fumarate

    monitor bleeding s/sx: combo may incr. risk of serious infection, GI ulceration, perforation, bleeding, including life-threatening (additive effects)

  • dinutuximab
  • dexamethasone sodium phosphate (generic)
    +
    dinutuximab
    1 interaction

    Monitor/Modify Tx

    dexamethasone + dinutuximab

    monitor potassium: combo may incr. risk of hypokalemia, serious infection (additive effects)

  • diphtheria/tetanus vaccine
  • dexamethasone sodium phosphate (generic)
    +
    diphtheria/ tetanus vaccine
    1 interaction

    Monitor/Modify Tx

    dexamethasone + diphtheria/ tetanus vaccine

    if possible, vaccinate at least 2wk before starting long-term (>2wk) high-dose systemic steroids; consider post-immunization titer check: combo may result in inadequate vaccine response (immunosuppressive effects)

  • diphtheria/tetanus/pertussis vaccine
  • dexamethasone sodium phosphate (generic)
    +
    diphtheria/ tetanus/ pertussis vaccine
    1 interaction

    Monitor/Modify Tx

    dexamethasone + diphtheria/ tetanus/ pertussis vaccine

    if possible, vaccinate at least 2wk before starting long-term (>2wk) high-dose systemic steroids; consider post-immunization titer check: combo may result in inadequate vaccine response (immunosuppressive effects)

  • diroximel fumarate
  • dexamethasone sodium phosphate (generic)
    +
    diroximel fumarate
    1 interaction

    Monitor/Modify Tx

    dexamethasone + diroximel fumarate

    monitor bleeding s/sx: combo may incr. risk of serious infection, GI ulceration, perforation, bleeding, including life-threatening (additive effects)

  • disopyramide
  • dexamethasone sodium phosphate (generic)
    +
    disopyramide
    1 interaction

    Monitor/Modify Tx

    dexamethasone + disopyramide

    monitor disopyramide levels: combo may decr. disopyramide levels, efficacy (hepatic metabolism induced)

  • dobutamine
  • dexamethasone sodium phosphate (generic)
    +
    dobutamine
    1 interaction

    Monitor/Modify Tx

    dexamethasone + dobutamine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • donepezil
  • dexamethasone sodium phosphate (generic)
    +
    donepezil
    1 interaction

    Monitor/Modify Tx

    dexamethasone + donepezil

    monitor bleeding s/sx: combo may incr. risk of GI ulceration, perforation, bleeding; may decr. donepezil levels, efficacy (additive effects; hepatic metabolism induced)

  • dopamine
  • dexamethasone sodium phosphate (generic)
    +
    dopamine
    1 interaction

    Monitor/Modify Tx

    dexamethasone + dopamine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • doxapram
  • dexamethasone sodium phosphate (generic)
    +
    doxapram
    1 interaction

    Monitor/Modify Tx

    dexamethasone + doxapram

    monitor BP: combo may incr. risk of HTN (additive effects)

  • doxazosin
  • dexamethasone sodium phosphate (generic)
    +
    doxazosin
    1 interaction

    Monitor/Modify Tx

    dexamethasone + doxazosin

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • dronabinol
  • dexamethasone sodium phosphate (generic)
    +
    dronabinol
    1 interaction

    Monitor/Modify Tx

    dexamethasone + dronabinol

    monitor BP: combo may incr. risk of HTN (additive effects)

  • drospirenone (hormone replacement)
  • dexamethasone sodium phosphate (generic)
    +
    drospirenone (hormone replacement)
    1 interaction

    Monitor/Modify Tx

    dexamethasone + drospirenone (hormone replacement)

    monitor thrombosis s/sx, especially if multiple myeloma use or w/ concomitant estrogen use: combo may decr. drospirenone levels, efficacy; may incr. risk of thromboembolism (hepatic metabolism induced; additive effects)

  • droxidopa
  • dexamethasone sodium phosphate (generic)
    +
    droxidopa
    1 interaction

    Monitor/Modify Tx

    dexamethasone + droxidopa

    monitor BP: combo may incr. risk of supine HTN (additive effects)

  • dulaglutide
  • dexamethasone sodium phosphate (generic)
    +
    dulaglutide
    1 interaction

    Monitor/Modify Tx

    dexamethasone + dulaglutide

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • ebola vaccine, live
  • dexamethasone sodium phosphate (generic)
    +
    ebola vaccine, live
    1 interaction

    Monitor/Modify Tx

    dexamethasone + ebola vaccine, live

    consider vaccinating at least 1mo before or 1mo after long-term (>2wk) high-dose systemic steroids: combo may result in inadequate vaccine response; may incr. risk of mild vesicular stomatitis virus infection (immunosuppressive effects, recombinant vaccine with vesicular stomatitis virus vector)

  • eletriptan
  • dexamethasone sodium phosphate (generic)
    +
    eletriptan
    1 interaction

    Monitor/Modify Tx

    dexamethasone + eletriptan

    monitor BP: combo may incr. risk of HTN (additive effects)

  • eltrombopag
  • dexamethasone sodium phosphate (generic)
    +
    eltrombopag
    1 interaction

    Monitor/Modify Tx

    dexamethasone + eltrombopag

    monitor platelets, thrombosis s/sx, especially if multiple myeloma use: combo may incr. risk of thromboembolism (additive effects)

  • emapalumab
  • dexamethasone sodium phosphate (generic)
    +
    emapalumab
    1 interaction

    Monitor/Modify Tx

    dexamethasone + emapalumab

    monitor potassium: combo may incr. risk of serious infection, hypokalemia (additive effects)

  • empagliflozin
  • dexamethasone sodium phosphate (generic)
    +
    empagliflozin
    1 interaction

    Monitor/Modify Tx

    dexamethasone + empagliflozin

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • enalapril
  • dexamethasone sodium phosphate (generic)
    +
    enalapril
    1 interaction

    Monitor/Modify Tx

    dexamethasone + enalapril

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • enalaprilat
  • dexamethasone sodium phosphate (generic)
    +
    enalaprilat
    1 interaction

    Monitor/Modify Tx

    dexamethasone + enalaprilat

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • ephedra
  • dexamethasone sodium phosphate (generic)
    +
    ephedra
    1 interaction

    Monitor/Modify Tx

    dexamethasone + ephedra

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ephedrine injection
  • dexamethasone sodium phosphate (generic)
    +
    ephedrine injection
    1 interaction

    Monitor/Modify Tx

    dexamethasone + ephedrine injection

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ephedrine oral
  • dexamethasone sodium phosphate (generic)
    +
    ephedrine oral
    1 interaction

    Monitor/Modify Tx

    dexamethasone + ephedrine oral

    monitor BP; consider dexamethasone dose adjustment: combo may incr. risk of HTN; may decr. dexamethasone levels, efficacy (additive effects; mechanism unknown, hepatic metabolism possibly induced)

  • epinephrine
  • dexamethasone sodium phosphate (generic)
    +
    epinephrine
    1 interaction

    Monitor/Modify Tx

    dexamethasone + epinephrine

    monitor potassium, ECG, BP: combo may incr. risk of hypokalemia, QT prolongation, cardiac arrhythmias, HTN (additive effects)

  • epirubicin
  • dexamethasone sodium phosphate (generic)
    +
    epirubicin
    1 interaction

    Monitor/Modify Tx

    dexamethasone + epirubicin

    monitor thrombosis s/sx, especially if multiple myeloma use: combo may incr. risk of serious infection, thromboembolism (additive effects)

  • eplerenone
  • dexamethasone sodium phosphate (generic)
    +
    eplerenone
    1 interaction

    Monitor/Modify Tx

    dexamethasone + eplerenone

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • epoetin alfa
  • dexamethasone sodium phosphate (generic)
    +
    epoetin alfa
    1 interaction

    Monitor/Modify Tx

    dexamethasone + epoetin alfa

    monitor BP, thrombosis s/sx, especially if multiple myeloma use: combo may incr. risk of HTN, thromboembolism (additive effects)

  • eptinezumab
  • dexamethasone sodium phosphate (generic)
    +
    eptinezumab
    1 interaction

    Monitor/Modify Tx

    dexamethasone + eptinezumab

    monitor BP: combo may incr. risk of HTN (additive effects)

  • erenumab
  • dexamethasone sodium phosphate (generic)
    +
    erenumab
    1 interaction

    Monitor/Modify Tx

    dexamethasone + erenumab

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ergotamine
  • dexamethasone sodium phosphate (generic)
    +
    ergotamine
    1 interaction

    Monitor/Modify Tx

    dexamethasone + ergotamine

    monitor BP: combo may incr. risk of severe HTN, vasospasm, ischemia (additive effects)

  • erlotinib
  • dexamethasone sodium phosphate (generic)
    +
    erlotinib
    1 interaction

    Monitor/Modify Tx

    dexamethasone + erlotinib

    monitor bleeding s/sx: combo may decr. erlotinib levels, efficacy; may incr. risk of GI ulceration, perforation, bleeding, including life-threatening (hepatic metabolism induced; additive effects)

  • ertugliflozin
  • dexamethasone sodium phosphate (generic)
    +
    ertugliflozin
    1 interaction

    Monitor/Modify Tx

    dexamethasone + ertugliflozin

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • esketamine
  • dexamethasone sodium phosphate (generic)
    +
    esketamine
    1 interaction

    Monitor/Modify Tx

    dexamethasone + esketamine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • esmolol
  • dexamethasone sodium phosphate (generic)
    +
    esmolol
    1 interaction

    Monitor/Modify Tx

    dexamethasone + esmolol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • estetrol (contraceptive)
  • dexamethasone sodium phosphate (generic)
    +
    estetrol (contraceptive)
    1 interaction

    Monitor/Modify Tx

    dexamethasone + estetrol (contraceptive)

    monitor BP, thrombosis s/sx, especially if multiple myeloma use: combo may alter corticosteroid levels, incr. risk of thromboembolism, HTN, other adverse effects or decr. efficacy (altered corticosteroid binding globulin, additive effects)

  • estradiol (hormone replacement)
  • dexamethasone sodium phosphate (generic)
    +
    estradiol (hormone replacement)
    1 interaction

    Monitor/Modify Tx

    dexamethasone + estradiol (hormone replacement)

    monitor thrombosis s/sx, especially if multiple myeloma use: combo may incr. corticosteroid adverse effects; may incr. risk of thromboembolism (mechanism unknown; additive effects)

  • estrogens, conjugated (hormone replacement)
  • dexamethasone sodium phosphate (generic)
    +
    estrogens, conjugated (hormone replacement)
    1 interaction

    Monitor/Modify Tx

    dexamethasone + estrogens, conjugated (hormone replacement)

    monitor thrombosis s/sx, especially if multiple myeloma use: combo may incr. corticosteroid adverse effects; may incr. risk of thromboembolism (mechanism unknown; additive effects)

  • estrogens, esterified (hormone replacement)
  • dexamethasone sodium phosphate (generic)
    +
    estrogens, esterified (hormone replacement)
    1 interaction

    Monitor/Modify Tx

    dexamethasone + estrogens, esterified (hormone replacement)

    monitor thrombosis s/sx, especially if multiple myeloma use: combo may incr. corticosteroid adverse effects; may incr. risk of thromboembolism (mechanism unknown; additive effects)

  • etelcalcetide
  • dexamethasone sodium phosphate (generic)
    +
    etelcalcetide
    1 interaction

    Monitor/Modify Tx

    dexamethasone + etelcalcetide

    monitor bleeding s/sx: combo may incr. risk of GI ulceration, perforation, bleeding (additive effects)

  • ethacrynic acid
  • dexamethasone sodium phosphate (generic)
    +
    ethacrynic acid
    1 interaction

    Monitor/Modify Tx

    dexamethasone + ethacrynic acid

    monitor potassium, BP: combo may incr. risk of hypokalemia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • ethanol (alcoholic beverage)
  • dexamethasone sodium phosphate (generic)
    +
    ethanol (alcoholic beverage)
    1 interaction

    Monitor/Modify Tx

    dexamethasone + ethanol (alcoholic beverage)

    monitor bleeding signs/symptoms, BP: combo may incr. risk of GI ulceration, perforation, bleeding, HTN (chronic alcohol use) (additive effects)

  • ethinyl estradiol (hormone replacement)
  • dexamethasone sodium phosphate (generic)
    +
    ethinyl estradiol (hormone replacement)
    1 interaction

    Monitor/Modify Tx

    dexamethasone + ethinyl estradiol (hormone replacement)

    monitor thrombosis s/sx, especially if multiple myeloma use: combo may incr. corticosteroid adverse effects; may incr. risk of thromboembolism (mechanism unknown; additive effects)

  • etodolac
  • dexamethasone sodium phosphate (generic)
    +
    etodolac
    1 interaction

    Monitor/Modify Tx

    dexamethasone + etodolac

    monitor BP, bleeding or thrombosis s/sx, especially if multiple myeloma use; use lowest effective etodolac dose, shortest effective tx duration: combo may incr. risk of GI ulceration, perforation, bleeding (including life-threatening), thromboembolism, HTN (additive effects)

  • etrasimod
  • dexamethasone sodium phosphate (generic)
    +
    etrasimod
    1 interaction

    Monitor/Modify Tx

    dexamethasone + etrasimod

    monitor BP; caution advised during and x5wk after etrasimod tx: combo may incr. risk of HTN, serious infection; infection risk may be prolonged (additive effects)

  • everolimus
  • dexamethasone sodium phosphate (generic)
    +
    everolimus
    1 interaction

    Monitor/Modify Tx

    dexamethasone + everolimus

    admin. PCP prophylaxis; BREAST CA, PNET, RENAL CELL CA, RENAL ANGIOMYOLIPOMA W/ TSC: monitor thrombosis s/sx, especially if multiple myeloma use; TSC-ASSOC. SEGA or TSC-ASSOC. PARTIAL-ONSET SEIZURES, TRANSPLANT: monitor everolimus levels, thrombosis s/sx, especially if multiple myeloma use: combo may decr. everolimus levels, efficacy; may incr. risk of serious infection, thromboembolism (hepatic metabolism induced; additive effects)

  • exenatide
  • dexamethasone sodium phosphate (generic)
    +
    exenatide
    1 interaction

    Monitor/Modify Tx

    dexamethasone + exenatide

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • factor XIII concentrate
  • dexamethasone sodium phosphate (generic)
    +
    factor XIII concentrate
    1 interaction

    Monitor/Modify Tx

    dexamethasone + factor XIII concentrate

    monitor thrombosis s/sx, especially if multiple myeloma use: combo may incr. risk of thromboembolism (additive effects)

  • faricimab
  • dexamethasone sodium phosphate (generic)
    +
    faricimab
    1 interaction

    Monitor/Modify Tx

    dexamethasone + faricimab

    monitor thrombosis s/sx, especially if multiple myeloma use: combo may incr. risk of thromboembolism (additive effects)

  • fedratinib
  • dexamethasone sodium phosphate (generic)
    +
    fedratinib
    1 interaction

    Monitor/Modify Tx

    dexamethasone + fedratinib

    monitor thrombosis s/sx, especially if multiple myeloma use: combo may incr. dexamethasone levels, risk of systemic corticosteroid effects including Cushing syndrome and adrenal suppression, serious infection, thromboembolism, other adverse effects; may decr. fedratinib levels, efficacy (hepatic metabolism inhibited, additive effects; hepatic metabolism induced)

  • felodipine
  • dexamethasone sodium phosphate (generic)
    +
    felodipine
    1 interaction

    Monitor/Modify Tx

    dexamethasone + felodipine

    monitor BP: combo may decr. felodipine levels, efficacy (hepatic metabolism induced, antagonistic effects)

  • fenfluramine
  • dexamethasone sodium phosphate (generic)
    +
    fenfluramine
    1 interaction

    Monitor/Modify Tx

    dexamethasone + fenfluramine

    monitor BP: combo may incr. risk of HTN (including hypertensive crisis); may alter seizure control (additive effects; antagonistic effects, dexamethasone may decr. seizure threshold)

  • fenofibrate
  • dexamethasone sodium phosphate (generic)
    +
    fenofibrate
    1 interaction

    Monitor/Modify Tx

    dexamethasone + fenofibrate

    monitor thrombosis s/sx, especially if multiple myeloma use: combo may incr. risk of thromboembolism (additive effects)

  • fenofibric acid
  • dexamethasone sodium phosphate (generic)
    +
    fenofibric acid
    1 interaction

    Monitor/Modify Tx

    dexamethasone + fenofibric acid

    monitor thrombosis s/sx, especially if multiple myeloma use: combo may incr. risk of thromboembolism (additive effects)

  • fenoldopam
  • dexamethasone sodium phosphate (generic)
    +
    fenoldopam
    1 interaction

    Monitor/Modify Tx

    dexamethasone + fenoldopam

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • fenoprofen
  • dexamethasone sodium phosphate (generic)
    +
    fenoprofen
    1 interaction

    Monitor/Modify Tx

    dexamethasone + fenoprofen

    monitor BP, bleeding s/sx or thrombosis s/sx, especially if multiple myeloma use; use lowest effective fenoprofen dose, shortest effective tx duration: combo may incr. risk of HTN, GI ulceration, perforation, bleeding (including life-threatening), thromboembolism (additive effects)

  • fibrinogen (human)
  • dexamethasone sodium phosphate (generic)
    +
    fibrinogen (human)
    1 interaction

    Monitor/Modify Tx

    dexamethasone + fibrinogen (human)

    monitor thrombosis s/sx, especially if multiple myeloma use: combo may incr. risk of thromboembolism (additive effects)

  • fingolimod
  • dexamethasone sodium phosphate (generic)
    +
    fingolimod
    1 interaction

    Monitor/Modify Tx

    dexamethasone + fingolimod

    monitor BP; caution advised during and x2mo after fingolimod tx: combo may incr. risk of HTN, serious infection; infection risk may be prolonged (additive effects)

  • fitusiran
  • dexamethasone sodium phosphate (generic)
    +
    fitusiran
    1 interaction

    Monitor/Modify Tx

    dexamethasone + fitusiran

    monitor antithrombin activity level, thrombosis s/sx, especially if multiple myeloma use: combo may incr. risk of thromboembolism (additive effects)

  • fludrocortisone
  • dexamethasone sodium phosphate (generic)
    +
    fludrocortisone
    1 interaction

    Monitor/Modify Tx

    dexamethasone + fludrocortisone

    monitor BP, potassium, bleeding s/sx: combo may incr. risk of systemic corticosteroid effects including Cushing syndrome and adrenal suppression, serious infection, GI ulceration, perforation, bleeding, hypokalemia, HTN, other adverse effects (additive effects, duplicate therapy)

  • flurbiprofen
  • dexamethasone sodium phosphate (generic)
    +
    flurbiprofen
    1 interaction

    Monitor/Modify Tx

    dexamethasone + flurbiprofen

    monitor BP, bleeding or thrombosis s/sx, especially if multiple myeloma use; use lowest effective flurbiprofen dose, shortest effective tx duration: combo may incr. risk of HTN, thromboembolism, GI ulceration, perforation, bleeding, including life-threatening (additive effects)

  • follitropin
  • dexamethasone sodium phosphate (generic)
    +
    follitropin
    1 interaction

    Monitor/Modify Tx

    dexamethasone + follitropin

    monitor thrombosis s/sx, especially if multiple myeloma use: combo may incr. risk of thromboembolism (additive effects)

  • formoterol inhaled
  • dexamethasone sodium phosphate (generic)
    +
    formoterol inhaled
    1 interaction

    Monitor/Modify Tx

    dexamethasone + formoterol inhaled

    monitor potassium, BP: combo may incr. risk of hypokalemia, HTN (additive effects)

  • fosaprepitant
  • dexamethasone sodium phosphate (generic)
    +
    fosaprepitant
    1 interaction

    Monitor/Modify Tx

    dexamethasone + fosaprepitant

    decr. dexamethasone PO dose 50%: combo may incr. dexamethasone levels, risk of systemic corticosteroid effects including Cushing syndrome and adrenal suppression, serious infection, other adverse effects; may decr. aprepitant levels, efficacy (hepatic metabolism inhibited; hepatic metabolism induced)

  • foscarnet
  • dexamethasone sodium phosphate (generic)
    +
    foscarnet
    1 interaction

    Monitor/Modify Tx

    dexamethasone + foscarnet

    monitor potassium, ECG: combo may incr. risk of hypokalemia, QT prolongation, cardiac arrhythmias (additive effects)

  • fosfomycin injection
  • dexamethasone sodium phosphate (generic)
    +
    fosfomycin injection
    1 interaction

    Monitor/Modify Tx

    dexamethasone + fosfomycin injection

    monitor potassium: combo may incr. risk of hypokalemia (additive effects)

  • fosinopril
  • dexamethasone sodium phosphate (generic)
    +
    fosinopril
    1 interaction

    Monitor/Modify Tx

    dexamethasone + fosinopril

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • fostamatinib
  • dexamethasone sodium phosphate (generic)
    +
    fostamatinib
    1 interaction

    Monitor/Modify Tx

    dexamethasone + fostamatinib

    monitor BP: combo may incr. risk of HTN; may decr. fostamatinib active metabolite levels, efficacy (additive effects; hepatic metabolism induced)

  • fremanezumab
  • dexamethasone sodium phosphate (generic)
    +
    fremanezumab
    1 interaction

    Monitor/Modify Tx

    dexamethasone + fremanezumab

    monitor BP: combo may incr. risk of HTN (additive effects)

  • frovatriptan
  • dexamethasone sodium phosphate (generic)
    +
    frovatriptan
    1 interaction

    Monitor/Modify Tx

    dexamethasone + frovatriptan

    monitor BP: combo may incr. risk of HTN (additive effects)

  • fruquintinib
  • dexamethasone sodium phosphate (generic)
    +
    fruquintinib
    1 interaction

    Monitor/Modify Tx

    dexamethasone + fruquintinib

    monitor BP, bleeding s/sx; monitor thrombosis s/sx, especially if multiple myeloma use: combo may decr. fruquintinib levels, efficacy; may incr. risk of serious infection, HTN (including hypertensive crisis), thromboembolism, GI ulceration, perforation, bleeding, including life-threatening (hepatic metabolism induced; additive effects)

  • galantamine
  • dexamethasone sodium phosphate (generic)
    +
    galantamine
    1 interaction

    Monitor/Modify Tx

    dexamethasone + galantamine

    monitor bleeding s/sx; D/C cholinesterase inhibitors >24h before starting corticosteroids: combo may incr. risk of GI ulceration, perforation, bleeding; may decr. cholinesterase inhibitor muscle-stimulating efficacy and cause extreme weakness in myasthenia gravis (additive effects; antagonistic effects, mechanism unknown)

  • galcanezumab
  • dexamethasone sodium phosphate (generic)
    +
    galcanezumab
    1 interaction

    Monitor/Modify Tx

    dexamethasone + galcanezumab

    monitor BP: combo may incr. risk of HTN (additive effects)

  • gefitinib
  • dexamethasone sodium phosphate (generic)
    +
    gefitinib
    1 interaction

    Monitor/Modify Tx

    dexamethasone + gefitinib

    monitor bleeding s/sx: combo may incr. risk of GI ulceration, perforation, bleeding, including life-threatening (additive effects)

  • glimepiride
  • dexamethasone sodium phosphate (generic)
    +
    glimepiride
    1 interaction

    Monitor/Modify Tx

    dexamethasone + glimepiride

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • glipizide
  • dexamethasone sodium phosphate (generic)
    +
    glipizide
    1 interaction

    Monitor/Modify Tx

    dexamethasone + glipizide

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • glyburide
  • dexamethasone sodium phosphate (generic)
    +
    glyburide
    1 interaction

    Monitor/Modify Tx

    dexamethasone + glyburide

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • glycerol phenylbutyrate
  • dexamethasone sodium phosphate (generic)
    +
    glycerol phenylbutyrate
    1 interaction

    Monitor/Modify Tx

    dexamethasone + glycerol phenylbutyrate

    monitor ammonia levels: combo may decr. glycerol phenylbutyrate efficacy (antagonistic effects)

  • guanfacine
  • dexamethasone sodium phosphate (generic)
    +
    guanfacine
    1 interaction

    Monitor/Modify Tx

    dexamethasone + guanfacine

    monitor BP: combo may decr. guanfacine levels, efficacy (hepatic metabolism induced, antagonistic effects)

  • Haemophilus b vaccine
  • dexamethasone sodium phosphate (generic)
    +
    Haemophilus b vaccine
    1 interaction

    Monitor/Modify Tx

    dexamethasone + Haemophilus b vaccine

    if possible, vaccinate at least 2wk before starting long-term (>2wk) high-dose systemic steroids; consider post-immunization titer check: combo may result in inadequate vaccine response (immunosuppressive effects)

  • hepatitis A vaccine
  • dexamethasone sodium phosphate (generic)
    +
    hepatitis A vaccine
    1 interaction

    Monitor/Modify Tx

    dexamethasone + hepatitis A vaccine

    if possible, vaccinate at least 2wk before starting long-term (>2wk) high-dose systemic steroids; consider post-immunization titer check: combo may result in inadequate vaccine response (immunosuppressive effects)

  • hepatitis B immune globulin
  • dexamethasone sodium phosphate (generic)
    +
    hepatitis B immune globulin
    1 interaction

    Monitor/Modify Tx

    dexamethasone + hepatitis B immune globulin

    monitor thrombosis s/sx, especially if multiple myeloma use; use lowest hepatitis B immune globulin infusion rate possible: combo may incr. risk of thromboembolism (additive effects)

  • hepatitis B vaccine
  • dexamethasone sodium phosphate (generic)
    +
    hepatitis B vaccine
    1 interaction

    Monitor/Modify Tx

    dexamethasone + hepatitis B vaccine

    if possible, vaccinate at least 2wk before starting long-term (>2wk) high-dose systemic steroids; consider post-immunization titer check: combo may result in inadequate vaccine response (immunosuppressive effects)

  • hoodia
  • dexamethasone sodium phosphate (generic)
    +
    hoodia
    1 interaction

    Monitor/Modify Tx

    dexamethasone + hoodia

    monitor BP: combo may incr. risk of HTN (additive effects)

  • human papillomavirus vaccine
  • dexamethasone sodium phosphate (generic)
    +
    human papillomavirus vaccine
    1 interaction

    Monitor/Modify Tx

    dexamethasone + human papillomavirus vaccine

    if possible, vaccinate at least 2wk before starting long-term (>2wk) high-dose systemic steroids; consider post-immunization titer check: combo may result in inadequate vaccine response (immunosuppressive effects)

  • hydralazine
  • dexamethasone sodium phosphate (generic)
    +
    hydralazine
    1 interaction

    Monitor/Modify Tx

    dexamethasone + hydralazine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • hydrochlorothiazide
  • dexamethasone sodium phosphate (generic)
    +
    hydrochlorothiazide
    1 interaction

    Monitor/Modify Tx

    dexamethasone + hydrochlorothiazide

    monitor potassium, BP: combo may incr. risk of hypokalemia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • hydroxocobalamin IV
  • dexamethasone sodium phosphate (generic)
    +
    hydroxocobalamin IV
    1 interaction

    Monitor/Modify Tx

    dexamethasone + hydroxocobalamin IV

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ibandronate
  • dexamethasone sodium phosphate (generic)
    +
    ibandronate
    1 interaction

    Monitor/Modify Tx

    dexamethasone + ibandronate

    monitor bleeding s/sx if oral ibandronate use: combo may incr. risk of upper GI ulceration, perforation, bleeding (additive effects)

  • ibrutinib
  • dexamethasone sodium phosphate (generic)
    +
    ibrutinib
    1 interaction

    Monitor/Modify Tx

    dexamethasone + ibrutinib

    monitor BP: combo may incr. risk of HTN, serious infection; may decr. ibrutinib levels, efficacy (additive effects; hepatic metabolism induced)

  • ibuprofen
  • dexamethasone sodium phosphate (generic)
    +
    ibuprofen
    1 interaction

    Monitor/Modify Tx

    dexamethasone + ibuprofen

    monitor BP, bleeding or thrombosis s/sx, especially if multiple myeloma use; use lowest effective ibuprofen dose, shortest effective tx duration: combo may incr. risk of GI ulceration, perforation, bleeding (including life-threatening), thromboembolism, HTN (additive effects)

  • ibuprofen lysine
  • dexamethasone sodium phosphate (generic)
    +
    ibuprofen lysine
    1 interaction

    Monitor/Modify Tx

    dexamethasone + ibuprofen lysine

    monitor bleeding s/sx: combo may incr. risk of GI ulceration, perforation, bleeding, including life-threatening (additive effects)

  • ifosfamide
  • dexamethasone sodium phosphate (generic)
    +
    ifosfamide
    1 interaction

    Monitor/Modify Tx

    dexamethasone + ifosfamide

    monitor CBC, renal, cardiac fxn; consider ifosfamide dose adjustment: combo may incr. ifosfamide active and toxic metabolite levels, risk of myelosuppression, serious infection, encephalopathy, nephrotoxicity, cardiotoxicity, other adverse effects (hepatic metabolism induced, incr. metabolite formation; additive effects)

  • imatinib
  • dexamethasone sodium phosphate (generic)
    +
    imatinib
    1 interaction

    Monitor/Modify Tx

    dexamethasone + imatinib

    monitor bleeding s/sx: combo may incr. dexamethasone levels, risk of systemic corticosteroid effects including Cushing syndrome and adrenal suppression, serious infection, GI ulceration, perforation, bleeding (including life-threatening), other adverse effects (hepatic metabolism inhibited, additive effects)

  • immune globulin
  • dexamethasone sodium phosphate (generic)
    +
    immune globulin
    1 interaction

    Monitor/Modify Tx

    dexamethasone + immune globulin

    monitor thrombosis s/sx, especially if multiple myeloma use; use lowest immune globulin dose, concentration and infusion rate possible: combo may incr. risk of thromboembolism (additive effects)

  • indapamide
  • dexamethasone sodium phosphate (generic)
    +
    indapamide
    1 interaction

    Monitor/Modify Tx

    dexamethasone + indapamide

    monitor potassium, BP: combo may incr. risk of hypokalemia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • indomethacin
  • dexamethasone sodium phosphate (generic)
    +
    indomethacin
    1 interaction

    Monitor/Modify Tx

    dexamethasone + indomethacin

    monitor BP, bleeding or thrombosis s/sx, especially if multiple myeloma use; use lowest effective indomethacin dose, shortest effective tx duration: combo may incr. risk of GI ulceration, perforation, bleeding (including life-threatening), thromboembolism, HTN (additive effects)

  • influenza H5N1 vaccine
  • dexamethasone sodium phosphate (generic)
    +
    influenza H5N1 vaccine
    1 interaction

    Monitor/Modify Tx

    dexamethasone + influenza H5N1 vaccine

    if possible, vaccinate at least 2wk before starting long-term (>2wk) high-dose systemic steroids; consider post-immunization titer check: combo may result in inadequate vaccine response (immunosuppressive effects)

  • influenza vaccine
  • dexamethasone sodium phosphate (generic)
    +
    influenza vaccine
    1 interaction

    Monitor/Modify Tx

    dexamethasone + influenza vaccine

    if possible, vaccinate at least 2wk before starting long-term (>2wk) high-dose systemic steroids: combo may result in inadequate vaccine response (immunosuppressive effects)

  • insulin
  • dexamethasone sodium phosphate (generic)
    +
    insulin
    1 interaction

    Monitor/Modify Tx

    dexamethasone + insulin

    monitor glucose, potassium: combo may incr. risk of hypokalemia; may decr. antidiabetic agent efficacy (additive effects, antagonistic effects)

  • iodixanol
  • dexamethasone sodium phosphate (generic)
    +
    iodixanol
    1 interaction

    Monitor/Modify Tx

    dexamethasone + iodixanol

    monitor thrombosis signs/symptoms, especially if multiple myeloma use: combo may incr. risk of thromboembolism (additive effects)

  • iomeprol
  • dexamethasone sodium phosphate (generic)
    +
    iomeprol
    1 interaction

    Monitor/Modify Tx

    dexamethasone + iomeprol

    monitor thrombosis s/sx, especially if multiple myeloma use: combo may incr. risk of thromboembolism (additive effects)

  • iopromide
  • dexamethasone sodium phosphate (generic)
    +
    iopromide
    1 interaction

    Monitor/Modify Tx

    dexamethasone + iopromide

    monitor thrombosis signs/symptoms, especially if multiple myeloma use: combo may incr. risk of thromboembolism (additive effects)

  • iothalamate meglumine
  • dexamethasone sodium phosphate (generic)
    +
    iothalamate meglumine
    1 interaction

    Monitor/Modify Tx

    dexamethasone + iothalamate meglumine

    if IV iothalamate meglumine use, monitor thrombosis signs/symptoms, especially if multiple myeloma use; retrograde cystography and cystourethrography use OK: combo may incr. risk of thromboembolism (additive effects)

  • ioversol
  • dexamethasone sodium phosphate (generic)
    +
    ioversol
    1 interaction

    Monitor/Modify Tx

    dexamethasone + ioversol

    monitor thrombosis signs/symptoms, especially if multiple myeloma use: combo may incr. risk of thromboembolism (additive effects)

  • irbesartan
  • dexamethasone sodium phosphate (generic)
    +
    irbesartan
    1 interaction

    Monitor/Modify Tx

    dexamethasone + irbesartan

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • isoproterenol
  • dexamethasone sodium phosphate (generic)
    +
    isoproterenol
    1 interaction

    Monitor/Modify Tx

    dexamethasone + isoproterenol

    monitor potassium: combo may incr. risk of hypokalemia (additive effects)

  • isradipine
  • dexamethasone sodium phosphate (generic)
    +
    isradipine
    1 interaction

    Monitor/Modify Tx

    dexamethasone + isradipine

    monitor BP: combo may decr. isradipine levels, efficacy (hepatic metabolism induced, antagonistic effects)

  • Japanese encephalitis vaccine
  • dexamethasone sodium phosphate (generic)
    +
    Japanese encephalitis vaccine
    1 interaction

    Monitor/Modify Tx

    dexamethasone + Japanese encephalitis vaccine

    if possible, vaccinate at least 2wk before starting long-term (>2wk) high-dose systemic steroids; consider post-immunization titer check: combo may result in inadequate vaccine response (immunosuppressive effects)

  • ketamine
  • dexamethasone sodium phosphate (generic)
    +
    ketamine
    1 interaction

    Monitor/Modify Tx

    dexamethasone + ketamine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ketoprofen
  • dexamethasone sodium phosphate (generic)
    +
    ketoprofen
    1 interaction

    Monitor/Modify Tx

    dexamethasone + ketoprofen

    monitor BP, bleeding or thrombosis s/sx, especially if multiple myeloma use; use lowest effective ketoprofen dose, shortest effective tx duration: combo may incr. risk of HTN, GI ulceration, perforation, bleeding (including life-threatening), thromboembolism (additive effects)

  • ketorolac
  • dexamethasone sodium phosphate (generic)
    +
    ketorolac
    1 interaction

    Monitor/Modify Tx

    dexamethasone + ketorolac

    monitor BP, bleeding or thrombosis s/sx, especially if multiple myeloma use; use lowest effective ketorolac dose, shortest effective tx duration: combo may incr. risk of HTN, GI ulceration, perforation, bleeding (including life-threatening), thromboembolism (additive effects)

  • labetalol
  • dexamethasone sodium phosphate (generic)
    +
    labetalol
    1 interaction

    Monitor/Modify Tx

    dexamethasone + labetalol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • lanreotide
  • dexamethasone sodium phosphate (generic)
    +
    lanreotide
    1 interaction

    Monitor/Modify Tx

    dexamethasone + lanreotide

    monitor BP: combo may incr. risk of HTN (additive effects)

  • lanthanum
  • dexamethasone sodium phosphate (generic)
    +
    lanthanum
    1 interaction

    Monitor/Modify Tx

    dexamethasone + lanthanum

    monitor bleeding s/sx: combo may incr. risk of GI ulceration, perforation, bleeding (additive effects)

  • lazertinib
  • dexamethasone sodium phosphate (generic)
    +
    lazertinib
    1 interaction

    Monitor/Modify Tx

    dexamethasone + lazertinib

    monitor thrombosis s/sx, especially if multiple myeloma use: combo may decr. lazertinib levels, efficacy; may incr. risk of thromboembolism (hepatic metabolism induced; additive effects)

  • leflunomide
  • dexamethasone sodium phosphate (generic)
    +
    leflunomide
    1 interaction

    Monitor/Modify Tx

    dexamethasone + leflunomide

    monitor BP: combo may incr. risk of serious infection, HTN (additive effects)

  • lenalidomide
  • dexamethasone sodium phosphate (generic)
    +
    lenalidomide
    1 interaction

    Monitor/Modify Tx

    dexamethasone + lenalidomide

    monitor potassium, thrombosis s/sx, especially if multiple myeloma use: combo may incr. risk of hypokalemia, thromboembolism, serious infection (additive effects)

  • lenvatinib
  • dexamethasone sodium phosphate (generic)
    +
    lenvatinib
    1 interaction

    Monitor/Modify Tx

    dexamethasone + lenvatinib

    monitor BP, bleeding or thrombosis s/sx, especially if multiple myeloma use: combo may incr. risk of HTN, thromboembolism, GI ulceration, perforation, bleeding, including life-threatening (additive effects)

  • levalbuterol inhaled
  • dexamethasone sodium phosphate (generic)
    +
    levalbuterol inhaled
    1 interaction

    Monitor/Modify Tx

    dexamethasone + levalbuterol inhaled

    monitor potassium, BP: combo may incr. risk of hypokalemia, HTN (additive effects)

  • levomilnacipran
  • dexamethasone sodium phosphate (generic)
    +
    levomilnacipran
    1 interaction

    Monitor/Modify Tx

    dexamethasone + levomilnacipran

    monitor BP: combo may incr. risk of HTN (additive effects)

  • levonorgestrel (hormone replacement)
  • dexamethasone sodium phosphate (generic)
    +
    levonorgestrel (hormone replacement)
    1 interaction

    Monitor/Modify Tx

    dexamethasone + levonorgestrel (hormone replacement)

    monitor thrombosis s/sx, especially if multiple myeloma use or w/ concomitant estrogen use: combo may incr. risk of thromboembolism (additive effects)

  • licorice
  • dexamethasone sodium phosphate (generic)
    +
    licorice
    1 interaction

    Monitor/Modify Tx

    dexamethasone + licorice

    monitor BP, potassium w/ large amounts of licorice: combo may incr. dexamethasone levels, duration of action, risk of HTN, hypokalemia, other adverse effects (mechanism unknown; additive effects)

  • linagliptin
  • dexamethasone sodium phosphate (generic)
    +
    linagliptin
    1 interaction

    Monitor/Modify Tx

    dexamethasone + linagliptin

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • liraglutide
  • dexamethasone sodium phosphate (generic)
    +
    liraglutide
    1 interaction

    Monitor/Modify Tx

    dexamethasone + liraglutide

    monitor glucose in type 2 diabetes mellitus pts: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • lisdexamfetamine
  • dexamethasone sodium phosphate (generic)
    +
    lisdexamfetamine
    1 interaction

    Monitor/Modify Tx

    dexamethasone + lisdexamfetamine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • lisinopril
  • dexamethasone sodium phosphate (generic)
    +
    lisinopril
    1 interaction

    Monitor/Modify Tx

    dexamethasone + lisinopril

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • lixisenatide
  • dexamethasone sodium phosphate (generic)
    +
    lixisenatide
    1 interaction

    Monitor/Modify Tx

    dexamethasone + lixisenatide

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • lorlatinib
  • dexamethasone sodium phosphate (generic)
    +
    lorlatinib
    1 interaction

    Monitor/Modify Tx

    dexamethasone + lorlatinib

    monitor BP: combo may decr. levels, efficacy of both drugs; may incr. risk of HTN (hepatic metabolism induced; additive effects)

  • losartan
  • dexamethasone sodium phosphate (generic)
    +
    losartan
    1 interaction

    Monitor/Modify Tx

    dexamethasone + losartan

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • luspatercept
  • dexamethasone sodium phosphate (generic)
    +
    luspatercept
    1 interaction

    Monitor/Modify Tx

    dexamethasone + luspatercept

    monitor BP; if beta thalassemia use, monitor thrombosis s/sx, especially if multiple myeloma use: combo may incr. risk of HTN, thromboembolism (additive effects)

  • lusutrombopag
  • dexamethasone sodium phosphate (generic)
    +
    lusutrombopag
    1 interaction

    Monitor/Modify Tx

    dexamethasone + lusutrombopag

    monitor platelets, thrombosis s/sx, especially if multiple myeloma use: combo may incr. risk of thromboembolism (additive effects)

  • magnesium citrate
  • dexamethasone sodium phosphate (generic)
    +
    magnesium citrate
    1 interaction

    Monitor/Modify Tx

    dexamethasone + magnesium citrate

    monitor potassium, consider monitoring ECG if magnesium citrate bowel prep use: combo may incr. risk of hypokalemia, QT prolongation, cardiac arrhythmias, seizures (additive effects)

  • magnesium salicylate
  • dexamethasone sodium phosphate (generic)
    +
    magnesium salicylate
    1 interaction

    Monitor/Modify Tx

    dexamethasone + magnesium salicylate

    monitor bleeding s/sx, BP w/ high-dose magnesium salicylate: combo may decr. salicylate levels, efficacy; may incr. risk of GI ulceration, perforation, bleeding, HTN (incr. clearance; additive effects)

  • mannitol
  • dexamethasone sodium phosphate (generic)
    +
    mannitol
    1 interaction

    Monitor/Modify Tx

    dexamethasone + mannitol

    monitor potassium, ECG: combo may incr. risk of hypokalemia, QT prolongation, cardiac arrhythmias (additive effects)

  • meclofenamate
  • dexamethasone sodium phosphate (generic)
    +
    meclofenamate
    1 interaction

    Monitor/Modify Tx

    dexamethasone + meclofenamate

    monitor BP, bleeding or thrombosis s/sx, especially if multiple myeloma use; use lowest effective meclofenamate dose, shortest effective tx duration: combo may incr. risk of HTN, GI ulceration, perforation, bleeding (including life-threatening), thromboembolism (additive effects)

  • medroxyprogesterone (hormone replacement)
  • dexamethasone sodium phosphate (generic)
    +
    medroxyprogesterone (hormone replacement)
    1 interaction

    Monitor/Modify Tx

    dexamethasone + medroxyprogesterone (hormone replacement)

    monitor thrombosis s/sx, especially if multiple myeloma use or w/ concomitant estrogen use: combo may incr. risk of thromboembolism (additive effects)

  • mefenamic acid
  • dexamethasone sodium phosphate (generic)
    +
    mefenamic acid
    1 interaction

    Monitor/Modify Tx

    dexamethasone + mefenamic acid

    monitor BP, bleeding s/sx or thrombosis s/sx, especially if multiple myeloma use; use lowest effective mefenamic acid dose, shortest effective tx duration: combo may incr. risk of HTN, GI ulceration, perforation, bleeding (including life-threatening), thromboembolism (additive effects)

  • megestrol
  • dexamethasone sodium phosphate (generic)
    +
    megestrol
    1 interaction

    Monitor/Modify Tx

    dexamethasone + megestrol

    monitor thrombosis s/sx, especially if multiple myeloma use: combo may incr. risk of thromboembolism (additive effects)

  • meloxicam
  • dexamethasone sodium phosphate (generic)
    +
    meloxicam
    1 interaction

    Monitor/Modify Tx

    dexamethasone + meloxicam

    monitor BP, bleeding or thrombosis s/sx, especially if multiple myeloma use; use lowest effective meloxicam dose, shortest effective tx duration: combo may incr. risk of HTN, GI ulceration, perforation, bleeding (including life-threatening), thromboembolism (additive effects)

  • meningococcal vaccine
  • dexamethasone sodium phosphate (generic)
    +
    meningococcal vaccine
    1 interaction

    Monitor/Modify Tx

    dexamethasone + meningococcal vaccine

    if possible, vaccinate at least 2wk before starting long-term (>2wk) high-dose systemic steroids; consider post-immunization titer check: combo may result in inadequate vaccine response (immunosuppressive effects)

  • menotropins
  • dexamethasone sodium phosphate (generic)
    +
    menotropins
    1 interaction

    Monitor/Modify Tx

    dexamethasone + menotropins

    monitor thrombosis s/sx, especially if multiple myeloma use: combo may incr. risk of thromboembolism (additive effects)

  • metformin
  • dexamethasone sodium phosphate (generic)
    +
    metformin
    1 interaction

    Monitor/Modify Tx

    dexamethasone + metformin

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • methamphetamine
  • dexamethasone sodium phosphate (generic)
    +
    methamphetamine
    1 interaction

    Monitor/Modify Tx

    dexamethasone + methamphetamine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • methazolamide
  • dexamethasone sodium phosphate (generic)
    +
    methazolamide
    1 interaction

    Monitor/Modify Tx

    dexamethasone + methazolamide

    monitor potassium: combo may incr. risk of hypokalemia (additive effects)

  • methotrexate
  • dexamethasone sodium phosphate (generic)
    +
    methotrexate
    1 interaction

    Monitor/Modify Tx

    dexamethasone + methotrexate

    monitor bleeding s/sx: combo may incr. risk of serious infection, GI ulceration, perforation, bleeding, including life-threatening (additive effects)

  • methoxy polyethylene glycol-epoetin beta
  • dexamethasone sodium phosphate (generic)
    +
    methoxy polyethylene glycol-epoetin beta
    1 interaction

    Monitor/Modify Tx

    dexamethasone + methoxy polyethylene glycol-epoetin beta

    monitor BP, thrombosis s/sx, especially if multiple myeloma use: combo may incr. risk of HTN, thromboembolism (additive effects)

  • methyldopa
  • dexamethasone sodium phosphate (generic)
    +
    methyldopa
    1 interaction

    Monitor/Modify Tx

    dexamethasone + methyldopa

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • methylergonovine
  • dexamethasone sodium phosphate (generic)
    +
    methylergonovine
    1 interaction

    Monitor/Modify Tx

    dexamethasone + methylergonovine

    monitor BP: combo may incr. risk of severe HTN, vasospasm, ischemia (additive effects)

  • methylphenidate
  • dexamethasone sodium phosphate (generic)
    +
    methylphenidate
    1 interaction

    Monitor/Modify Tx

    dexamethasone + methylphenidate

    monitor BP: combo may incr. risk of HTN (additive effects)

  • methyltestosterone
  • dexamethasone sodium phosphate (generic)
    +
    methyltestosterone
    1 interaction

    Monitor/Modify Tx

    dexamethasone + methyltestosterone

    monitor BP, thrombosis s/sx, especially if multiple myeloma use: combo may incr. risk of HTN, thromboembolism (additive effects)

  • metoclopramide
  • dexamethasone sodium phosphate (generic)
    +
    metoclopramide
    1 interaction

    Monitor/Modify Tx

    dexamethasone + metoclopramide

    monitor BP: combo may incr. risk of HTN (additive effects)

  • metolazone
  • dexamethasone sodium phosphate (generic)
    +
    metolazone
    1 interaction

    Monitor/Modify Tx

    dexamethasone + metolazone

    monitor potassium, BP: combo may incr. risk of hypokalemia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • metoprolol
  • dexamethasone sodium phosphate (generic)
    +
    metoprolol
    1 interaction

    Monitor/Modify Tx

    dexamethasone + metoprolol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • metyrapone
  • dexamethasone sodium phosphate (generic)
    +
    metyrapone
    1 interaction

    Monitor/Modify Tx

    dexamethasone + metyrapone

    D/C dexamethasone 5 half-lives before metyrapone test: combo may alter test results (antagonistic effects, exogenous corticosteroids may interfere with test)

  • miglitol
  • dexamethasone sodium phosphate (generic)
    +
    miglitol
    1 interaction

    Monitor/Modify Tx

    dexamethasone + miglitol

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • milnacipran
  • dexamethasone sodium phosphate (generic)
    +
    milnacipran
    1 interaction

    Monitor/Modify Tx

    dexamethasone + milnacipran

    monitor BP: combo may incr. risk of HTN (additive effects)

  • minoxidil
  • dexamethasone sodium phosphate (generic)
    +
    minoxidil
    1 interaction

    Monitor/Modify Tx

    dexamethasone + minoxidil

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • mirabegron
  • dexamethasone sodium phosphate (generic)
    +
    mirabegron
    1 interaction

    Monitor/Modify Tx

    dexamethasone + mirabegron

    monitor BP: combo may incr. risk of HTN (additive effects)

  • mitapivat
  • dexamethasone sodium phosphate (generic)
    +
    mitapivat
    1 interaction

    Monitor/Modify Tx

    dexamethasone + mitapivat

    monitor Hgb: combo may decr. levels of both drugs, efficacy (hepatic metabolism induced)

  • mitomycin
  • dexamethasone sodium phosphate (generic)
    +
    mitomycin
    1 interaction

    Monitor/Modify Tx

    dexamethasone + mitomycin

    caution advised; risk may be lower w/ intravesical mitomycin administration: combo may incr. risk of serious infection (additive effects)

  • modafinil
  • dexamethasone sodium phosphate (generic)
    +
    modafinil
    1 interaction

    Monitor/Modify Tx

    dexamethasone + modafinil

    monitor BP: combo may decr. dexamethasone levels, efficacy; may incr. risk of HTN (hepatic metabolism induced; additive effects)

  • moexipril
  • dexamethasone sodium phosphate (generic)
    +
    moexipril
    1 interaction

    Monitor/Modify Tx

    dexamethasone + moexipril

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • momelotinib
  • dexamethasone sodium phosphate (generic)
    +
    momelotinib
    1 interaction

    Monitor/Modify Tx

    dexamethasone + momelotinib

    monitor thrombosis s/sx, especially if multiple myeloma use: combo may incr. risk of serious infection, thromboembolism (additive effects)

  • monomethyl fumarate
  • dexamethasone sodium phosphate (generic)
    +
    monomethyl fumarate
    1 interaction

    Monitor/Modify Tx

    dexamethasone + monomethyl fumarate

    monitor bleeding s/sx: combo may incr. risk of serious infection, GI ulceration, perforation, bleeding, including life-threatening (additive effects)

  • motixafortide
  • dexamethasone sodium phosphate (generic)
    +
    motixafortide
    1 interaction

    Monitor/Modify Tx

    dexamethasone + motixafortide

    monitor potassium: combo may incr. risk of hypokalemia (additive effects)

  • mycophenolate mofetil
  • dexamethasone sodium phosphate (generic)
    +
    mycophenolate mofetil
    1 interaction

    Monitor/Modify Tx

    dexamethasone + mycophenolate mofetil

    monitor bleeding s/sx: combo may incr. risk of serious infection, GI ulceration, perforation, bleeding (additive effects)

  • mycophenolic acid
  • dexamethasone sodium phosphate (generic)
    +
    mycophenolic acid
    1 interaction

    Monitor/Modify Tx

    dexamethasone + mycophenolic acid

    monitor bleeding s/sx: combo may incr. risk of serious infection, GI ulceration, perforation, bleeding (additive effects)

  • nabumetone
  • dexamethasone sodium phosphate (generic)
    +
    nabumetone
    1 interaction

    Monitor/Modify Tx

    dexamethasone + nabumetone

    monitor BP, bleeding or thrombosis s/sx, especially if multiple myeloma use; use lowest effective nabumetone dose, shortest effective tx duration: combo may incr. risk of HTN, GI ulceration, perforation, bleeding (including life-threatening), thromboembolism (additive effects)

  • nadolol
  • dexamethasone sodium phosphate (generic)
    +
    nadolol
    1 interaction

    Monitor/Modify Tx

    dexamethasone + nadolol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • naproxen
  • dexamethasone sodium phosphate (generic)
    +
    naproxen
    1 interaction

    Monitor/Modify Tx

    dexamethasone + naproxen

    monitor BP, bleeding or thrombosis s/sx, especially if multiple myeloma use; use lowest effective naproxen dose, shortest effective tx duration: combo may incr. risk of HTN, GI ulceration, perforation, bleeding (including life-threatening), thromboembolism (additive effects)

  • naratriptan
  • dexamethasone sodium phosphate (generic)
    +
    naratriptan
    1 interaction

    Monitor/Modify Tx

    dexamethasone + naratriptan

    monitor BP: combo may incr. risk of HTN (additive effects)

  • nateglinide
  • dexamethasone sodium phosphate (generic)
    +
    nateglinide
    1 interaction

    Monitor/Modify Tx

    dexamethasone + nateglinide

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • naxitamab
  • dexamethasone sodium phosphate (generic)
    +
    naxitamab
    1 interaction

    Monitor/Modify Tx

    dexamethasone + naxitamab

    monitor BP: combo may incr. risk of HTN (additive effects)

  • nebivolol
  • dexamethasone sodium phosphate (generic)
    +
    nebivolol
    1 interaction

    Monitor/Modify Tx

    dexamethasone + nebivolol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • necitumumab
  • dexamethasone sodium phosphate (generic)
    +
    necitumumab
    1 interaction

    Monitor/Modify Tx

    dexamethasone + necitumumab

    monitor potassium; monitor thrombosis s/sx, especially if multiple myeloma use: combo may incr. risk of hypokalemia, thromboembolism (additive effects)

  • neostigmine
  • dexamethasone sodium phosphate (generic)
    +
    neostigmine
    1 interaction

    Monitor/Modify Tx

    dexamethasone + neostigmine

    if possible, D/C cholinesterase inhibitor at least 24h before starting corticosteroid tx: combo may cause severe weakness in myasthenia gravis (mechanism unknown)

  • netupitant
  • dexamethasone sodium phosphate (generic)
    +
    netupitant
    1 interaction

    Monitor/Modify Tx

    dexamethasone + netupitant

    give dexamethasone 12 mg PO x1, then if highly emetogenic chemo, give dexamethasone 8 mg PO x1 on days 2-4: combo may incr. dexamethasone levels, risk of systemic corticosteroid effects including Cushing syndrome and adrenal suppression, serious infection, other adverse effects (hepatic metabolism inhibited)

  • nicardipine
  • dexamethasone sodium phosphate (generic)
    +
    nicardipine
    1 interaction

    Monitor/Modify Tx

    dexamethasone + nicardipine

    monitor BP: combo may decr. nicardipine levels, efficacy (hepatic metabolism induced, antagonistic effects)

  • nifedipine
  • dexamethasone sodium phosphate (generic)
    +
    nifedipine
    1 interaction

    Monitor/Modify Tx

    dexamethasone + nifedipine

    monitor BP: combo may decr. nifedipine levels, efficacy (hepatic metabolism induced, antagonistic effects)

  • nilotinib
  • dexamethasone sodium phosphate (generic)
    +
    nilotinib
    1 interaction

    Monitor/Modify Tx

    dexamethasone + nilotinib

    monitor potassium, bleeding s/sx: combo may incr. dexamethasone levels, risk of systemic corticosteroid effects including Cushing syndrome and adrenal suppression, serious infection, hypokalemia, GI ulceration, perforation, bleeding (including life-threatening), other adverse effects; may decr. nilotinib levels, efficacy (hepatic metabolism inhibited, additive effects; hepatic metabolism induced)

  • nimodipine
  • dexamethasone sodium phosphate (generic)
    +
    nimodipine
    1 interaction

    Monitor/Modify Tx

    dexamethasone + nimodipine

    monitor BP: combo may decr. nimodipine levels, efficacy (hepatic metabolism induced, antagonistic effects)

  • nintedanib
  • dexamethasone sodium phosphate (generic)
    +
    nintedanib
    1 interaction

    Monitor/Modify Tx

    dexamethasone + nintedanib

    monitor bleeding or thrombosis s/sx, especially if multiple myeloma use: combo may incr. risk of GI ulceration, perforation, bleeding (including life-threatening), thromboembolism (additive effects)

  • niraparib
  • dexamethasone sodium phosphate (generic)
    +
    niraparib
    1 interaction

    Monitor/Modify Tx

    dexamethasone + niraparib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • nisoldipine
  • dexamethasone sodium phosphate (generic)
    +
    nisoldipine
    1 interaction

    Monitor/Modify Tx

    dexamethasone + nisoldipine

    monitor BP: combo may decr. nisoldipine levels, efficacy (hepatic metabolism induced, antagonistic effects)

  • norepinephrine
  • dexamethasone sodium phosphate (generic)
    +
    norepinephrine
    1 interaction

    Monitor/Modify Tx

    dexamethasone + norepinephrine

    monitor BP: combo may incr. risk of severe HTN (additive effects)

  • norethindrone (hormone replacement)
  • dexamethasone sodium phosphate (generic)
    +
    norethindrone (hormone replacement)
    1 interaction

    Monitor/Modify Tx

    dexamethasone + norethindrone (hormone replacement)

    monitor thrombosis s/sx, especially if multiple myeloma use: combo may incr. risk of thromboembolism (additive effects)

  • obinutuzumab
  • dexamethasone sodium phosphate (generic)
    +
    obinutuzumab
    1 interaction

    Monitor/Modify Tx

    dexamethasone + obinutuzumab

    monitor BP, thrombosis s/sx, especially if multiple myeloma use: combo may incr. risk of serious infection, thromboembolism, HTN, including hypertensive crisis (additive effects)

  • olaparib
  • dexamethasone sodium phosphate (generic)
    +
    olaparib
    1 interaction

    Monitor/Modify Tx

    dexamethasone + olaparib

    monitor thrombosis s/sx, especially if multiple myeloma use: combo may decr. olaparib levels, efficacy; may incr. risk of thromboembolism (hepatic metabolism induced; additive effects)

  • olmesartan medoxomil
  • dexamethasone sodium phosphate (generic)
    +
    olmesartan medoxomil
    1 interaction

    Monitor/Modify Tx

    dexamethasone + olmesartan medoxomil

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • olodaterol inhaled
  • dexamethasone sodium phosphate (generic)
    +
    olodaterol inhaled
    1 interaction

    Monitor/Modify Tx

    dexamethasone + olodaterol inhaled

    monitor potassium, BP: combo may incr. risk of hypokalemia, HTN (additive effects)

  • osilodrostat
  • dexamethasone sodium phosphate (generic)
    +
    osilodrostat
    1 interaction

    Monitor/Modify Tx

    dexamethasone + osilodrostat

    monitor BP, potassium: combo may incr. risk of HTN, hypokalemia (additive effects)

  • ospemifene
  • dexamethasone sodium phosphate (generic)
    +
    ospemifene
    1 interaction

    Monitor/Modify Tx

    dexamethasone + ospemifene

    monitor thrombosis s/sx, especially if multiple myeloma use: combo may incr. risk of thromboembolism (additive effects)

  • oxaprozin
  • dexamethasone sodium phosphate (generic)
    +
    oxaprozin
    1 interaction

    Monitor/Modify Tx

    dexamethasone + oxaprozin

    monitor BP, bleeding or thrombosis s/sx, especially if multiple myeloma use; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of GI ulceration, perforation, bleeding (including life-threatening), HTN, thromboembolism (additive effects)

  • oxymetazoline nasal
  • dexamethasone sodium phosphate (generic)
    +
    oxymetazoline nasal
    1 interaction

    Monitor/Modify Tx

    dexamethasone + oxymetazoline nasal

    monitor BP: combo may incr. risk of HTN (additive effects)

  • oxytocin
  • dexamethasone sodium phosphate (generic)
    +
    oxytocin
    1 interaction

    Monitor/Modify Tx

    dexamethasone + oxytocin

    monitor BP: combo may incr. risk of HTN, including life-threatening (additive effects)

  • ozanimod
  • dexamethasone sodium phosphate (generic)
    +
    ozanimod
    1 interaction

    Monitor/Modify Tx

    dexamethasone + ozanimod

    monitor BP; caution advised during and x3mo after ozanimod tx: combo may incr. risk of HTN (including hypertensive crisis), serious infection; infection risk may be prolonged (additive effects)

  • pacritinib
  • dexamethasone sodium phosphate (generic)
    +
    pacritinib
    1 interaction

    Monitor/Modify Tx

    dexamethasone + pacritinib

    monitor thrombosis s/sx, especially if multiple myeloma use: combo may decr. dexamethasone levels, efficacy; may incr. risk of thromboembolism (hepatic metabolism induced; additive effects)

  • pamidronate
  • dexamethasone sodium phosphate (generic)
    +
    pamidronate
    1 interaction

    Monitor/Modify Tx

    dexamethasone + pamidronate

    monitor potassium: combo may incr. risk of hypokalemia (additive effects)

  • panitumumab
  • dexamethasone sodium phosphate (generic)
    +
    panitumumab
    1 interaction

    Monitor/Modify Tx

    dexamethasone + panitumumab

    monitor potassium: combo may incr. risk of hypokalemia (additive effects)

  • pazopanib
  • dexamethasone sodium phosphate (generic)
    +
    pazopanib
    1 interaction

    Monitor/Modify Tx

    dexamethasone + pazopanib

    monitor BP, bleeding or thrombosis s/sx, especially if multiple myeloma use: combo may incr. risk of HTN, GI ulceration, perforation, bleeding (including life-threatening), thromboembolism (additive effects)

  • pegaspargase
  • dexamethasone sodium phosphate (generic)
    +
    pegaspargase
    1 interaction

    Monitor/Modify Tx

    dexamethasone + pegaspargase

    monitor thrombosis s/sx, especially if multiple myeloma use: combo may incr. dexamethasone levels, risk of glucocorticoid toxicities, including osteonecrosis; may incr. risk of thromboembolism (mechanism unknown; additive effects)

  • perindopril
  • dexamethasone sodium phosphate (generic)
    +
    perindopril
    1 interaction

    Monitor/Modify Tx

    dexamethasone + perindopril

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • pexidartinib
  • dexamethasone sodium phosphate (generic)
    +
    pexidartinib
    1 interaction

    Monitor/Modify Tx

    dexamethasone + pexidartinib

    monitor BP: combo may decr. dexamethasone levels, efficacy; may incr. risk of HTN (hepatic metabolism induced; additive effects)

  • phendimetrazine
  • dexamethasone sodium phosphate (generic)
    +
    phendimetrazine
    1 interaction

    Monitor/Modify Tx

    dexamethasone + phendimetrazine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • phenoxybenzamine
  • dexamethasone sodium phosphate (generic)
    +
    phenoxybenzamine
    1 interaction

    Monitor/Modify Tx

    dexamethasone + phenoxybenzamine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • phentermine
  • dexamethasone sodium phosphate (generic)
    +
    phentermine
    1 interaction

    Monitor/Modify Tx

    dexamethasone + phentermine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • phentolamine
  • dexamethasone sodium phosphate (generic)
    +
    phentolamine
    1 interaction

    Monitor/Modify Tx

    dexamethasone + phentolamine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • phenylephrine
  • dexamethasone sodium phosphate (generic)
    +
    phenylephrine
    1 interaction

    Monitor/Modify Tx

    dexamethasone + phenylephrine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • phenylephrine injection
  • dexamethasone sodium phosphate (generic)
    +
    phenylephrine injection
    1 interaction

    Monitor/Modify Tx

    dexamethasone + phenylephrine injection

    monitor BP: combo may incr. risk of HTN (additive effects)

  • phenylephrine nasal
  • dexamethasone sodium phosphate (generic)
    +
    phenylephrine nasal
    1 interaction

    Monitor/Modify Tx

    dexamethasone + phenylephrine nasal

    monitor BP: combo may incr. risk of HTN (additive effects)

  • phenylephrine ophthalmic
  • dexamethasone sodium phosphate (generic)
    +
    phenylephrine ophthalmic
    1 interaction

    Monitor/Modify Tx

    dexamethasone + phenylephrine ophthalmic

    monitor BP; HTN risk may be lower w/ phenylephrine ophthalmic 2.5%: combo may incr. risk of HTN (additive effects)

  • phenylephrine rectal
  • dexamethasone sodium phosphate (generic)
    +
    phenylephrine rectal
    1 interaction

    Monitor/Modify Tx

    dexamethasone + phenylephrine rectal

    monitor BP: combo may incr. risk of HTN (additive effects)

  • pindolol
  • dexamethasone sodium phosphate (generic)
    +
    pindolol
    1 interaction

    Monitor/Modify Tx

    dexamethasone + pindolol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • pioglitazone
  • dexamethasone sodium phosphate (generic)
    +
    pioglitazone
    1 interaction

    Monitor/Modify Tx

    dexamethasone + pioglitazone

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • piroxicam
  • dexamethasone sodium phosphate (generic)
    +
    piroxicam
    1 interaction

    Monitor/Modify Tx

    dexamethasone + piroxicam

    monitor BP, bleeding or thrombosis s/sx, especially if multiple myeloma use; use lowest effective piroxicam dose, shortest effective tx duration: combo may incr. risk of HTN, thromboembolism, GI ulceration, perforation, bleeding, including life-threatening (additive effects)

  • pneumococcal vaccine
  • dexamethasone sodium phosphate (generic)
    +
    pneumococcal vaccine
    1 interaction

    Monitor/Modify Tx

    dexamethasone + pneumococcal vaccine

    if possible, vaccinate at least 2wk before starting long-term (>2wk) high-dose systemic steroids; consider post-immunization titer check: combo may result in inadequate vaccine response (immunosuppressive effects)

  • poliovirus vaccine
  • dexamethasone sodium phosphate (generic)
    +
    poliovirus vaccine
    1 interaction

    Monitor/Modify Tx

    dexamethasone + poliovirus vaccine

    if possible, vaccinate at least 2wk before starting long-term (>2wk) high-dose systemic steroids; consider post-immunization titer check: combo may result in inadequate vaccine response (immunosuppressive effects)

  • polyethylene glycol
  • dexamethasone sodium phosphate (generic)
    +
    polyethylene glycol
    1 interaction

    Monitor/Modify Tx

    dexamethasone + polyethylene glycol

    monitor potassium, consider monitoring ECG if polyethylene glycol bowel prep use: combo may incr. risk of hypokalemia, QT prolongation, cardiac arrhythmias, seizures (additive effects)

  • polyethylene glycol/electrolytes
  • dexamethasone sodium phosphate (generic)
    +
    polyethylene glycol/ electrolytes
    1 interaction

    Monitor/Modify Tx

    dexamethasone + polyethylene glycol/ electrolytes

    monitor potassium, consider monitoring ECG: combo may incr. risk of hypokalemia, QT prolongation, cardiac arrhythmias, seizures (additive effects)

  • pomalidomide
  • dexamethasone sodium phosphate (generic)
    +
    pomalidomide
    1 interaction

    Monitor/Modify Tx

    dexamethasone + pomalidomide

    monitor thrombosis s/sx, especially if multiple myeloma use: combo may incr. risk of serious infection, thromboembolism (additive effects)

  • ponatinib
  • dexamethasone sodium phosphate (generic)
    +
    ponatinib
    1 interaction

    Monitor/Modify Tx

    dexamethasone + ponatinib

    monitor BP, bleeding or thrombosis s/sx, especially if multiple myeloma use: combo may decr. ponatinib levels, efficacy; may incr. risk of HTN, GI ulceration, perforation, bleeding (including life-threatening), thromboembolism, serious infection (hepatic metabolism induced; additive effects)

  • ponesimod
  • dexamethasone sodium phosphate (generic)
    +
    ponesimod
    1 interaction

    Monitor/Modify Tx

    dexamethasone + ponesimod

    monitor BP; caution advised during and x1-2wk after ponesimod tx: combo may incr. risk of HTN, serious infection; infection risk may be prolonged (additive effects)

  • porfimer
  • dexamethasone sodium phosphate (generic)
    +
    porfimer
    1 interaction

    Monitor/Modify Tx

    dexamethasone + porfimer

    monitor bleeding or thrombosis s/sx, especially if multiple myeloma use: combo may incr. risk of GI ulceration, perforation, bleeding (including life-threatening), thromboembolism (additive effects)

  • pralsetinib
  • dexamethasone sodium phosphate (generic)
    +
    pralsetinib
    1 interaction

    Monitor/Modify Tx

    dexamethasone + pralsetinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • pramlintide
  • dexamethasone sodium phosphate (generic)
    +
    pramlintide
    1 interaction

    Monitor/Modify Tx

    dexamethasone + pramlintide

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • prazosin
  • dexamethasone sodium phosphate (generic)
    +
    prazosin
    1 interaction

    Monitor/Modify Tx

    dexamethasone + prazosin

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • progesterone (hormone replacement)
  • dexamethasone sodium phosphate (generic)
    +
    progesterone (hormone replacement)
    1 interaction

    Monitor/Modify Tx

    dexamethasone + progesterone (hormone replacement)

    monitor thrombosis s/sx, especially if multiple myeloma use or w/ concomitant estrogen use: combo may incr. risk of thromboembolism (additive effects)

  • progesterone vaginal (hormone replacement)
  • dexamethasone sodium phosphate (generic)
    +
    progesterone vaginal (hormone replacement)
    1 interaction

    Monitor/Modify Tx

    dexamethasone + progesterone vaginal (hormone replacement)

    monitor thrombosis s/sx, especially if multiple myeloma use: combo may incr. risk of thromboembolism (additive effects)

  • propranolol
  • dexamethasone sodium phosphate (generic)
    +
    propranolol
    1 interaction

    Monitor/Modify Tx

    dexamethasone + propranolol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • prothrombin complex concentrate (human)
  • dexamethasone sodium phosphate (generic)
    +
    prothrombin complex concentrate (human)
    1 interaction

    Monitor/Modify Tx

    dexamethasone + prothrombin complex concentrate (human)

    monitor thrombosis s/sx, especially if multiple myeloma use: combo may incr. risk of thromboembolism (additive effects)

  • pseudoephedrine
  • dexamethasone sodium phosphate (generic)
    +
    pseudoephedrine
    1 interaction

    Monitor/Modify Tx

    dexamethasone + pseudoephedrine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • pyridostigmine
  • dexamethasone sodium phosphate (generic)
    +
    pyridostigmine
    1 interaction

    Monitor/Modify Tx

    dexamethasone + pyridostigmine

    monitor bleeding s/sx; D/C cholinesterase inhibitors >24h before starting corticosteroids: combo may incr. risk of GI ulceration, perforation, bleeding; may decr. cholinesterase inhibitor muscle-stimulating efficacy and cause extreme weakness in myasthenia gravis (additive effects; antagonistic effects, mechanism unknown)

  • quetiapine
  • dexamethasone sodium phosphate (generic)
    +
    quetiapine
    1 interaction

    Monitor/Modify Tx

    dexamethasone + quetiapine

    monitor BP, especially in pts <18 yo: combo may decr. quetiapine levels, efficacy; may incr. risk of HTN (hepatic metabolism induced; additive effects)

  • quinapril
  • dexamethasone sodium phosphate (generic)
    +
    quinapril
    1 interaction

    Monitor/Modify Tx

    dexamethasone + quinapril

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • quinidine (antiarrhythmic)
  • dexamethasone sodium phosphate (generic)
    +
    quinidine (antiarrhythmic)
    1 interaction

    Monitor/Modify Tx

    dexamethasone + quinidine (antiarrhythmic)

    monitor quinidine levels: combo may decr. quinidine levels, efficacy (hepatic metabolism induced)

  • raloxifene
  • dexamethasone sodium phosphate (generic)
    +
    raloxifene
    1 interaction

    Monitor/Modify Tx

    dexamethasone + raloxifene

    monitor thrombosis s/sx, especially if multiple myeloma use: combo may incr. risk of thromboembolism (additive effects)

  • ramipril
  • dexamethasone sodium phosphate (generic)
    +
    ramipril
    1 interaction

    Monitor/Modify Tx

    dexamethasone + ramipril

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • ramucirumab
  • dexamethasone sodium phosphate (generic)
    +
    ramucirumab
    1 interaction

    Monitor/Modify Tx

    dexamethasone + ramucirumab

    monitor BP, bleeding or thrombosis s/sx, especially if multiple myeloma use: combo may incr. risk of HTN, GI ulceration, perforation, bleeding (including life-threatening), thromboembolism (additive effects)

  • ranibizumab
  • dexamethasone sodium phosphate (generic)
    +
    ranibizumab
    1 interaction

    Monitor/Modify Tx

    dexamethasone + ranibizumab

    monitor thrombosis s/sx, especially if multiple myeloma use; risk may be lower if ocular implant use: combo may incr. risk of thromboembolism (additive effects)

  • regorafenib
  • dexamethasone sodium phosphate (generic)
    +
    regorafenib
    1 interaction

    Monitor/Modify Tx

    dexamethasone + regorafenib

    monitor BP, bleeding s/sx: combo may incr. risk of HTN, GI ulceration, perforation, bleeding (including life-threatening), serious infection (additive effects)

  • repaglinide
  • dexamethasone sodium phosphate (generic)
    +
    repaglinide
    1 interaction

    Monitor/Modify Tx

    dexamethasone + repaglinide

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • respiratory syncytial virus vaccine
  • dexamethasone sodium phosphate (generic)
    +
    respiratory syncytial virus vaccine
    1 interaction

    Monitor/Modify Tx

    dexamethasone + respiratory syncytial virus vaccine

    if possible, vaccinate at least 2wk before starting long-term (>2wk) high-dose systemic steroids; consider post-immunization titer check: combo may result in inadequate vaccine response (immunosuppressive effects)

  • Rho(D) immune globulin
  • dexamethasone sodium phosphate (generic)
    +
    Rho(D) immune globulin
    1 interaction

    Monitor/Modify Tx

    dexamethasone + Rho(D) immune globulin

    monitor thrombosis s/sx, especially if multiple myeloma use; use lowest Rho(D) immune globulin infusion rate possible: combo may incr. risk of thromboembolism (additive effects)

  • rimegepant
  • dexamethasone sodium phosphate (generic)
    +
    rimegepant
    1 interaction

    Monitor/Modify Tx

    dexamethasone + rimegepant

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ripretinib
  • dexamethasone sodium phosphate (generic)
    +
    ripretinib
    1 interaction

    Monitor/Modify Tx

    dexamethasone + ripretinib

    monitor BP: combo may decr. ripretinib and active metabolite levels, efficacy; may incr. risk of HTN (hepatic metabolism induced; additive effects)

  • risedronate
  • dexamethasone sodium phosphate (generic)
    +
    risedronate
    1 interaction

    Monitor/Modify Tx

    dexamethasone + risedronate

    monitor bleeding s/sx: combo may incr. risk of upper GI ulceration, perforation, bleeding (additive effects)

  • ritlecitinib
  • dexamethasone sodium phosphate (generic)
    +
    ritlecitinib
    1 interaction

    Monitor/Modify Tx

    dexamethasone + ritlecitinib

    monitor thrombosis s/sx, especially if multiple myeloma use: combo may incr. risk of serious infection, thromboembolism (additive effects)

  • rivastigmine
  • dexamethasone sodium phosphate (generic)
    +
    rivastigmine
    1 interaction

    Monitor/Modify Tx

    dexamethasone + rivastigmine

    monitor bleeding s/sx; D/C cholinesterase inhibitors >24h before starting corticosteroids: combo may incr. risk of GI ulceration, perforation, bleeding; may decr. cholinesterase inhibitor muscle-stimulating efficacy and cause extreme weakness in myasthenia gravis (additive effects; antagonistic effects, mechanism unknown)

  • rizatriptan
  • dexamethasone sodium phosphate (generic)
    +
    rizatriptan
    1 interaction

    Monitor/Modify Tx

    dexamethasone + rizatriptan

    monitor BP: combo may incr. risk of HTN (additive effects)

  • romiplostim
  • dexamethasone sodium phosphate (generic)
    +
    romiplostim
    1 interaction

    Monitor/Modify Tx

    dexamethasone + romiplostim

    monitor platelets, thrombosis s/sx, especially if multiple myeloma use: combo may incr. risk of thromboembolism (additive effects)

  • ropinirole
  • dexamethasone sodium phosphate (generic)
    +
    ropinirole
    1 interaction

    Monitor/Modify Tx

    dexamethasone + ropinirole

    monitor BP: combo may incr. risk of HTN (additive effects)

  • rosiglitazone
  • dexamethasone sodium phosphate (generic)
    +
    rosiglitazone
    1 interaction

    Monitor/Modify Tx

    dexamethasone + rosiglitazone

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • rotigotine transdermal
  • dexamethasone sodium phosphate (generic)
    +
    rotigotine transdermal
    1 interaction

    Monitor/Modify Tx

    dexamethasone + rotigotine transdermal

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ruxolitinib
  • dexamethasone sodium phosphate (generic)
    +
    ruxolitinib
    1 interaction

    Monitor/Modify Tx

    dexamethasone + ruxolitinib

    monitor thrombosis s/sx, especially if multiple myeloma use: combo may incr. risk of serious infection, thromboembolism (additive effects)

  • ruxolitinib topical
  • dexamethasone sodium phosphate (generic)
    +
    ruxolitinib topical
    1 interaction

    Monitor/Modify Tx

    dexamethasone + ruxolitinib topical

    monitor thrombosis s/sx, especially if multiple myeloma use: combo may incr. risk of serious infection, thromboembolism (additive effects)

  • sacituzumab govitecan
  • dexamethasone sodium phosphate (generic)
    +
    sacituzumab govitecan
    1 interaction

    Monitor/Modify Tx

    dexamethasone + sacituzumab govitecan

    monitor potassium: combo may incr. risk of hypokalemia (additive effects)

  • salmeterol inhaled
  • dexamethasone sodium phosphate (generic)
    +
    salmeterol inhaled
    1 interaction

    Monitor/Modify Tx

    dexamethasone + salmeterol inhaled

    monitor potassium, BP: combo may incr. risk of hypokalemia, HTN (additive effects)

  • salsalate
  • dexamethasone sodium phosphate (generic)
    +
    salsalate
    1 interaction

    Monitor/Modify Tx

    dexamethasone + salsalate

    monitor bleeding or thrombosis s/sx, especially if multiple myeloma use, BP w/ high-dose salsalate: combo may decr. salicylate levels, efficacy; may incr. risk of GI ulceration, perforation, bleeding (including life-threatening), thromboembolism, HTN (incr. clearance; additive effects)

  • saxagliptin
  • dexamethasone sodium phosphate (generic)
    +
    saxagliptin
    1 interaction

    Monitor/Modify Tx

    dexamethasone + saxagliptin

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • selinexor
  • dexamethasone sodium phosphate (generic)
    +
    selinexor
    1 interaction

    Monitor/Modify Tx

    dexamethasone + selinexor

    monitor potassium: combo may incr. risk of hypokalemia, serious infection (additive effects)

  • selpercatinib
  • dexamethasone sodium phosphate (generic)
    +
    selpercatinib
    1 interaction

    Monitor/Modify Tx

    dexamethasone + selpercatinib

    monitor BP: combo may decr. selpercatinib levels, efficacy; may incr. risk of HTN (hepatic metabolism induced; additive effects)

  • semaglutide
  • dexamethasone sodium phosphate (generic)
    +
    semaglutide
    1 interaction

    Monitor/Modify Tx

    dexamethasone + semaglutide

    monitor glucose in type 2 diabetes mellitus pts: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • siponimod
  • dexamethasone sodium phosphate (generic)
    +
    siponimod
    1 interaction

    Monitor/Modify Tx

    dexamethasone + siponimod

    caution advised during and x3-4wk after siponimod tx; monitor BP: combo may incr. risk of HTN, serious infection; infection risk may be prolonged (additive effects)

  • sipuleucel-T
  • dexamethasone sodium phosphate (generic)
    +
    sipuleucel-T
    1 interaction

    Monitor/Modify Tx

    dexamethasone + sipuleucel-T

    monitor thrombosis s/sx, especially if multiple myeloma use; consider decr. dexamethasone dose or D/C during leukapheresis and sipuleucel-T admin.: combo may decr. efficacy of sipuleucel-T; may incr. risk of thromboembolism, other adverse effects (antagonistic effects; additive effects)

  • sirolimus
  • dexamethasone sodium phosphate (generic)
    +
    sirolimus
    1 interaction

    Monitor/Modify Tx

    dexamethasone + sirolimus

    monitor sirolimus levels: combo may decr. sirolimus levels, efficacy; may incr. risk of serious infection (hepatic metabolism induced; additive effects)

  • sirolimus albumin-bound
  • dexamethasone sodium phosphate (generic)
    +
    sirolimus albumin-bound
    1 interaction

    Monitor/Modify Tx

    dexamethasone + sirolimus albumin-bound

    monitor potassium: combo may decr. sirolimus albumin-bound levels, efficacy; may incr. risk of serious infection, hypokalemia (hepatic metabolism induced; additive effects)

  • sitagliptin
  • dexamethasone sodium phosphate (generic)
    +
    sitagliptin
    1 interaction

    Monitor/Modify Tx

    dexamethasone + sitagliptin

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • smallpox/mpox vaccine, live
  • dexamethasone sodium phosphate (generic)
    +
    smallpox/ mpox vaccine, live
    1 interaction

    Monitor/Modify Tx

    dexamethasone + smallpox/ mpox vaccine, live

    consider vaccinating at least 1mo before or 1mo after long-term (>2wk) high-dose systemic steroids: combo may result in inadequate vaccine response (immunosuppressive effects)

  • sodium acid phosphate
  • dexamethasone sodium phosphate (generic)
    +
    sodium acid phosphate
    1 interaction

    Monitor/Modify Tx

    dexamethasone + sodium acid phosphate

    monitor sodium: combo may incr. risk of hypernatremia (additive effects)

  • sodium benzoate
  • dexamethasone sodium phosphate (generic)
    +
    sodium benzoate
    1 interaction

    Monitor/Modify Tx

    dexamethasone + sodium benzoate

    monitor potassium, especially if hyperammonemia use: combo may incr. risk of hypokalemia (additive effects)

  • sodium phenylacetate
  • dexamethasone sodium phosphate (generic)
    +
    sodium phenylacetate
    1 interaction

    Monitor/Modify Tx

    dexamethasone + sodium phenylacetate

    monitor potassium, ammonia levels: combo may incr. risk of hypokalemia; may decr. sodium phenylacetate efficacy (additive effects; antagonistic effects)

  • sodium phenylbutyrate
  • dexamethasone sodium phosphate (generic)
    +
    sodium phenylbutyrate
    1 interaction

    Monitor/Modify Tx

    dexamethasone + sodium phenylbutyrate

    monitor potassium, ammonia levels: combo may decr. sodium phenylbutyrate efficacy; may incr. risk of hypokalemia (antagonistic effects; additive effects)

  • sodium polystyrene sulfonate
  • dexamethasone sodium phosphate (generic)
    +
    sodium polystyrene sulfonate
    1 interaction

    Monitor/Modify Tx

    dexamethasone + sodium polystyrene sulfonate

    monitor potassium, ECG: combo may incr. risk of hypokalemia, QT prolongation, cardiac arrhythmias (additive effects)

  • sodium tetradecyl sulfate
  • dexamethasone sodium phosphate (generic)
    +
    sodium tetradecyl sulfate
    1 interaction

    Monitor/Modify Tx

    dexamethasone + sodium tetradecyl sulfate

    monitor thrombosis s/sx, especially if multiple myeloma use: combo may incr. risk of thromboembolism (additive effects)

  • sodium thiosulfate
  • dexamethasone sodium phosphate (generic)
    +
    sodium thiosulfate
    1 interaction

    Monitor/Modify Tx

    dexamethasone + sodium thiosulfate

    if ototoxicity risk reduction use, monitor potassium; otherwise, caution advised: combo may incr. risk of hypokalemia (additive effects)

  • solriamfetol
  • dexamethasone sodium phosphate (generic)
    +
    solriamfetol
    1 interaction

    Monitor/Modify Tx

    dexamethasone + solriamfetol

    monitor BP: combo may incr. risk of HTN (additive effects)

  • somapacitan
  • dexamethasone sodium phosphate (generic)
    +
    somapacitan
    1 interaction

    Monitor/Modify Tx

    dexamethasone + somapacitan

    consider incr. dexamethasone stress/maintenance dose: combo may decr. corticosteroid levels, efficacy (metabolism inhibited, decr. conversion to active metabolite)

  • somatrogon
  • dexamethasone sodium phosphate (generic)
    +
    somatrogon
    1 interaction

    Monitor/Modify Tx

    dexamethasone + somatrogon

    consider incr. dexamethasone stress/maintenance dose: combo may decr. corticosteroid levels, efficacy; may decr. somatrogon efficacy (metabolism inhibited, decr. conversion to active metabolite; antagonistic effects)

  • somatropin
  • dexamethasone sodium phosphate (generic)
    +
    somatropin
    1 interaction

    Monitor/Modify Tx

    dexamethasone + somatropin

    consider incr. dexamethasone stress/maintenance dose: combo may decr. corticosteroid levels, efficacy (metabolism inhibited, decr. conversion to active metabolite)

  • sorafenib
  • dexamethasone sodium phosphate (generic)
    +
    sorafenib
    1 interaction

    Monitor/Modify Tx

    dexamethasone + sorafenib

    monitor BP, bleeding s/sx: combo may incr. risk of HTN, GI ulceration, perforation, bleeding, including life-threatening (additive effects)

  • sotatercept
  • dexamethasone sodium phosphate (generic)
    +
    sotatercept
    1 interaction

    Monitor/Modify Tx

    dexamethasone + sotatercept

    monitor Hgb, thrombosis s/sx, especially if multiple myeloma use: combo may incr. risk of thromboembolism (additive effects)

  • spironolactone
  • dexamethasone sodium phosphate (generic)
    +
    spironolactone
    1 interaction

    Monitor/Modify Tx

    dexamethasone + spironolactone

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • sulfate bowel prep
  • dexamethasone sodium phosphate (generic)
    +
    sulfate bowel prep
    1 interaction

    Monitor/Modify Tx

    dexamethasone + sulfate bowel prep

    monitor potassium, consider monitoring ECG: combo may incr. risk of hypokalemia, QT prolongation, cardiac arrhythmias, seizures (additive effects)

  • sulindac
  • dexamethasone sodium phosphate (generic)
    +
    sulindac
    1 interaction

    Monitor/Modify Tx

    dexamethasone + sulindac

    monitor BP, bleeding s/sx or thrombosis s/sx, especially if multiple myeloma use; use lowest effective sulindac dose, shortest effective tx duration: combo may incr. risk of HTN, GI ulceration, perforation, bleeding (including life-threatening), thromboembolism (additive effects)

  • sumatriptan
  • dexamethasone sodium phosphate (generic)
    +
    sumatriptan
    1 interaction

    Monitor/Modify Tx

    dexamethasone + sumatriptan

    monitor BP: combo may incr. risk of HTN (additive effects)

  • sunitinib
  • dexamethasone sodium phosphate (generic)
    +
    sunitinib
    1 interaction

    Monitor/Modify Tx

    dexamethasone + sunitinib

    monitor BP, bleeding s/sx: combo may incr. risk of HTN, GI ulceration, perforation, bleeding, including life-threatening (additive effects)

  • tacrolimus
  • dexamethasone sodium phosphate (generic)
    +
    tacrolimus
    1 interaction

    Monitor/Modify Tx

    dexamethasone + tacrolimus

    monitor tacrolimus levels, BP: combo may decr. tacrolimus levels, efficacy; may incr. risk of HTN, serious infection (hepatic metabolism induced; additive effects)

  • tafasitamab
  • dexamethasone sodium phosphate (generic)
    +
    tafasitamab
    1 interaction

    Monitor/Modify Tx

    dexamethasone + tafasitamab

    monitor potassium: combo may incr. risk of hypokalemia, serious infection (additive effects)

  • tagraxofusp
  • dexamethasone sodium phosphate (generic)
    +
    tagraxofusp
    1 interaction

    Monitor/Modify Tx

    dexamethasone + tagraxofusp

    monitor BP: combo may incr. risk of HTN (additive effects)

  • tamoxifen
  • dexamethasone sodium phosphate (generic)
    +
    tamoxifen
    1 interaction

    Monitor/Modify Tx

    dexamethasone + tamoxifen

    monitor thrombosis s/sx, especially if multiple myeloma use: combo may decr. tamoxifen and active metabolite levels, efficacy; may incr. risk of thromboembolism (hepatic metabolism induced; additive effects)

  • telmisartan
  • dexamethasone sodium phosphate (generic)
    +
    telmisartan
    1 interaction

    Monitor/Modify Tx

    dexamethasone + telmisartan

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • temsirolimus
  • dexamethasone sodium phosphate (generic)
    +
    temsirolimus
    1 interaction

    Monitor/Modify Tx

    dexamethasone + temsirolimus

    monitor bleeding signs/symptoms: combo may decr. temsirolimus and active metabolite sirolimus levels, efficacy; may incr. risk of serious infection, GI ulceration, perforation, bleeding (hepatic metabolism induced; additive effects)

  • terazosin
  • dexamethasone sodium phosphate (generic)
    +
    terazosin
    1 interaction

    Monitor/Modify Tx

    dexamethasone + terazosin

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • terbutaline
  • dexamethasone sodium phosphate (generic)
    +
    terbutaline
    1 interaction

    Monitor/Modify Tx

    dexamethasone + terbutaline

    monitor potassium, BP: combo may incr. risk of hypokalemia, HTN (additive effects)

  • teriflunomide
  • dexamethasone sodium phosphate (generic)
    +
    teriflunomide
    1 interaction

    Monitor/Modify Tx

    dexamethasone + teriflunomide

    monitor BP: combo may incr. risk of serious infection, HTN (additive effects)

  • tesamorelin
  • dexamethasone sodium phosphate (generic)
    +
    tesamorelin
    1 interaction

    Monitor/Modify Tx

    dexamethasone + tesamorelin

    consider incr. dexamethasone stress/maintenance dose: combo may decr. corticosteroid levels, efficacy (metabolism inhibited, decr. conversion to active metabolite)

  • testosterone
  • dexamethasone sodium phosphate (generic)
    +
    testosterone
    1 interaction

    Monitor/Modify Tx

    dexamethasone + testosterone

    monitor BP, thrombosis s/sx, especially if multiple myeloma use: combo may incr. risk of HTN, thromboembolism (additive effects)

  • thalidomide
  • dexamethasone sodium phosphate (generic)
    +
    thalidomide
    1 interaction

    Monitor/Modify Tx

    dexamethasone + thalidomide

    monitor thrombosis s/sx, especially if multiple myeloma use: combo may incr. risk of thromboembolism, toxic epidermal necrolysis (additive effects, mechanism unknown)

  • tiagabine
  • dexamethasone sodium phosphate (generic)
    +
    tiagabine
    1 interaction

    Monitor/Modify Tx

    dexamethasone + tiagabine

    consider tiagabine dose adjustment if not on concurrent enzyme-inducing AEDs; titrate tiagabine dose to effect if already on enzyme-inducing AEDs: combo may decr. tiagabine levels, efficacy; may alter seizure control (hepatic metabolism induced; further induction possible if on concurrent enzyme-inducing AEDs; antagonistic effects, dexamethasone may decr. seizure threshold)

  • tick-borne encephalitis vaccine
  • dexamethasone sodium phosphate (generic)
    +
    tick-borne encephalitis vaccine
    1 interaction

    Monitor/Modify Tx

    dexamethasone + tick-borne encephalitis vaccine

    if possible, vaccinate at least 2wk before starting long-term (>2wk) high-dose systemic steroids; consider post-immunization titer check: combo may result in inadequate vaccine response (immunosuppressive effects)

  • timolol
  • dexamethasone sodium phosphate (generic)
    +
    timolol
    1 interaction

    Monitor/Modify Tx

    dexamethasone + timolol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • tirzepatide
  • dexamethasone sodium phosphate (generic)
    +
    tirzepatide
    1 interaction

    Monitor/Modify Tx

    dexamethasone + tirzepatide

    monitor glucose if type 2 diabetes mellitus use: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • tivozanib
  • dexamethasone sodium phosphate (generic)
    +
    tivozanib
    1 interaction

    Monitor/Modify Tx

    dexamethasone + tivozanib

    monitor BP, bleeding or thrombosis s/sx, especially if multiple myeloma use: combo may incr. risk of HTN (including hypertensive crisis), thromboembolism, GI ulceration, perforation, bleeding, including life-threatening (additive effects)

  • tocilizumab
  • dexamethasone sodium phosphate (generic)
    +
    tocilizumab
    1 interaction

    Monitor/Modify Tx

    dexamethasone + tocilizumab

    monitor bleeding s/sx: combo may incr. risk of serious infection, GI ulceration, perforation, bleeding (additive effects)

  • tofacitinib
  • dexamethasone sodium phosphate (generic)
    +
    tofacitinib
    1 interaction

    Monitor/Modify Tx

    dexamethasone + tofacitinib

    monitor thrombosis s/sx, especially if multiple myeloma use: combo may decr. tofacitinib levels, efficacy; may incr. risk of serious infection, thromboembolism (hepatic metabolism induced; additive effects)

  • tolmetin
  • dexamethasone sodium phosphate (generic)
    +
    tolmetin
    1 interaction

    Monitor/Modify Tx

    dexamethasone + tolmetin

    monitor BP, bleeding or thrombosis s/sx, especially if multiple myeloma use; use lowest effective tolmetin dose, shortest effective tx duration: combo may incr. risk of HTN, GI ulceration, perforation, bleeding (including life-threatening), thromboembolism (additive effects)

  • topiramate
  • dexamethasone sodium phosphate (generic)
    +
    topiramate
    1 interaction

    Monitor/Modify Tx

    dexamethasone + topiramate

    monitor potassium: combo may incr. risk of hypokalemia; may alter seizure control (additive effects; antagonistic effects, dexamethasone may decr. seizure threshold)

  • toremifene
  • dexamethasone sodium phosphate (generic)
    +
    toremifene
    1 interaction

    Monitor/Modify Tx

    dexamethasone + toremifene

    monitor thrombosis s/sx, especially if multiple myeloma use: combo may decr. toremifene levels, efficacy; may incr. risk of thromboembolism (hepatic metabolism induced; additive effects)

  • torsemide
  • dexamethasone sodium phosphate (generic)
    +
    torsemide
    1 interaction

    Monitor/Modify Tx

    dexamethasone + torsemide

    monitor potassium, BP: combo may incr. risk of hypokalemia; may decr. antihypertensive agent efficacy (additive effects; antagonistic effects)

  • trametinib
  • dexamethasone sodium phosphate (generic)
    +
    trametinib
    1 interaction

    Monitor/Modify Tx

    dexamethasone + trametinib

    monitor BP, bleeding or thrombosis s/sx, especially if multiple myeloma use or in combo w/ dabrafenib: combo may incr. risk of HTN, GI ulceration, perforation, bleeding (including life-threatening), thromboembolism (additive effects)

  • trandolapril
  • dexamethasone sodium phosphate (generic)
    +
    trandolapril
    1 interaction

    Monitor/Modify Tx

    dexamethasone + trandolapril

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • tretinoin
  • dexamethasone sodium phosphate (generic)
    +
    tretinoin
    1 interaction

    Monitor/Modify Tx

    dexamethasone + tretinoin

    monitor thrombosis s/sx, especially if multiple myeloma use and/or during 1st month of tretinoin use: combo may incr. risk of thromboembolism (additive effects)

  • triamcinolone
  • dexamethasone sodium phosphate (generic)
    +
    triamcinolone
    1 interaction

    Monitor/Modify Tx

    dexamethasone + triamcinolone

    monitor BP, potassium, bleeding s/sx: combo may incr. risk of systemic corticosteroid effects including Cushing syndrome and adrenal suppression, serious infection, GI ulceration, perforation, bleeding, hypokalemia, HTN, other adverse effects (additive effects, duplicate therapy)

  • triamterene
  • dexamethasone sodium phosphate (generic)
    +
    triamterene
    1 interaction

    Monitor/Modify Tx

    dexamethasone + triamterene

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • typhoid vaccine
  • dexamethasone sodium phosphate (generic)
    +
    typhoid vaccine
    1 interaction

    Monitor/Modify Tx

    dexamethasone + typhoid vaccine

    if possible, vaccinate at least 2wk before starting long-term (>2wk) high-dose systemic steroids; consider post-immunization titer check: combo may result in inadequate vaccine response (immunosuppressive effects)

  • ubrogepant
  • dexamethasone sodium phosphate (generic)
    +
    ubrogepant
    1 interaction

    Monitor/Modify Tx

    dexamethasone + ubrogepant

    monitor BP; increase ubrogepant dose to 100 mg, may give second 100 mg dose after 2h if needed: combo may decr. ubrogepant levels, efficacy; may incr. risk of HTN (hepatic metabolism induced; additive effects)

  • upadacitinib
  • dexamethasone sodium phosphate (generic)
    +
    upadacitinib
    1 interaction

    Monitor/Modify Tx

    dexamethasone + upadacitinib

    monitor bleeding or thrombosis s/sx, especially if multiple myeloma use: combo may incr. risk of GI ulceration, perforation, bleeding, serious infection, thromboembolism (additive effects)

  • vadadustat
  • dexamethasone sodium phosphate (generic)
    +
    vadadustat
    1 interaction

    Monitor/Modify Tx

    dexamethasone + vadadustat

    monitor BP, bleeding s/sx; monitor Hgb, thrombosis s/sx and use lowest effective vadadustat dose, especially if multiple myeloma use: combo may incr. risk of HTN (including hypertensive crisis), thromboembolism, GI ulceration, perforation, bleeding (additive effects)

  • valoctocogene roxaparvovec
  • dexamethasone sodium phosphate (generic)
    +
    valoctocogene roxaparvovec
    1 interaction

    Monitor/Modify Tx

    dexamethasone + valoctocogene roxaparvovec

    monitor thrombosis s/sx, especially if multiple myeloma use: combo may incr. risk of thromboembolism (additive effects)

  • valsartan
  • dexamethasone sodium phosphate (generic)
    +
    valsartan
    1 interaction

    Monitor/Modify Tx

    dexamethasone + valsartan

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • vandetanib
  • dexamethasone sodium phosphate (generic)
    +
    vandetanib
    1 interaction

    Monitor/Modify Tx

    dexamethasone + vandetanib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • varicella zoster immune globulin
  • dexamethasone sodium phosphate (generic)
    +
    varicella zoster immune globulin
    1 interaction

    Monitor/Modify Tx

    dexamethasone + varicella zoster immune globulin

    monitor thrombosis s/sx, especially if multiple myeloma use: combo may incr. risk of thromboembolism (additive effects)

  • vasopressin
  • dexamethasone sodium phosphate (generic)
    +
    vasopressin
    1 interaction

    Monitor/Modify Tx

    dexamethasone + vasopressin

    monitor BP: combo may incr. risk of HTN (additive effects)

  • venlafaxine
  • dexamethasone sodium phosphate (generic)
    +
    venlafaxine
    1 interaction

    Monitor/Modify Tx

    dexamethasone + venlafaxine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • verapamil
  • dexamethasone sodium phosphate (generic)
    +
    verapamil
    1 interaction

    Monitor/Modify Tx

    dexamethasone + verapamil

    monitor BP: combo may incr. dexamethasone levels, risk of systemic corticosteroid effects including Cushing syndrome and adrenal suppression, serious infection, other adverse effects; may decr. verapamil levels, efficacy (hepatic metabolism inhibited; hepatic metabolism induced, antagonistic effects)

  • vilanterol inhaled
  • dexamethasone sodium phosphate (generic)
    +
    vilanterol inhaled
    1 interaction

    Monitor/Modify Tx

    dexamethasone + vilanterol inhaled

    monitor potassium, BP: combo may incr. risk of hypokalemia, HTN (additive effects)

  • viloxazine
  • dexamethasone sodium phosphate (generic)
    +
    viloxazine
    1 interaction

    Monitor/Modify Tx

    dexamethasone + viloxazine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • voclosporin
  • dexamethasone sodium phosphate (generic)
    +
    voclosporin
    1 interaction

    Monitor/Modify Tx

    dexamethasone + voclosporin

    monitor BP: combo may decr. voclosporin levels, efficacy; may incr. risk of HTN, serious infection (hepatic metabolism induced; additive effects)

  • von Willebrand factor
  • dexamethasone sodium phosphate (generic)
    +
    von Willebrand factor
    1 interaction

    Monitor/Modify Tx

    dexamethasone + von Willebrand factor

    monitor thrombosis s/sx, especially if multiple myeloma use: combo may incr. risk of thromboembolism (additive effects)

  • vorinostat
  • dexamethasone sodium phosphate (generic)
    +
    vorinostat
    1 interaction

    Monitor/Modify Tx

    dexamethasone + vorinostat

    monitor thrombosis s/sx, especially if multiple myeloma use: combo may incr. risk of thromboembolism (additive effects)

  • warfarin
  • dexamethasone sodium phosphate (generic)
    +
    warfarin
    1 interaction

    Monitor/Modify Tx

    dexamethasone + warfarin

    monitor INR: combo may decr. warfarin levels, efficacy; may incr. or decr. INR (hepatic metabolism induced; mechanism unknown)

  • willow bark
  • dexamethasone sodium phosphate (generic)
    +
    willow bark
    1 interaction

    Monitor/Modify Tx

    dexamethasone + willow bark

    monitor bleeding s/sx: combo may incr. risk of GI ulceration, perforation, bleeding, including life-threatening (additive effects, willow bark may contain salicylates)

  • yohimbe
  • dexamethasone sodium phosphate (generic)
    +
    yohimbe
    1 interaction

    Monitor/Modify Tx

    dexamethasone + yohimbe

    monitor BP: combo may incr. risk of HTN (additive effects)

  • zavegepant
  • dexamethasone sodium phosphate (generic)
    +
    zavegepant
    1 interaction

    Monitor/Modify Tx

    dexamethasone + zavegepant

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ziv-aflibercept
  • dexamethasone sodium phosphate (generic)
    +
    ziv-aflibercept
    1 interaction

    Monitor/Modify Tx

    dexamethasone + ziv-aflibercept

    monitor BP, bleeding or thrombosis s/sx, especially if multiple myeloma use: combo may incr. risk of HTN, thromboembolism, GI ulceration, perforation, bleeding, including life-threatening (additive effects)

  • zolmitriptan
  • dexamethasone sodium phosphate (generic)
    +
    zolmitriptan
    1 interaction

    Monitor/Modify Tx

    dexamethasone + zolmitriptan

    monitor BP: combo may incr. risk of HTN (additive effects)

  • zonisamide
  • dexamethasone sodium phosphate (generic)
    +
    zonisamide
    1 interaction

    Monitor/Modify Tx

    dexamethasone + zonisamide

    monitor potassium: combo may incr. risk of hypokalemia; may alter seizure control (additive effects; antagonistic effects, dexamethasone may decr. seizure threshold)

  • zopapogene imadenovec
  • dexamethasone sodium phosphate (generic)
    +
    zopapogene imadenovec
    1 interaction

    Monitor/Modify Tx

    dexamethasone + zopapogene imadenovec

    monitor thrombosis s/sx, especially if multiple myeloma use: combo may incr. risk of thromboembolism (additive effects)

Caution Advised

  • abatacept
  • dexamethasone sodium phosphate (generic)
    +
    abatacept
    1 interaction

    Caution Advised

    dexamethasone + abatacept

    caution advised: combo may incr. risk of serious infection (additive effects)

  • acalabrutinib
  • dexamethasone sodium phosphate (generic)
    +
    acalabrutinib
    1 interaction

    Caution Advised

    dexamethasone + acalabrutinib

    caution advised: combo may decr. acalabrutinib levels, efficacy; may incr. risk of serious infection (hepatic metabolism induced; additive effects)

  • adalimumab
  • dexamethasone sodium phosphate (generic)
    +
    adalimumab
    1 interaction

    Caution Advised

    dexamethasone + adalimumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • albendazole
  • dexamethasone sodium phosphate (generic)
    +
    albendazole
    1 interaction

    Caution Advised

    dexamethasone + albendazole

    caution advised: combo may incr. albendazole levels, risk of adverse effects (mechanism unknown)

  • alemtuzumab
  • dexamethasone sodium phosphate (generic)
    +
    alemtuzumab
    1 interaction

    Caution Advised

    dexamethasone + alemtuzumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • alfentanil
  • dexamethasone sodium phosphate (generic)
    +
    alfentanil
    1 interaction

    Caution Advised

    dexamethasone + alfentanil

    caution advised: combo may decr. alfentanil levels, efficacy (hepatic metabolism induced)

  • alprazolam
  • dexamethasone sodium phosphate (generic)
    +
    alprazolam
    1 interaction

    Caution Advised

    dexamethasone + alprazolam

    caution advised: combo may decr. alprazolam levels, efficacy (hepatic metabolism induced)

  • amiodarone
  • dexamethasone sodium phosphate (generic)
    +
    amiodarone
    1 interaction

    Caution Advised

    dexamethasone + amiodarone

    caution advised: combo may decr. amiodarone levels, efficacy (hepatic metabolism induced)

  • anakinra
  • dexamethasone sodium phosphate (generic)
    +
    anakinra
    1 interaction

    Caution Advised

    dexamethasone + anakinra

    caution advised: combo may incr. risk of serious infection (additive effects)

  • anifrolumab
  • dexamethasone sodium phosphate (generic)
    +
    anifrolumab
    1 interaction

    Caution Advised

    dexamethasone + anifrolumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • anti-thymocyte globulin
  • dexamethasone sodium phosphate (generic)
    +
    anti-thymocyte globulin
    1 interaction

    Caution Advised

    dexamethasone + anti-thymocyte globulin

    caution advised: combo may incr. risk of serious infection (additive effects)

  • atorvastatin
  • dexamethasone sodium phosphate (generic)
    +
    atorvastatin
    1 interaction

    Caution Advised

    dexamethasone + atorvastatin

    caution advised: combo may decr. atorvastatin levels, efficacy (hepatic metabolism induced)

  • avacopan
  • dexamethasone sodium phosphate (generic)
    +
    avacopan
    1 interaction

    Caution Advised

    dexamethasone + avacopan

    caution advised: combo may incr. dexamethasone levels, risk of systemic corticosteroid effects including Cushing syndrome and adrenal suppression, serious infection, other adverse effects; may decr. avacopan levels, efficacy (hepatic metabolism inhibited, additive effects; hepatic metabolism induced)

  • avapritinib
  • dexamethasone sodium phosphate (generic)
    +
    avapritinib
    1 interaction

    Caution Advised

    dexamethasone + avapritinib

    caution advised: combo may decr. avapritinib levels, efficacy (hepatic metabolism induced)

  • azacitidine
  • dexamethasone sodium phosphate (generic)
    +
    azacitidine
    1 interaction

    Caution Advised

    dexamethasone + azacitidine

    caution advised: combo may incr. risk of serious infection (additive effects)

  • azathioprine
  • dexamethasone sodium phosphate (generic)
    +
    azathioprine
    1 interaction

    Caution Advised

    dexamethasone + azathioprine

    caution advised: combo may incr. risk of serious infection (additive effects)

  • basiliximab
  • dexamethasone sodium phosphate (generic)
    +
    basiliximab
    1 interaction

    Caution Advised

    dexamethasone + basiliximab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • beclomethasone inhaled
  • dexamethasone sodium phosphate (generic)
    +
    beclomethasone inhaled
    1 interaction

    Caution Advised

    dexamethasone + beclomethasone inhaled

    caution advised: combo may incr. risk of systemic corticosteroid effects including Cushing syndrome and adrenal suppression, serious infection, other adverse effects (additive effects, duplicate therapy)

  • beclomethasone nasal
  • dexamethasone sodium phosphate (generic)
    +
    beclomethasone nasal
    1 interaction

    Caution Advised

    dexamethasone + beclomethasone nasal

    caution advised: combo may incr. risk of systemic corticosteroid effects including Cushing syndrome and adrenal suppression, serious infection, other adverse effects (additive effects, duplicate therapy)

  • belatacept
  • dexamethasone sodium phosphate (generic)
    +
    belatacept
    1 interaction

    Caution Advised

    dexamethasone + belatacept

    caution advised: combo may incr. risk of serious infection (additive effects)

  • belimumab
  • dexamethasone sodium phosphate (generic)
    +
    belimumab
    1 interaction

    Caution Advised

    dexamethasone + belimumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • belinostat
  • dexamethasone sodium phosphate (generic)
    +
    belinostat
    1 interaction

    Caution Advised

    dexamethasone + belinostat

    caution advised: combo may incr. risk of serious infection (additive effects)

  • bendamustine
  • dexamethasone sodium phosphate (generic)
    +
    bendamustine
    1 interaction

    Caution Advised

    dexamethasone + bendamustine

    caution advised: combo may incr. risk of serious infection (additive effects)

  • berotralstat
  • dexamethasone sodium phosphate (generic)
    +
    berotralstat
    1 interaction

    Caution Advised

    dexamethasone + berotralstat

    caution advised: combo may incr. dexamethasone levels, risk of systemic corticosteroid effects including Cushing syndrome and adrenal suppression, serious infection, other adverse effects (hepatic metabolism inhibited)

  • bictegravir
  • dexamethasone sodium phosphate (generic)
    +
    bictegravir
    1 interaction

    Caution Advised

    dexamethasone + bictegravir

    caution advised if also combined w/ UGT1A1 inducer: combo may decr. bictegravir levels, efficacy (hepatic metabolism induced)

  • bimekizumab
  • dexamethasone sodium phosphate (generic)
    +
    bimekizumab
    1 interaction

    Caution Advised

    dexamethasone + bimekizumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • blinatumomab
  • dexamethasone sodium phosphate (generic)
    +
    blinatumomab
    1 interaction

    Caution Advised

    dexamethasone + blinatumomab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • bortezomib
  • dexamethasone sodium phosphate (generic)
    +
    bortezomib
    1 interaction

    Caution Advised

    dexamethasone + bortezomib

    caution advised: combo may incr. risk of serious infection (additive effects)

  • bosentan
  • dexamethasone sodium phosphate (generic)
    +
    bosentan
    1 interaction

    Caution Advised

    dexamethasone + bosentan

    caution advised: combo may decr. dexamethasone levels, efficacy (hepatic metabolism induced)

  • bosutinib
  • dexamethasone sodium phosphate (generic)
    +
    bosutinib
    1 interaction

    Caution Advised

    dexamethasone + bosutinib

    caution advised: combo may decr. bosutinib levels, efficacy (hepatic metabolism induced)

  • brivaracetam
  • dexamethasone sodium phosphate (generic)
    +
    brivaracetam
    1 interaction

    Caution Advised

    dexamethasone + brivaracetam

    caution advised: combo may alter seizure control (antagonistic effects, dexamethasone may decr. seizure threshold)

  • brodalumab
  • dexamethasone sodium phosphate (generic)
    +
    brodalumab
    1 interaction

    Caution Advised

    dexamethasone + brodalumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • budesonide inhaled
  • dexamethasone sodium phosphate (generic)
    +
    budesonide inhaled
    1 interaction

    Caution Advised

    dexamethasone + budesonide inhaled

    caution advised: combo may incr. risk of systemic corticosteroid effects including Cushing syndrome and adrenal suppression, serious infection, other adverse effects (additive effects, duplicate therapy)

  • budesonide nasal
  • dexamethasone sodium phosphate (generic)
    +
    budesonide nasal
    1 interaction

    Caution Advised

    dexamethasone + budesonide nasal

    caution advised: combo may incr. risk of systemic corticosteroid effects including Cushing syndrome and adrenal suppression, serious infection, other adverse effects (additive effects, duplicate therapy)

  • budesonide rectal
  • dexamethasone sodium phosphate (generic)
    +
    budesonide rectal
    1 interaction

    Caution Advised

    dexamethasone + budesonide rectal

    caution advised: combo may incr. risk of systemic corticosteroid effects including Cushing syndrome and adrenal suppression, serious infection, other adverse effects (additive effects, duplicate therapy)

  • buspirone
  • dexamethasone sodium phosphate (generic)
    +
    buspirone
    1 interaction

    Caution Advised

    dexamethasone + buspirone

    caution advised: combo may decr. buspirone levels, efficacy (hepatic metabolism induced)

  • busulfan
  • dexamethasone sodium phosphate (generic)
    +
    busulfan
    1 interaction

    Caution Advised

    dexamethasone + busulfan

    caution advised: combo may incr. risk of serious infection, seizures (additive effects)

  • canakinumab
  • dexamethasone sodium phosphate (generic)
    +
    canakinumab
    1 interaction

    Caution Advised

    dexamethasone + canakinumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • cannabidiol
  • dexamethasone sodium phosphate (generic)
    +
    cannabidiol
    1 interaction

    Caution Advised

    dexamethasone + cannabidiol

    caution advised if seizure disorder use: combo may alter seizure control (antagonistic effects, dexamethasone may decr. seizure threshold)

  • capivasertib
  • dexamethasone sodium phosphate (generic)
    +
    capivasertib
    1 interaction

    Caution Advised

    dexamethasone + capivasertib

    caution advised: combo may decr. capivasertib levels, efficacy (hepatic metabolism induced)

  • capmatinib
  • dexamethasone sodium phosphate (generic)
    +
    capmatinib
    1 interaction

    Caution Advised

    dexamethasone + capmatinib

    caution advised: combo may decr. capmatinib levels, efficacy (hepatic metabolism induced)

  • carboplatin
  • dexamethasone sodium phosphate (generic)
    +
    carboplatin
    1 interaction

    Caution Advised

    dexamethasone + carboplatin

    caution advised: combo may incr. risk of serious infection (additive effects)

  • carmustine
  • dexamethasone sodium phosphate (generic)
    +
    carmustine
    1 interaction

    Caution Advised

    dexamethasone + carmustine

    caution advised: combo may incr. risk of serious infection (additive effects)

  • cat's claw
  • dexamethasone sodium phosphate (generic)
    +
    cat's claw
    1 interaction

    Caution Advised

    dexamethasone + cat's claw

    caution advised: combo may decr. dexamethasone efficacy (antagonistic effects)

  • cenobamate
  • dexamethasone sodium phosphate (generic)
    +
    cenobamate
    1 interaction

    Caution Advised

    dexamethasone + cenobamate

    caution advised: combo may decr. dexamethasone levels, efficacy; may alter seizure control (hepatic metabolism induced; antagonistic effects, dexamethasone may decr. seizure threshold)

  • certolizumab pegol
  • dexamethasone sodium phosphate (generic)
    +
    certolizumab pegol
    1 interaction

    Caution Advised

    dexamethasone + certolizumab pegol

    caution advised: combo may incr. risk of serious infection (additive effects)

  • chlorambucil
  • dexamethasone sodium phosphate (generic)
    +
    chlorambucil
    1 interaction

    Caution Advised

    dexamethasone + chlorambucil

    caution advised: combo may incr. risk of serious infection, seizures (additive effects)

  • ciprofloxacin
  • dexamethasone sodium phosphate (generic)
    +
    ciprofloxacin
    1 interaction

    Caution Advised

    dexamethasone + ciprofloxacin

    caution advised: combo may incr. dexamethasone levels, risk of systemic corticosteroid effects including Cushing syndrome and adrenal suppression, serious infection, other adverse effects; may incr. risk of tendon rupture (hepatic metabolism inhibited; mechanism unknown)

  • cladribine injection
  • dexamethasone sodium phosphate (generic)
    +
    cladribine injection
    1 interaction

    Caution Advised

    dexamethasone + cladribine injection

    caution advised: combo may incr. risk of serious infection (additive effects)

  • clobazam
  • dexamethasone sodium phosphate (generic)
    +
    clobazam
    1 interaction

    Caution Advised

    dexamethasone + clobazam

    caution advised: combo may alter seizure control (antagonistic effects, dexamethasone may decr. seizure threshold)

  • clobetasol ophthalmic
  • dexamethasone sodium phosphate (generic)
    +
    clobetasol ophthalmic
    1 interaction

    Caution Advised

    dexamethasone + clobetasol ophthalmic

    caution advised: combo may incr. risk of systemic corticosteroid effects including Cushing syndrome and adrenal suppression, serious infection, other adverse effects (additive effects, duplicate therapy)

  • clofarabine
  • dexamethasone sodium phosphate (generic)
    +
    clofarabine
    1 interaction

    Caution Advised

    dexamethasone + clofarabine

    caution advised: combo may incr. risk of serious infection (additive effects)

  • clofazimine
  • dexamethasone sodium phosphate (generic)
    +
    clofazimine
    1 interaction

    Caution Advised

    dexamethasone + clofazimine

    caution advised: combo may incr. dexamethasone levels, risk of systemic corticosteroid effects including Cushing syndrome and adrenal suppression, serious infection, other adverse effects (hepatic metabolism inhibited)

  • clomipramine
  • dexamethasone sodium phosphate (generic)
    +
    clomipramine
    1 interaction

    Caution Advised

    dexamethasone + clomipramine

    caution advised: combo may incr. risk of seizures (additive effects)

  • clonazepam
  • dexamethasone sodium phosphate (generic)
    +
    clonazepam
    1 interaction

    Caution Advised

    dexamethasone + clonazepam

    caution advised if seizure disorder use: combo may alter seizure control (antagonistic effects, dexamethasone may decr. seizure threshold)

  • clorazepate
  • dexamethasone sodium phosphate (generic)
    +
    clorazepate
    1 interaction

    Caution Advised

    dexamethasone + clorazepate

    caution advised if seizure disorder use: combo may alter seizure control (antagonistic effects, dexamethasone may decr. seizure threshold)

  • cobimetinib
  • dexamethasone sodium phosphate (generic)
    +
    cobimetinib
    1 interaction

    Caution Advised

    dexamethasone + cobimetinib

    caution advised: combo may decr. cobimetinib levels, efficacy (hepatic metabolism induced)

  • coccidioides immitis skin test antigen
  • dexamethasone sodium phosphate (generic)
    +
    coccidioides immitis skin test antigen
    1 interaction

    Caution Advised

    dexamethasone + coccidioides immitis skin test antigen

    caution advised during and after long-term (>2wk) high-dose systemic steroids: combo may interfere with test results (antagonistic effects)

  • conivaptan
  • dexamethasone sodium phosphate (generic)
    +
    conivaptan
    1 interaction

    Caution Advised

    dexamethasone + conivaptan

    caution advised during and x7 days after conivaptan tx: combo may incr. dexamethasone levels, risk of systemic corticosteroid effects including Cushing syndrome and adrenal suppression, serious infection, other adverse effects (hepatic metabolism inhibited)

  • crovalimab
  • dexamethasone sodium phosphate (generic)
    +
    crovalimab
    1 interaction

    Caution Advised

    dexamethasone + crovalimab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • cytarabine
  • dexamethasone sodium phosphate (generic)
    +
    cytarabine
    1 interaction

    Caution Advised

    dexamethasone + cytarabine

    caution advised: combo may incr. risk of serious infection (additive effects)

  • dabrafenib
  • dexamethasone sodium phosphate (generic)
    +
    dabrafenib
    1 interaction

    Caution Advised

    dexamethasone + dabrafenib

    caution advised: combo may decr. dexamethasone levels, efficacy (hepatic metabolism induced)

  • dactinomycin
  • dexamethasone sodium phosphate (generic)
    +
    dactinomycin
    1 interaction

    Caution Advised

    dexamethasone + dactinomycin

    caution advised: combo may incr. risk of serious infection (additive effects)

  • danicopan
  • dexamethasone sodium phosphate (generic)
    +
    danicopan
    1 interaction

    Caution Advised

    dexamethasone + danicopan

    caution advised: combo may incr. risk of serious infection (additive effects)

  • daratumumab
  • dexamethasone sodium phosphate (generic)
    +
    daratumumab
    1 interaction

    Caution Advised

    dexamethasone + daratumumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • daridorexant
  • dexamethasone sodium phosphate (generic)
    +
    daridorexant
    1 interaction

    Caution Advised

    dexamethasone + daridorexant

    caution advised: combo may decr. daridorexant levels, efficacy (hepatic metabolism induced)

  • dasatinib
  • dexamethasone sodium phosphate (generic)
    +
    dasatinib
    1 interaction

    Caution Advised

    dexamethasone + dasatinib

    caution advised: combo may decr. dasatinib levels, efficacy (hepatic metabolism induced)

  • daunorubicin
  • dexamethasone sodium phosphate (generic)
    +
    daunorubicin
    1 interaction

    Caution Advised

    dexamethasone + daunorubicin

    caution advised: combo may incr. risk of serious infection (additive effects)

  • defactinib
  • dexamethasone sodium phosphate (generic)
    +
    defactinib
    1 interaction

    Caution Advised

    dexamethasone + defactinib

    caution advised: combo may decr. defactinib levels, efficacy (hepatic metabolism induced)

  • delgocitinib topical
  • dexamethasone sodium phosphate (generic)
    +
    delgocitinib topical
    1 interaction

    Caution Advised

    dexamethasone + delgocitinib topical

    caution advised: combo may incr. risk of serious infection (additive effects)

  • deucravacitinib
  • dexamethasone sodium phosphate (generic)
    +
    deucravacitinib
    1 interaction

    Caution Advised

    dexamethasone + deucravacitinib

    caution advised: combo may incr. risk of serious infection (additive effects)

  • dexamethasone ophthalmic
  • dexamethasone sodium phosphate (generic)
    +
    dexamethasone ophthalmic
    1 interaction

    Caution Advised

    dexamethasone + dexamethasone ophthalmic

    caution advised: combo may incr. risk of systemic corticosteroid effects including Cushing syndrome and adrenal suppression, serious infection, other adverse effects (additive effects, duplicate therapy)

  • diazepam
  • dexamethasone sodium phosphate (generic)
    +
    diazepam
    1 interaction

    Caution Advised

    dexamethasone + diazepam

    caution advised: combo may decr. diazepam levels, efficacy; may alter seizure control (hepatic metabolism possibly induced; antagonistic effects, dexamethasone may decr. seizure threshold)

  • difluprednate ophthalmic
  • dexamethasone sodium phosphate (generic)
    +
    difluprednate ophthalmic
    1 interaction

    Caution Advised

    dexamethasone + difluprednate ophthalmic

    caution advised: combo may incr. risk of systemic corticosteroid effects including Cushing syndrome and adrenal suppression, serious infection, other adverse effects (additive effects, duplicate therapy)

  • docetaxel
  • dexamethasone sodium phosphate (generic)
    +
    docetaxel
    1 interaction

    Caution Advised

    dexamethasone + docetaxel

    caution advised: combo may incr. risk of serious infection (additive effects)

  • doravirine
  • dexamethasone sodium phosphate (generic)
    +
    doravirine
    1 interaction

    Caution Advised

    dexamethasone + doravirine

    caution advised: combo may decr. doravirine levels, efficacy (hepatic metabolism induced)

  • dordaviprone
  • dexamethasone sodium phosphate (generic)
    +
    dordaviprone
    1 interaction

    Caution Advised

    dexamethasone + dordaviprone

    caution advised: combo may decr. dordaviprone levels, efficacy (hepatic metabolism induced)

  • doxorubicin
  • dexamethasone sodium phosphate (generic)
    +
    doxorubicin
    1 interaction

    Caution Advised

    dexamethasone + doxorubicin

    caution advised: combo may incr. risk of serious infection (additive effects)

  • dronedarone
  • dexamethasone sodium phosphate (generic)
    +
    dronedarone
    1 interaction

    Caution Advised

    dexamethasone + dronedarone

    caution advised: combo may incr. dexamethasone levels, risk of systemic corticosteroid effects including Cushing syndrome and adrenal suppression, serious infection, other adverse effects; may decr. dronedarone levels, efficacy (hepatic metabolism inhibited; hepatic metabolism induced)

  • dupilumab
  • dexamethasone sodium phosphate (generic)
    +
    dupilumab
    1 interaction

    Caution Advised

    dexamethasone + dupilumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • duvelisib
  • dexamethasone sodium phosphate (generic)
    +
    duvelisib
    1 interaction

    Caution Advised

    dexamethasone + duvelisib

    caution advised: combo may incr. dexamethasone levels, risk of systemic corticosteroid effects including Cushing syndrome and adrenal suppression, serious infection, other adverse effects (hepatic metabolism inhibited, additive effects)

  • echinacea
  • dexamethasone sodium phosphate (generic)
    +
    echinacea
    1 interaction

    Caution Advised

    dexamethasone + echinacea

    caution advised: combo may decr. dexamethasone efficacy (antagonistic effects)

  • eculizumab
  • dexamethasone sodium phosphate (generic)
    +
    eculizumab
    1 interaction

    Caution Advised

    dexamethasone + eculizumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • efavirenz
  • dexamethasone sodium phosphate (generic)
    +
    efavirenz
    1 interaction

    Caution Advised

    dexamethasone + efavirenz

    caution advised: combo may decr. dexamethasone levels, efficacy (hepatic metabolism induced)

  • efgartigimod alfa
  • dexamethasone sodium phosphate (generic)
    +
    efgartigimod alfa
    1 interaction

    Caution Advised

    dexamethasone + efgartigimod alfa

    caution advised: combo may incr. risk of serious infection (additive effects)

  • elacestrant
  • dexamethasone sodium phosphate (generic)
    +
    elacestrant
    1 interaction

    Caution Advised

    dexamethasone + elacestrant

    caution advised: combo may decr. elacestrant levels, efficacy (hepatic metabolism induced)

  • elbasvir
  • dexamethasone sodium phosphate (generic)
    +
    elbasvir
    1 interaction

    Caution Advised

    dexamethasone + elbasvir

    caution advised: combo may decr. elbasvir levels, efficacy (hepatic metabolism induced)

  • eleuthero
  • dexamethasone sodium phosphate (generic)
    +
    eleuthero
    1 interaction

    Caution Advised

    dexamethasone + eleuthero

    caution advised: combo may decr. dexamethasone efficacy (antagonistic effects)

  • elexacaftor/tezacaftor/ivacaftor
  • dexamethasone sodium phosphate (generic)
    +
    elexacaftor/ tezacaftor/ ivacaftor
    1 interaction

    Caution Advised

    dexamethasone + elexacaftor/ tezacaftor/ ivacaftor

    caution advised: combo may decr. elexacaftor/tezacaftor/ivacaftor levels, efficacy (hepatic metabolism induced)

  • eliglustat
  • dexamethasone sodium phosphate (generic)
    +
    eliglustat
    1 interaction

    Caution Advised

    dexamethasone + eliglustat

    caution advised: combo may decr. eliglustat levels, efficacy (hepatic metabolism induced)

  • elivaldogene autotemcel
  • dexamethasone sodium phosphate (generic)
    +
    elivaldogene autotemcel
    1 interaction

    Caution Advised

    dexamethasone + elivaldogene autotemcel

    caution advised: combo may incr. risk of serious infection (additive effects)

  • elotuzumab
  • dexamethasone sodium phosphate (generic)
    +
    elotuzumab
    1 interaction

    Caution Advised

    dexamethasone + elotuzumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • elranatamab
  • dexamethasone sodium phosphate (generic)
    +
    elranatamab
    1 interaction

    Caution Advised

    dexamethasone + elranatamab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • entrectinib
  • dexamethasone sodium phosphate (generic)
    +
    entrectinib
    1 interaction

    Caution Advised

    dexamethasone + entrectinib

    caution advised: combo may decr. erdafitinib levels, efficacy (hepatic metabolism induced)

  • epcoritamab
  • dexamethasone sodium phosphate (generic)
    +
    epcoritamab
    1 interaction

    Caution Advised

    dexamethasone + epcoritamab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • erdafitinib
  • dexamethasone sodium phosphate (generic)
    +
    erdafitinib
    1 interaction

    Caution Advised

    dexamethasone + erdafitinib

    caution advised: combo may decr. erdafitinib levels, efficacy (hepatic metabolism induced)

  • eribulin
  • dexamethasone sodium phosphate (generic)
    +
    eribulin
    1 interaction

    Caution Advised

    dexamethasone + eribulin

    caution advised: combo may incr. risk of serious infection (additive effects)

  • erythromycin
  • dexamethasone sodium phosphate (generic)
    +
    erythromycin
    1 interaction

    Caution Advised

    dexamethasone + erythromycin

    caution advised: combo may incr. dexamethasone levels, risk of systemic corticosteroid effects including Cushing syndrome and adrenal suppression, serious infection, other adverse effects; may decr. erythromycin levels, efficacy (hepatic metabolism inhibited; hepatic metabolism possibly induced)

  • eslicarbazepine acetate
  • dexamethasone sodium phosphate (generic)
    +
    eslicarbazepine acetate
    1 interaction

    Caution Advised

    dexamethasone + eslicarbazepine acetate

    caution advised: combo may alter seizure control (antagonistic effects, dexamethasone may decr. seizure threshold)

  • etanercept
  • dexamethasone sodium phosphate (generic)
    +
    etanercept
    1 interaction

    Caution Advised

    dexamethasone + etanercept

    caution advised: combo may incr. risk of serious infection (additive effects)

  • ethosuximide
  • dexamethasone sodium phosphate (generic)
    +
    ethosuximide
    1 interaction

    Caution Advised

    dexamethasone + ethosuximide

    caution advised: combo may alter seizure control (antagonistic effects, dexamethasone may decr. seizure threshold)

  • etoposide
  • dexamethasone sodium phosphate (generic)
    +
    etoposide
    1 interaction

    Caution Advised

    dexamethasone + etoposide

    caution advised: combo may incr. risk of serious infection (additive effects)

  • etuvetidigene autotemcel
  • dexamethasone sodium phosphate (generic)
    +
    etuvetidigene autotemcel
    1 interaction

    Caution Advised

    dexamethasone + etuvetidigene autotemcel

    caution advised: combo may incr. risk of serious infection (additive effects)

  • felbamate
  • dexamethasone sodium phosphate (generic)
    +
    felbamate
    1 interaction

    Caution Advised

    dexamethasone + felbamate

    caution advised: combo may alter seizure control (antagonistic effects, dexamethasone may decr. seizure threshold)

  • fexinidazole
  • dexamethasone sodium phosphate (generic)
    +
    fexinidazole
    1 interaction

    Caution Advised

    dexamethasone + fexinidazole

    caution advised: combo may decr. dexamethasone levels, efficacy (hepatic metabolism induced)

  • finerenone
  • dexamethasone sodium phosphate (generic)
    +
    finerenone
    1 interaction

    Caution Advised

    dexamethasone + finerenone

    caution advised: combo may decr. finerenone levels, efficacy (hepatic metabolism induced)

  • floxuridine
  • dexamethasone sodium phosphate (generic)
    +
    floxuridine
    1 interaction

    Caution Advised

    dexamethasone + floxuridine

    caution advised: combo may incr. risk of serious infection (additive effects)

  • fluconazole
  • dexamethasone sodium phosphate (generic)
    +
    fluconazole
    1 interaction

    Caution Advised

    dexamethasone + fluconazole

    caution advised: combo may incr. dexamethasone levels, risk of systemic corticosteroid effects including Cushing syndrome and adrenal suppression, serious infection, other adverse effects (hepatic metabolism inhibited)

  • fludarabine
  • dexamethasone sodium phosphate (generic)
    +
    fludarabine
    1 interaction

    Caution Advised

    dexamethasone + fludarabine

    caution advised: combo may incr. risk of serious infection (additive effects)

  • flunisolide nasal
  • dexamethasone sodium phosphate (generic)
    +
    flunisolide nasal
    1 interaction

    Caution Advised

    dexamethasone + flunisolide nasal

    caution advised: combo may incr. risk of systemic corticosteroid effects including Cushing syndrome and adrenal suppression, serious infection, other adverse effects (additive effects, duplicate therapy)

  • fluocinolone intravitreal
  • dexamethasone sodium phosphate (generic)
    +
    fluocinolone intravitreal
    1 interaction

    Caution Advised

    dexamethasone + fluocinolone intravitreal

    caution advised: combo may incr. risk of systemic corticosteroid effects including Cushing syndrome and adrenal suppression, serious infection, other adverse effects (additive effects, duplicate therapy)

  • fluorometholone ophthalmic
  • dexamethasone sodium phosphate (generic)
    +
    fluorometholone ophthalmic
    1 interaction

    Caution Advised

    dexamethasone + fluorometholone ophthalmic

    caution advised: combo may incr. risk of systemic corticosteroid effects including Cushing syndrome and adrenal suppression, serious infection, other adverse effects (additive effects, duplicate therapy)

  • fluticasone furoate
  • dexamethasone sodium phosphate (generic)
    +
    fluticasone furoate
    1 interaction

    Caution Advised

    dexamethasone + fluticasone furoate

    caution advised: combo may incr. risk of systemic corticosteroid effects including Cushing syndrome and adrenal suppression, serious infection, other adverse effects (additive effects, duplicate therapy)

  • fluticasone propionate
  • dexamethasone sodium phosphate (generic)
    +
    fluticasone propionate
    1 interaction

    Caution Advised

    dexamethasone + fluticasone propionate

    caution advised: combo may incr. risk of systemic corticosteroid effects, including Cushing syndrome, adrenal suppression, serious infection, other adverse effects (additive effects, duplicate therapy)

  • fosamprenavir
  • dexamethasone sodium phosphate (generic)
    +
    fosamprenavir
    1 interaction

    Caution Advised

    dexamethasone + fosamprenavir

    caution advised: combo may decr. amprenavir levels, efficacy; may incr. dexamethasone levels, risk of systemic corticosteroid effects including Cushing syndrome and adrenal suppression, serious infection, other adverse effects (hepatic metabolism induced; hepatic metabolism inhibited)

  • gabapentin
  • dexamethasone sodium phosphate (generic)
    +
    gabapentin
    1 interaction

    Caution Advised

    dexamethasone + gabapentin

    caution advised if seizure disorder use: combo may alter seizure control (antagonistic effects, dexamethasone may decr. seizure threshold)

  • ganaxolone
  • dexamethasone sodium phosphate (generic)
    +
    ganaxolone
    1 interaction

    Caution Advised

    dexamethasone + ganaxolone

    caution advised: combo may alter seizure control (antagonistic effects, dexamethasone may decr. seizure threshold)

  • gemtuzumab ozogamicin
  • dexamethasone sodium phosphate (generic)
    +
    gemtuzumab ozogamicin
    1 interaction

    Caution Advised

    dexamethasone + gemtuzumab ozogamicin

    caution advised: combo may incr. risk of serious infection (additive effects)

  • gepirone
  • dexamethasone sodium phosphate (generic)
    +
    gepirone
    1 interaction

    Caution Advised

    dexamethasone + gepirone

    caution advised: combo may decr. gepirone levels, efficacy (hepatic metabolism induced)

  • gilteritinib
  • dexamethasone sodium phosphate (generic)
    +
    gilteritinib
    1 interaction

    Caution Advised

    dexamethasone + gilteritinib

    caution advised: combo may decr. gilteritinib levels, efficacy (hepatic metabolism induced)

  • ginseng, Asian
  • dexamethasone sodium phosphate (generic)
    +
    ginseng, Asian
    1 interaction

    Caution Advised

    dexamethasone + ginseng, Asian

    caution advised: combo may decr. dexamethasone efficacy (antagonistic effects)

  • glasdegib
  • dexamethasone sodium phosphate (generic)
    +
    glasdegib
    1 interaction

    Caution Advised

    dexamethasone + glasdegib

    caution advised: combo may decr. glasdegib levels, efficacy (hepatic metabolism induced)

  • glecaprevir
  • dexamethasone sodium phosphate (generic)
    +
    glecaprevir
    1 interaction

    Caution Advised

    dexamethasone + glecaprevir

    caution advised: combo may decr. glecaprevir levels, efficacy (hepatic metabolism induced)

  • glofitamab
  • dexamethasone sodium phosphate (generic)
    +
    glofitamab
    1 interaction

    Caution Advised

    dexamethasone + glofitamab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • golimumab
  • dexamethasone sodium phosphate (generic)
    +
    golimumab
    1 interaction

    Caution Advised

    dexamethasone + golimumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • grapefruit
  • dexamethasone sodium phosphate (generic)
    +
    grapefruit
    1 interaction

    Caution Advised

    dexamethasone + grapefruit

    caution advised w/ oral dexamethasone: combo may incr. dexamethasone levels, risk of systemic corticosteroid effects including Cushing syndrome and adrenal suppression, serious infection, other adverse effects (GI metabolism inhibited)

  • grazoprevir
  • dexamethasone sodium phosphate (generic)
    +
    grazoprevir
    1 interaction

    Caution Advised

    dexamethasone + grazoprevir

    caution advised: combo may decr. grazoprevir levels, efficacy (hepatic metabolism induced)

  • guselkumab
  • dexamethasone sodium phosphate (generic)
    +
    guselkumab
    1 interaction

    Caution Advised

    dexamethasone + guselkumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • haloperidol
  • dexamethasone sodium phosphate (generic)
    +
    haloperidol
    1 interaction

    Caution Advised

    dexamethasone + haloperidol

    caution advised: combo may decr. haloperidol levels, efficacy (hepatic metabolism induced)

  • hydrocortisone ophthalmic
  • dexamethasone sodium phosphate (generic)
    +
    hydrocortisone ophthalmic
    1 interaction

    Caution Advised

    dexamethasone + hydrocortisone ophthalmic

    caution advised: combo may incr. risk of systemic corticosteroid effects including Cushing syndrome and adrenal suppression, serious infection, other adverse effects (additive effects, duplicate therapy)

  • hydroxychloroquine
  • dexamethasone sodium phosphate (generic)
    +
    hydroxychloroquine
    1 interaction

    Caution Advised

    dexamethasone + hydroxychloroquine

    caution advised: combo may incr. risk of seizures (additive effects)

  • hydroxyurea
  • dexamethasone sodium phosphate (generic)
    +
    hydroxyurea
    1 interaction

    Caution Advised

    dexamethasone + hydroxyurea

    caution advised: combo may incr. risk of serious infection (additive effects)

  • ibritumomab tiuxetan
  • dexamethasone sodium phosphate (generic)
    +
    ibritumomab tiuxetan
    1 interaction

    Caution Advised

    dexamethasone + ibritumomab tiuxetan

    caution advised: combo may incr. risk of serious infection (additive effects)

  • icotrokinra
  • dexamethasone sodium phosphate (generic)
    +
    icotrokinra
    1 interaction

    Caution Advised

    dexamethasone + icotrokinra

    caution advised: combo may incr. risk of serious infection (additive effects)

  • idarubicin
  • dexamethasone sodium phosphate (generic)
    +
    idarubicin
    1 interaction

    Caution Advised

    dexamethasone + idarubicin

    caution advised: combo may incr. risk of serious infection (additive effects)

  • inebilizumab
  • dexamethasone sodium phosphate (generic)
    +
    inebilizumab
    1 interaction

    Caution Advised

    dexamethasone + inebilizumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • infliximab
  • dexamethasone sodium phosphate (generic)
    +
    infliximab
    1 interaction

    Caution Advised

    dexamethasone + infliximab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • inotuzumab ozogamicin
  • dexamethasone sodium phosphate (generic)
    +
    inotuzumab ozogamicin
    1 interaction

    Caution Advised

    dexamethasone + inotuzumab ozogamicin

    caution advised: combo may incr. risk of serious infection (additive effects)

  • iptacopan
  • dexamethasone sodium phosphate (generic)
    +
    iptacopan
    1 interaction

    Caution Advised

    dexamethasone + iptacopan

    caution advised: combo may incr. risk of serious infection (additive effects)

  • irinotecan
  • dexamethasone sodium phosphate (generic)
    +
    irinotecan
    1 interaction

    Caution Advised

    dexamethasone + irinotecan

    caution advised: combo may incr. risk of serious infection (additive effects)

  • isatuximab
  • dexamethasone sodium phosphate (generic)
    +
    isatuximab
    1 interaction

    Caution Advised

    dexamethasone + isatuximab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • isavuconazonium
  • dexamethasone sodium phosphate (generic)
    +
    isavuconazonium
    1 interaction

    Caution Advised

    dexamethasone + isavuconazonium

    caution advised: combo may incr. dexamethasone levels, risk of systemic corticosteroid effects including Cushing syndrome and adrenal suppression, serious infection, other adverse effects; may decr. isavuconazole levels, efficacy (hepatic metabolism inhibited; hepatic metabolism induced)

  • isoniazid
  • dexamethasone sodium phosphate (generic)
    +
    isoniazid
    1 interaction

    Caution Advised

    dexamethasone + isoniazid

    caution advised: combo may decr. isoniazid levels, efficacy (mechanism unknown)

  • isotretinoin
  • dexamethasone sodium phosphate (generic)
    +
    isotretinoin
    1 interaction

    Caution Advised

    dexamethasone + isotretinoin

    caution advised: combo may incr. risk of bone loss (additive effects)

  • istradefylline
  • dexamethasone sodium phosphate (generic)
    +
    istradefylline
    1 interaction

    Caution Advised

    dexamethasone + istradefylline

    caution advised: combo may decr. istradefylline levels, efficacy (hepatic metabolism induced)

  • ivacaftor
  • dexamethasone sodium phosphate (generic)
    +
    ivacaftor
    1 interaction

    Caution Advised

    dexamethasone + ivacaftor

    caution advised: combo may decr. ivacaftor levels, efficacy (hepatic metabolism induced)

  • ixabepilone
  • dexamethasone sodium phosphate (generic)
    +
    ixabepilone
    1 interaction

    Caution Advised

    dexamethasone + ixabepilone

    caution advised: combo may incr. risk of serious infection (additive effects)

  • ixekizumab
  • dexamethasone sodium phosphate (generic)
    +
    ixekizumab
    1 interaction

    Caution Advised

    dexamethasone + ixekizumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • lacosamide
  • dexamethasone sodium phosphate (generic)
    +
    lacosamide
    1 interaction

    Caution Advised

    dexamethasone + lacosamide

    caution advised: combo may alter seizure control (antagonistic effects, dexamethasone may decr. seizure threshold)

  • lamotrigine
  • dexamethasone sodium phosphate (generic)
    +
    lamotrigine
    1 interaction

    Caution Advised

    dexamethasone + lamotrigine

    caution advised if seizure disorder use: combo may alter seizure control (antagonistic effects, dexamethasone may decr. seizure threshold)

  • lapatinib
  • dexamethasone sodium phosphate (generic)
    +
    lapatinib
    1 interaction

    Caution Advised

    dexamethasone + lapatinib

    caution advised: combo may decr. lapatinib levels, efficacy (hepatic metabolism induced)

  • larotrectinib
  • dexamethasone sodium phosphate (generic)
    +
    larotrectinib
    1 interaction

    Caution Advised

    dexamethasone + larotrectinib

    caution advised: combo may decr. larotrectinib levels, efficacy (hepatic metabolism induced)

  • lebrikizumab
  • dexamethasone sodium phosphate (generic)
    +
    lebrikizumab
    1 interaction

    Caution Advised

    dexamethasone + lebrikizumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • lefamulin
  • dexamethasone sodium phosphate (generic)
    +
    lefamulin
    1 interaction

    Caution Advised

    dexamethasone + lefamulin

    ORAL LEFAMULIN: caution advised; IV lefamulin use OK: combo may incr. dexamethasone levels, risk of systemic corticosteroid effects including Cushing syndrome and adrenal suppression, serious infection, other adverse effects; may decr. oral lefamulin levels, efficacy (hepatic metabolism inhibited; hepatic metabolism induced)

  • lenacapavir
  • dexamethasone sodium phosphate (generic)
    +
    lenacapavir
    1 interaction

    Caution Advised

    dexamethasone + lenacapavir

    caution advised during and x9mo after lenacapavir tx: combo may incr. dexamethasone levels, risk of systemic corticosteroid effects including Cushing syndrome and adrenal suppression, serious infection, other adverse effects; may decr. lenacapavir levels, efficacy (hepatic metabolism inhibited; hepatic metabolism induced)

  • leniolisib
  • dexamethasone sodium phosphate (generic)
    +
    leniolisib
    1 interaction

    Caution Advised

    dexamethasone + leniolisib

    caution advised: combo may decr. leniolisib levels, efficacy (hepatic metabolism induced)

  • letermovir
  • dexamethasone sodium phosphate (generic)
    +
    letermovir
    1 interaction

    Caution Advised

    dexamethasone + letermovir

    caution advised: combo may incr. dexamethasone levels, risk of systemic corticosteroid effects including Cushing syndrome and adrenal suppression, serious infection, other adverse effects; may decr. letermovir levels, efficacy (hepatic metabolism inhibited; hepatic metabolism induced)

  • levetiracetam
  • dexamethasone sodium phosphate (generic)
    +
    levetiracetam
    1 interaction

    Caution Advised

    dexamethasone + levetiracetam

    caution advised: combo may alter seizure control (antagonistic effects, dexamethasone may decr. seizure threshold)

  • levofloxacin
  • dexamethasone sodium phosphate (generic)
    +
    levofloxacin
    1 interaction

    Caution Advised

    dexamethasone + levofloxacin

    caution advised: combo may incr. risk of tendon rupture (mechanism unknown)

  • levonorgestrel intrauterine device (contraceptive)
  • dexamethasone sodium phosphate (generic)
    +
    levonorgestrel intrauterine device (contraceptive)
    1 interaction

    Caution Advised

    dexamethasone + levonorgestrel intrauterine device (contraceptive)

    caution advised: combo may decr. levonorgestrel levels, contraceptive efficacy (hepatic metabolism possibly induced)

  • linvoseltamab
  • dexamethasone sodium phosphate (generic)
    +
    linvoseltamab
    1 interaction

    Caution Advised

    dexamethasone + linvoseltamab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • lomustine
  • dexamethasone sodium phosphate (generic)
    +
    lomustine
    1 interaction

    Caution Advised

    dexamethasone + lomustine

    caution advised: combo may incr. risk of serious infection (additive effects)

  • loncastuximab tesirine
  • dexamethasone sodium phosphate (generic)
    +
    loncastuximab tesirine
    1 interaction

    Caution Advised

    dexamethasone + loncastuximab tesirine

    caution advised: combo may incr. risk of serious infection (additive effects)

  • lorazepam
  • dexamethasone sodium phosphate (generic)
    +
    lorazepam
    1 interaction

    Caution Advised

    dexamethasone + lorazepam

    caution advised if seizure disorder use: combo may alter seizure control (antagonistic effects, dexamethasone may decr. seizure threshold)

  • loteprednol ophthalmic
  • dexamethasone sodium phosphate (generic)
    +
    loteprednol ophthalmic
    1 interaction

    Caution Advised

    dexamethasone + loteprednol ophthalmic

    caution advised: combo may incr. risk of systemic corticosteroid effects including Cushing syndrome and adrenal suppression, serious infection, other adverse effects (additive effects, duplicate therapy)

  • lurasidone
  • dexamethasone sodium phosphate (generic)
    +
    lurasidone
    1 interaction

    Caution Advised

    dexamethasone + lurasidone

    caution advised: combo may decr. lurasidone levels, efficacy (hepatic metabolism induced)

  • lymphocyte immune globulin, anti-thymocyte globulin
  • dexamethasone sodium phosphate (generic)
    +
    lymphocyte immune globulin, anti-thymocyte globulin
    1 interaction

    Caution Advised

    dexamethasone + lymphocyte immune globulin, anti-thymocyte globulin

    caution advised: combo may incr. risk of serious infection, mask anti-thymocyte globulin adverse reactions (additive effects)

  • macitentan
  • dexamethasone sodium phosphate (generic)
    +
    macitentan
    1 interaction

    Caution Advised

    dexamethasone + macitentan

    caution advised: combo may decr. macitentan levels, efficacy (hepatic metabolism induced)

  • maraviroc
  • dexamethasone sodium phosphate (generic)
    +
    maraviroc
    1 interaction

    Caution Advised

    dexamethasone + maraviroc

    caution advised: combo may decr. maraviroc levels, efficacy (hepatic metabolism induced)

  • melphalan
  • dexamethasone sodium phosphate (generic)
    +
    melphalan
    1 interaction

    Caution Advised

    dexamethasone + melphalan

    caution advised: combo may incr. risk of serious infection (additive effects)

  • mercaptopurine
  • dexamethasone sodium phosphate (generic)
    +
    mercaptopurine
    1 interaction

    Caution Advised

    dexamethasone + mercaptopurine

    caution advised: combo may incr. risk of serious infection (additive effects)

  • methacholine inhaled
  • dexamethasone sodium phosphate (generic)
    +
    methacholine inhaled
    1 interaction

    Caution Advised

    dexamethasone + methacholine inhaled

    caution advised: combo may interfere with test results (antagonistic effects)

  • methadone
  • dexamethasone sodium phosphate (generic)
    +
    methadone
    1 interaction

    Caution Advised

    dexamethasone + methadone

    caution advised: combo may decr. methadone levels, efficacy (hepatic metabolism induced)

  • methsuximide
  • dexamethasone sodium phosphate (generic)
    +
    methsuximide
    1 interaction

    Caution Advised

    dexamethasone + methsuximide

    caution advised: combo may alter seizure control (antagonistic effects, dexamethasone may decr. seizure threshold)

  • midazolam
  • dexamethasone sodium phosphate (generic)
    +
    midazolam
    1 interaction

    Caution Advised

    dexamethasone + midazolam

    caution advised w/ oral midazolam; other midazolam routes OK: combo may decr. midazolam levels, efficacy; may alter seizure control (hepatic metabolism induced; antagonistic effects, dexamethasone may decr. seizure threshold)

  • midostaurin
  • dexamethasone sodium phosphate (generic)
    +
    midostaurin
    1 interaction

    Caution Advised

    dexamethasone + midostaurin

    caution advised: combo may decr. midostaurin levels, efficacy (hepatic metabolism induced)

  • mirikizumab
  • dexamethasone sodium phosphate (generic)
    +
    mirikizumab
    1 interaction

    Caution Advised

    dexamethasone + mirikizumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • mitoxantrone
  • dexamethasone sodium phosphate (generic)
    +
    mitoxantrone
    1 interaction

    Caution Advised

    dexamethasone + mitoxantrone

    caution advised: combo may incr. risk of serious infection (additive effects)

  • mobocertinib
  • dexamethasone sodium phosphate (generic)
    +
    mobocertinib
    1 interaction

    Caution Advised

    dexamethasone + mobocertinib

    caution advised: combo may decr. mobocertinib levels, efficacy (hepatic metabolism induced)

  • mogamulizumab
  • dexamethasone sodium phosphate (generic)
    +
    mogamulizumab
    1 interaction

    Caution Advised

    dexamethasone + mogamulizumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • mometasone implant
  • dexamethasone sodium phosphate (generic)
    +
    mometasone implant
    1 interaction

    Caution Advised

    dexamethasone + mometasone implant

    caution advised: combo may incr. risk of systemic corticosteroid effects including Cushing syndrome and adrenal suppression, serious infection, other adverse effects (additive effects, duplicate therapy)

  • mometasone inhaled
  • dexamethasone sodium phosphate (generic)
    +
    mometasone inhaled
    1 interaction

    Caution Advised

    dexamethasone + mometasone inhaled

    caution advised: combo may incr. risk of systemic corticosteroid effects including Cushing syndrome and adrenal suppression, serious infection, other adverse effects (additive effects, duplicate therapy)

  • mometasone nasal
  • dexamethasone sodium phosphate (generic)
    +
    mometasone nasal
    1 interaction

    Caution Advised

    dexamethasone + mometasone nasal

    caution advised: combo may incr. risk of systemic corticosteroid effects including Cushing syndrome and adrenal suppression, serious infection, other adverse effects (additive effects, duplicate therapy)

  • mosunetuzumab
  • dexamethasone sodium phosphate (generic)
    +
    mosunetuzumab
    1 interaction

    Caution Advised

    dexamethasone + mosunetuzumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • moxifloxacin
  • dexamethasone sodium phosphate (generic)
    +
    moxifloxacin
    1 interaction

    Caution Advised

    dexamethasone + moxifloxacin

    caution advised: combo may incr. risk of tendon rupture (mechanism unknown)

  • nadofaragene firadenovec intravesical
  • dexamethasone sodium phosphate (generic)
    +
    nadofaragene firadenovec intravesical
    1 interaction

    Caution Advised

    dexamethasone + nadofaragene firadenovec intravesical

    caution advised: combo may incr. risk of disseminated adenovirus infection (immunosuppressive effects)

  • nafarelin nasal
  • dexamethasone sodium phosphate (generic)
    +
    nafarelin nasal
    1 interaction

    Caution Advised

    dexamethasone + nafarelin nasal

    caution advised: combo may incr. risk of bone loss (additive effects)

  • nafcillin
  • dexamethasone sodium phosphate (generic)
    +
    nafcillin
    1 interaction

    Caution Advised

    dexamethasone + nafcillin

    caution advised: combo may decr. dexamethasone levels, efficacy (hepatic metabolism induced)

  • naldemedine
  • dexamethasone sodium phosphate (generic)
    +
    naldemedine
    1 interaction

    Caution Advised

    dexamethasone + naldemedine

    caution advised: combo may decr. naldemedine levels, efficacy (hepatic metabolism induced)

  • naloxegol
  • dexamethasone sodium phosphate (generic)
    +
    naloxegol
    1 interaction

    Caution Advised

    dexamethasone + naloxegol

    caution advised: combo may decr. naloxegol levels, efficacy (hepatic metabolism induced)

  • narsoplimab
  • dexamethasone sodium phosphate (generic)
    +
    narsoplimab
    1 interaction

    Caution Advised

    dexamethasone + narsoplimab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • nelarabine
  • dexamethasone sodium phosphate (generic)
    +
    nelarabine
    1 interaction

    Caution Advised

    dexamethasone + nelarabine

    caution advised: combo may incr. risk of serious infection (additive effects)

  • neratinib
  • dexamethasone sodium phosphate (generic)
    +
    neratinib
    1 interaction

    Caution Advised

    dexamethasone + neratinib

    caution advised: combo may decr. neratinib levels, efficacy (hepatic metabolism induced)

  • nipocalimab
  • dexamethasone sodium phosphate (generic)
    +
    nipocalimab
    1 interaction

    Caution Advised

    dexamethasone + nipocalimab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • nirmatrelvir
  • dexamethasone sodium phosphate (generic)
    +
    nirmatrelvir
    1 interaction

    Caution Advised

    dexamethasone + nirmatrelvir

    caution advised: combo may decr. nirmatrelvir levels, efficacy (hepatic metabolism induced)

  • nirogacestat
  • dexamethasone sodium phosphate (generic)
    +
    nirogacestat
    1 interaction

    Caution Advised

    dexamethasone + nirogacestat

    caution advised: combo may incr. dexamethasone levels, risk of systemic corticosteroid effects including Cushing syndrome and adrenal suppression, serious infection, other adverse effects; may decr. nirogacestat levels, efficacy (hepatic metabolism inhibited; hepatic metabolism induced)

  • ocrelizumab
  • dexamethasone sodium phosphate (generic)
    +
    ocrelizumab
    1 interaction

    Caution Advised

    dexamethasone + ocrelizumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • ofatumumab
  • dexamethasone sodium phosphate (generic)
    +
    ofatumumab
    1 interaction

    Caution Advised

    dexamethasone + ofatumumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • ofloxacin
  • dexamethasone sodium phosphate (generic)
    +
    ofloxacin
    1 interaction

    Caution Advised

    dexamethasone + ofloxacin

    caution advised: combo may incr. risk of tendon rupture (mechanism unknown)

  • olutasidenib
  • dexamethasone sodium phosphate (generic)
    +
    olutasidenib
    1 interaction

    Caution Advised

    dexamethasone + olutasidenib

    caution advised: combo may decr. olutasidenib levels, efficacy (hepatic metabolism induced)

  • oxaliplatin
  • dexamethasone sodium phosphate (generic)
    +
    oxaliplatin
    1 interaction

    Caution Advised

    dexamethasone + oxaliplatin

    caution advised: combo may incr. risk of serious infection (additive effects)

  • oxcarbazepine
  • dexamethasone sodium phosphate (generic)
    +
    oxcarbazepine
    1 interaction

    Caution Advised

    dexamethasone + oxcarbazepine

    caution advised if seizure disorder use: combo may alter seizure control (antagonistic effects, dexamethasone may decr. seizure threshold)

  • paclitaxel
  • dexamethasone sodium phosphate (generic)
    +
    paclitaxel
    1 interaction

    Caution Advised

    dexamethasone + paclitaxel

    caution advised: combo may incr. risk of serious infection (additive effects)

  • palbociclib
  • dexamethasone sodium phosphate (generic)
    +
    palbociclib
    1 interaction

    Caution Advised

    dexamethasone + palbociclib

    caution advised: combo may decr. palbociclib levels, efficacy (hepatic metabolism induced)

  • pegcetacoplan
  • dexamethasone sodium phosphate (generic)
    +
    pegcetacoplan
    1 interaction

    Caution Advised

    dexamethasone + pegcetacoplan

    caution advised: combo may incr. risk of serious infection (additive effects)

  • pemigatinib
  • dexamethasone sodium phosphate (generic)
    +
    pemigatinib
    1 interaction

    Caution Advised

    dexamethasone + pemigatinib

    caution advised: combo may decr. pemigatinib levels, efficacy (hepatic metabolism induced)

  • pentostatin
  • dexamethasone sodium phosphate (generic)
    +
    pentostatin
    1 interaction

    Caution Advised

    dexamethasone + pentostatin

    caution advised: combo may incr. risk of serious infection (additive effects)

  • perampanel
  • dexamethasone sodium phosphate (generic)
    +
    perampanel
    1 interaction

    Caution Advised

    dexamethasone + perampanel

    caution advised: combo may decr. perampanel levels, efficacy; may alter seizure control (hepatic metabolism induced; antagonistic effects, dexamethasone may decr. seizure threshold)

  • pimavanserin
  • dexamethasone sodium phosphate (generic)
    +
    pimavanserin
    1 interaction

    Caution Advised

    dexamethasone + pimavanserin

    caution advised: combo may decr. pimavanserin levels, efficacy (hepatic metabolism induced)

  • pirtobrutinib
  • dexamethasone sodium phosphate (generic)
    +
    pirtobrutinib
    1 interaction

    Caution Advised

    dexamethasone + pirtobrutinib

    caution advised: combo may decr. pirtobrutinib levels, efficacy; may incr. risk of serious infection (hepatic metabolism induced; additive effects)

  • polatuzumab vedotin
  • dexamethasone sodium phosphate (generic)
    +
    polatuzumab vedotin
    1 interaction

    Caution Advised

    dexamethasone + polatuzumab vedotin

    caution advised: combo may incr. risk of serious infection (additive effects)

  • pozelimab
  • dexamethasone sodium phosphate (generic)
    +
    pozelimab
    1 interaction

    Caution Advised

    dexamethasone + pozelimab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • praziquantel
  • dexamethasone sodium phosphate (generic)
    +
    praziquantel
    1 interaction

    Caution Advised

    dexamethasone + praziquantel

    caution advised: combo may decr. praziquantel levels, efficacy (hepatic metabolism induced)

  • prednisolone ophthalmic
  • dexamethasone sodium phosphate (generic)
    +
    prednisolone ophthalmic
    1 interaction

    Caution Advised

    dexamethasone + prednisolone ophthalmic

    caution advised: combo may incr. risk of systemic corticosteroid effects including Cushing syndrome and adrenal suppression, serious infection, other adverse effects (additive effects, duplicate therapy)

  • pregabalin
  • dexamethasone sodium phosphate (generic)
    +
    pregabalin
    1 interaction

    Caution Advised

    dexamethasone + pregabalin

    caution advised if seizure disorder use: combo may alter seizure control (antagonistic effects, dexamethasone may decr. seizure threshold)

  • pretomanid
  • dexamethasone sodium phosphate (generic)
    +
    pretomanid
    1 interaction

    Caution Advised

    dexamethasone + pretomanid

    caution advised: combo may decr. pretomanid levels, efficacy (hepatic metabolism induced)

  • procarbazine
  • dexamethasone sodium phosphate (generic)
    +
    procarbazine
    1 interaction

    Caution Advised

    dexamethasone + procarbazine

    caution advised: combo may incr. risk of serious infection (additive effects)

  • promethazine
  • dexamethasone sodium phosphate (generic)
    +
    promethazine
    1 interaction

    Caution Advised

    dexamethasone + promethazine

    caution advised: combo may incr. risk of seizures (additive effects)

  • quinine
  • dexamethasone sodium phosphate (generic)
    +
    quinine
    1 interaction

    Caution Advised

    dexamethasone + quinine

    caution advised: combo may decr. quinine levels, efficacy (hepatic metabolism induced)

  • quizartinib
  • dexamethasone sodium phosphate (generic)
    +
    quizartinib
    1 interaction

    Caution Advised

    dexamethasone + quizartinib

    caution advised: combo may decr. quizartinib levels, efficacy; may incr. risk of serious infection (hepatic metabolism induced; additive effects)

  • ravulizumab
  • dexamethasone sodium phosphate (generic)
    +
    ravulizumab
    1 interaction

    Caution Advised

    dexamethasone + ravulizumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • repotrectinib
  • dexamethasone sodium phosphate (generic)
    +
    repotrectinib
    1 interaction

    Caution Advised

    dexamethasone + repotrectinib

    caution advised: combo may decr. levels of both drugs, efficacy (hepatic metabolism induced)

  • rifapentine
  • dexamethasone sodium phosphate (generic)
    +
    rifapentine
    1 interaction

    Caution Advised

    dexamethasone + rifapentine

    caution advised: combo may decr. dexamethasone levels, efficacy (hepatic metabolism induced)

  • rilonacept
  • dexamethasone sodium phosphate (generic)
    +
    rilonacept
    1 interaction

    Caution Advised

    dexamethasone + rilonacept

    caution advised: combo may incr. risk of serious infection (additive effects)

  • rilzabrutinib
  • dexamethasone sodium phosphate (generic)
    +
    rilzabrutinib
    1 interaction

    Caution Advised

    dexamethasone + rilzabrutinib

    caution advised: combo may incr. dexamethasone levels, risk of systemic corticosteroid effects including Cushing syndrome and adrenal suppression, serious infection, other adverse effects (hepatic metabolism inhibited, additive effects)

  • risankizumab
  • dexamethasone sodium phosphate (generic)
    +
    risankizumab
    1 interaction

    Caution Advised

    dexamethasone + risankizumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • rituximab
  • dexamethasone sodium phosphate (generic)
    +
    rituximab
    1 interaction

    Caution Advised

    dexamethasone + rituximab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • roflumilast
  • dexamethasone sodium phosphate (generic)
    +
    roflumilast
    1 interaction

    Caution Advised

    dexamethasone + roflumilast

    caution advised: combo may decr. roflumilast levels, efficacy (hepatic metabolism induced)

  • romidepsin
  • dexamethasone sodium phosphate (generic)
    +
    romidepsin
    1 interaction

    Caution Advised

    dexamethasone + romidepsin

    caution advised: combo may incr. risk of serious infection (additive effects)

  • ropeginterferon alfa-2b
  • dexamethasone sodium phosphate (generic)
    +
    ropeginterferon alfa-2b
    1 interaction

    Caution Advised

    dexamethasone + ropeginterferon alfa-2b

    caution advised: combo may incr. risk of serious infection (additive effects)

  • rozanolixizumab
  • dexamethasone sodium phosphate (generic)
    +
    rozanolixizumab
    1 interaction

    Caution Advised

    dexamethasone + rozanolixizumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • rufinamide
  • dexamethasone sodium phosphate (generic)
    +
    rufinamide
    1 interaction

    Caution Advised

    dexamethasone + rufinamide

    caution advised: combo may alter seizure control (antagonistic effects, dexamethasone may decr. seizure threshold)

  • samidorphan
  • dexamethasone sodium phosphate (generic)
    +
    samidorphan
    1 interaction

    Caution Advised

    dexamethasone + samidorphan

    caution advised: combo may decr. samidorphan levels, efficacy (hepatic metabolism induced)

  • sarilumab
  • dexamethasone sodium phosphate (generic)
    +
    sarilumab
    1 interaction

    Caution Advised

    dexamethasone + sarilumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • satralizumab
  • dexamethasone sodium phosphate (generic)
    +
    satralizumab
    1 interaction

    Caution Advised

    dexamethasone + satralizumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • sebetralstat
  • dexamethasone sodium phosphate (generic)
    +
    sebetralstat
    1 interaction

    Caution Advised

    dexamethasone + sebetralstat

    caution advised: combo may decr. sebetralstat levels, efficacy (hepatic metabolism induced)

  • secukinumab
  • dexamethasone sodium phosphate (generic)
    +
    secukinumab
    1 interaction

    Caution Advised

    dexamethasone + secukinumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • selumetinib
  • dexamethasone sodium phosphate (generic)
    +
    selumetinib
    1 interaction

    Caution Advised

    dexamethasone + selumetinib

    caution advised: combo may decr. selumetinib levels, efficacy (hepatic metabolism induced)

  • sibeprenlimab
  • dexamethasone sodium phosphate (generic)
    +
    sibeprenlimab
    1 interaction

    Caution Advised

    dexamethasone + sibeprenlimab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • siltuximab
  • dexamethasone sodium phosphate (generic)
    +
    siltuximab
    1 interaction

    Caution Advised

    dexamethasone + siltuximab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • simvastatin
  • dexamethasone sodium phosphate (generic)
    +
    simvastatin
    1 interaction

    Caution Advised

    dexamethasone + simvastatin

    caution advised: combo may decr. simvastatin levels, efficacy (hepatic metabolism induced)

  • sodium picosulfate
  • dexamethasone sodium phosphate (generic)
    +
    sodium picosulfate
    1 interaction

    Caution Advised

    dexamethasone + sodium picosulfate

    caution advised: combo may incr. risk of seizures (additive effects)

  • sonidegib
  • dexamethasone sodium phosphate (generic)
    +
    sonidegib
    1 interaction

    Caution Advised

    dexamethasone + sonidegib

    caution advised: combo may decr. sonidegib levels, efficacy (hepatic metabolism induced)

  • sotorasib
  • dexamethasone sodium phosphate (generic)
    +
    sotorasib
    1 interaction

    Caution Advised

    dexamethasone + sotorasib

    caution advised: combo may decr. dexamethasone levels, efficacy (hepatic metabolism induced)

  • spesolimab
  • dexamethasone sodium phosphate (generic)
    +
    spesolimab
    1 interaction

    Caution Advised

    dexamethasone + spesolimab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • stiripentol
  • dexamethasone sodium phosphate (generic)
    +
    stiripentol
    1 interaction

    Caution Advised

    dexamethasone + stiripentol

    caution advised: combo may alter seizure control (antagonistic effects, dexamethasone may decr. seizure threshold)

  • sulfasalazine
  • dexamethasone sodium phosphate (generic)
    +
    sulfasalazine
    1 interaction

    Caution Advised

    dexamethasone + sulfasalazine

    caution advised: combo may incr. risk of serious infection (additive effects)

  • sutimlimab
  • dexamethasone sodium phosphate (generic)
    +
    sutimlimab
    1 interaction

    Caution Advised

    dexamethasone + sutimlimab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • suzetrigine
  • dexamethasone sodium phosphate (generic)
    +
    suzetrigine
    1 interaction

    Caution Advised

    dexamethasone + suzetrigine

    caution advised: combo may decr. suzetrigine and active metabolite levels, efficacy (hepatic metabolism induced)

  • tadalafil
  • dexamethasone sodium phosphate (generic)
    +
    tadalafil
    1 interaction

    Caution Advised

    dexamethasone + tadalafil

    caution advised: combo may decr. tadalafil levels, efficacy (hepatic metabolism induced)

  • taletrectinib
  • dexamethasone sodium phosphate (generic)
    +
    taletrectinib
    1 interaction

    Caution Advised

    dexamethasone + taletrectinib

    caution advised: combo may decr. taletrectinib levels, efficacy (hepatic metabolism induced)

  • talquetamab
  • dexamethasone sodium phosphate (generic)
    +
    talquetamab
    1 interaction

    Caution Advised

    dexamethasone + talquetamab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • tarlatamab
  • dexamethasone sodium phosphate (generic)
    +
    tarlatamab
    1 interaction

    Caution Advised

    dexamethasone + tarlatamab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • tasimelteon
  • dexamethasone sodium phosphate (generic)
    +
    tasimelteon
    1 interaction

    Caution Advised

    dexamethasone + tasimelteon

    caution advised: combo may decr. tasimelteon levels, efficacy (hepatic metabolism induced)

  • tazemetostat
  • dexamethasone sodium phosphate (generic)
    +
    tazemetostat
    1 interaction

    Caution Advised

    dexamethasone + tazemetostat

    caution advised: combo may decr. tazemetostat levels, efficacy (hepatic metabolism induced)

  • teclistamab
  • dexamethasone sodium phosphate (generic)
    +
    teclistamab
    1 interaction

    Caution Advised

    dexamethasone + teclistamab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • temozolomide
  • dexamethasone sodium phosphate (generic)
    +
    temozolomide
    1 interaction

    Caution Advised

    dexamethasone + temozolomide

    caution advised: combo may incr. risk of serious infection (additive effects)

  • teplizumab
  • dexamethasone sodium phosphate (generic)
    +
    teplizumab
    1 interaction

    Caution Advised

    dexamethasone + teplizumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • teriparatide
  • dexamethasone sodium phosphate (generic)
    +
    teriparatide
    1 interaction

    Caution Advised

    dexamethasone + teriparatide

    caution advised: combo may incr. risk of calciphylaxis (additive effects)

  • tezacaftor/ivacaftor
  • dexamethasone sodium phosphate (generic)
    +
    tezacaftor/ ivacaftor
    1 interaction

    Caution Advised

    dexamethasone + tezacaftor/ ivacaftor

    caution advised: combo may decr. tezacaftor/ivacaftor levels, efficacy (hepatic metabolism induced)

  • tezepelumab
  • dexamethasone sodium phosphate (generic)
    +
    tezepelumab
    1 interaction

    Caution Advised

    dexamethasone + tezepelumab

    caution advised w/ high-dose systemic corticosteroid use: combo may incr. risk of serious infection (possible additive effects)

  • thioguanine
  • dexamethasone sodium phosphate (generic)
    +
    thioguanine
    1 interaction

    Caution Advised

    dexamethasone + thioguanine

    caution advised: combo may incr. risk of serious infection (additive effects)

  • thiotepa
  • dexamethasone sodium phosphate (generic)
    +
    thiotepa
    1 interaction

    Caution Advised

    dexamethasone + thiotepa

    caution advised: combo may incr. risk of serious infection (additive effects)

  • ticagrelor
  • dexamethasone sodium phosphate (generic)
    +
    ticagrelor
    1 interaction

    Caution Advised

    dexamethasone + ticagrelor

    caution advised: combo may decr. ticagrelor levels, efficacy (hepatic metabolism induced)

  • tildrakizumab
  • dexamethasone sodium phosphate (generic)
    +
    tildrakizumab
    1 interaction

    Caution Advised

    dexamethasone + tildrakizumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • tolvaptan
  • dexamethasone sodium phosphate (generic)
    +
    tolvaptan
    1 interaction

    Caution Advised

    dexamethasone + tolvaptan

    caution advised: combo may decr. tolvaptan levels, efficacy (hepatic metabolism induced)

  • topotecan
  • dexamethasone sodium phosphate (generic)
    +
    topotecan
    1 interaction

    Caution Advised

    dexamethasone + topotecan

    caution advised: combo may incr. risk of serious infection (additive effects)

  • trabectedin
  • dexamethasone sodium phosphate (generic)
    +
    trabectedin
    1 interaction

    Caution Advised

    dexamethasone + trabectedin

    caution advised: combo may incr. risk of serious infection (additive effects)

  • tralokinumab
  • dexamethasone sodium phosphate (generic)
    +
    tralokinumab
    1 interaction

    Caution Advised

    dexamethasone + tralokinumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • treosulfan
  • dexamethasone sodium phosphate (generic)
    +
    treosulfan
    1 interaction

    Caution Advised

    dexamethasone + treosulfan

    caution advised: combo may incr. risk of seizures (additive effects)

  • tuberculin purified protein derivative
  • dexamethasone sodium phosphate (generic)
    +
    tuberculin purified protein derivative
    1 interaction

    Caution Advised

    dexamethasone + tuberculin purified protein derivative

    caution advised during and x5-6wk after dexamethasone tx: combo may interfere with test results (antagonistic effects)

  • ublituximab
  • dexamethasone sodium phosphate (generic)
    +
    ublituximab
    1 interaction

    Caution Advised

    dexamethasone + ublituximab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • ustekinumab
  • dexamethasone sodium phosphate (generic)
    +
    ustekinumab
    1 interaction

    Caution Advised

    dexamethasone + ustekinumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • valproic acid
  • dexamethasone sodium phosphate (generic)
    +
    valproic acid
    1 interaction

    Caution Advised

    dexamethasone + valproic acid

    caution advised if seizure disorder use: combo may alter seizure control (antagonistic effects, dexamethasone may decr. seizure threshold)

  • vanzacaftor/tezacaftor/deutivacaftor
  • dexamethasone sodium phosphate (generic)
    +
    vanzacaftor/ tezacaftor/ deutivacaftor
    1 interaction

    Caution Advised

    dexamethasone + vanzacaftor/ tezacaftor/ deutivacaftor

    caution advised: combo may decr. vanzacaftor/tezacaftor/deutivacaftor levels, efficacy (hepatic metabolism induced)

  • vedolizumab
  • dexamethasone sodium phosphate (generic)
    +
    vedolizumab
    1 interaction

    Caution Advised

    dexamethasone + vedolizumab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • velpatasvir
  • dexamethasone sodium phosphate (generic)
    +
    velpatasvir
    1 interaction

    Caution Advised

    dexamethasone + velpatasvir

    caution advised: combo may decr. velpatasvir levels, efficacy (hepatic metabolism induced)

  • venetoclax
  • dexamethasone sodium phosphate (generic)
    +
    venetoclax
    1 interaction

    Caution Advised

    dexamethasone + venetoclax

    caution advised: combo may decr. venetoclax levels, efficacy; may incr. risk of serious infection (hepatic metabolism induced; additive effects)

  • vigabatrin
  • dexamethasone sodium phosphate (generic)
    +
    vigabatrin
    1 interaction

    Caution Advised

    dexamethasone + vigabatrin

    caution advised: combo may alter seizure control (antagonistic effects, dexamethasone may decr. seizure threshold)

  • vilobelimab
  • dexamethasone sodium phosphate (generic)
    +
    vilobelimab
    1 interaction

    Caution Advised

    dexamethasone + vilobelimab

    caution advised: combo may incr. risk of serious infection (additive effects)

  • vinblastine
  • dexamethasone sodium phosphate (generic)
    +
    vinblastine
    1 interaction

    Caution Advised

    dexamethasone + vinblastine

    caution advised: combo may incr. risk of serious infection (additive effects)

  • vincristine
  • dexamethasone sodium phosphate (generic)
    +
    vincristine
    1 interaction

    Caution Advised

    dexamethasone + vincristine

    caution advised: combo may incr. risk of serious infection (additive effects)

  • vinorelbine
  • dexamethasone sodium phosphate (generic)
    +
    vinorelbine
    1 interaction

    Caution Advised

    dexamethasone + vinorelbine

    caution advised: combo may incr. risk of serious infection (additive effects)

  • vonoprazan
  • dexamethasone sodium phosphate (generic)
    +
    vonoprazan
    1 interaction

    Caution Advised

    dexamethasone + vonoprazan

    caution advised: combo may decr. vonoprazan levels, efficacy (hepatic metabolism induced)

  • voxilaprevir
  • dexamethasone sodium phosphate (generic)
    +
    voxilaprevir
    1 interaction

    Caution Advised

    dexamethasone + voxilaprevir

    caution advised: combo may decr. voxilaprevir levels, efficacy (hepatic metabolism induced)

  • zanubrutinib
  • dexamethasone sodium phosphate (generic)
    +
    zanubrutinib
    1 interaction

    Caution Advised

    dexamethasone + zanubrutinib

    caution advised: combo may decr. zanubrutinib levels, efficacy; may incr. risk of serious infection (hepatic metabolism induced; additive effects)

  • ziftomenib
  • dexamethasone sodium phosphate (generic)
    +
    ziftomenib
    1 interaction

    Caution Advised

    dexamethasone + ziftomenib

    caution advised: combo may decr. ziftomenib levels, efficacy (hepatic metabolism induced)

  • zilucoplan
  • dexamethasone sodium phosphate (generic)
    +
    zilucoplan
    1 interaction

    Caution Advised

    dexamethasone + zilucoplan

    caution advised: combo may incr. risk of serious infection (additive effects)

Adverse Reactions .

Serious Reactions

    com.epocrates.rxweb.beans.StringCollection@5b7679
  • anaphylaxis
  • adrenal insufficiency
  • steroid psychosis
  • steroid myopathy
  • Cushing syndrome
  • infection
  • diabetes mellitus
  • pseudotumor cerebri
  • ICP incr.
  • seizures
  • tumor lysis syndrome
  • hypokalemic alkalosis
  • HTN
  • CHF
  • pancreatitis
  • GI perforation
  • PUD
  • exophthalmos
  • osteonecrosis
  • tendon rupture
  • osteoporosis (long-term use)
  • glaucoma (long-term use)
  • cataracts (long-term use)
  • immunosuppression (long-term use)
  • Kaposi sarcoma (long-term use)
  • withdrawal symptoms if abrupt D/C (high-dose or long-term use)
  • growth suppression (long-term use in peds patients)

Common Reactions

    com.epocrates.rxweb.beans.StringCollection@215e57fa
  • Cushingoid appearance
  • hirsutism
  • weight gain
  • erythema
  • abdominal discomfort
  • appetite changes
  • emotional lability
  • urticaria
  • rash
  • nausea
  • vomiting
  • sodium retention
  • fluid retention
  • hypokalemia
  • BP elevated
  • edema
  • diaphoresis
  • muscle atrophy
  • impaired wound healing (long-term use)
  • skin atrophy (long-term use)
  • petechiae
  • ecchymosis
  • skin pigmentation abnormality
  • acne
  • headache
  • dizziness
  • vertigo
  • insomnia
  • depression
  • anxiety
  • glucose intolerance
  • Cushing syndrome (long-term use)
  • menstrual irregularities
  • IOP incr.
  • post-injection flare (intra-articular use)

Safety/Monitoring .

Monitoring Parameters
electrolytes; BP; weight; TB, HBV screening at baseline if prolonged tx; 2h postprandial glucose, height (peds), chest x-ray if prolonged tx; ophthalmic exam if tx >6wk; BMD if prolonged tx or in patients 65 yo and older; consider upper GI x-ray if PUD history or significant dyspepsia

Look/Sound-Alike Drug Names
dexamethasone confused with: betamethasone; dexmedetomidine; doxazosin; methadone; methylPREDNISolone

Pregnancy/Lactation .

Pregnancy

Clinical Summary

Fetal Lung Maturation Use: may use during pregnancy; possible risk of orofacial cleft based on conflicting human data and animal data; possible risk of low birth wt and preterm birth based on limited human data; possible risk of fetal adrenal suppression based on drug's mechanism of action

All Other Uses: weigh risk/benefit during pregnancy, especially in 1st trimester or with long-term use; possible risk of orofacial cleft based on conflicting human data and animal data; possible risk of low birth wt and preterm birth based on limited human data; possible risk of fetal adrenal suppression based on drug's mechanism of action

Lactation

Clinical Summary

weigh risk/benefit while breastfeeding; no human data available, though possible risk of suppressed infant growth and endogenous steroid production based on drug's mechanism of action; no human data available, though possible transient decr. milk production based on limited human data with high-dose depot steroid injection

Pharmacology .

com.epocrates.rxweb.beans.DrugOtherInfoBean@2c797eb8

Metabolism: for dexamethasone: liver; CYP450: 3A4 substrate

Excretion: for dexamethasone: urine primarily; Half-life: 1.9-2.3h

Subclass: Antiemetics, Corticosteroids ; Corticosteroids, Localized ; Corticosteroids, Systemic ; Osteoarthritis, Local Agents

Mechanism of Action
for dexamethasone: exact mechanism of anti-inflammatory action unknown; inhibits multiple inflammatory cytokines; produces multiple glucocorticoid and mineralocorticoid effects

Formulary .

No Formulary Selected

Manufacturer/Pricing .

Manufacturer: generic

com.epocrates.rxweb.beans.DrugOtherInfoBean@28fd26a2

DEA/FDA: Rx

Retail Price

Estimated prices only. For current pricing, visit GoodRx.

injectable solution:

  • 10 mg/mL (1 vial, 10 mL): $10.00

injectable solution:

  • 4 mg/mL (1 vial, 1 mL): $5.00
  • 10 mg/mL (1 vial, 1 mL): $5.00

injectable solution:

  • 4 mg/mL (6 vial, 5 mL): $12.00

injectable solution:

  • 4 mg/mL (1 vial, 30 mL): $12.00

Join Now to View Patient Handouts!

Create a FREE epocrates Online account to access patient medication instructions. Your patients and caregivers will appreciate you printing these friendly handouts, available in English and Spanish. Each handout addresses common concerns such as how to take the medication, and possible side effects.

Current Members: Sign In.

Sign Up Now - It's Free >>

Pill Pictures

Join Now to View Pill Pictures!

Create a FREE epocrates Online account to access full-color images of medications within the drug monograph.

Current Members: Sign In.

Sign Up Now - It's Free >>

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information